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 For decades, synthetic organic chemists have constructed organic molecules by 
manipulating functionality already existing on the scaffold. Simple chemical feedstocks, 
typically derived from petroleum, are pre-installed with oxidized moieties, which can then 
undergo a series of transformations known as functional group manipulations to build up 
molecular complexity. Recently, a different approach has emerged wherein inert and ubiquitous 
C—H bonds in organic molecules can be specifically targeted for chemical transformations, 
obviating the need for preexisting functional groups.  However, this approach confronts organic 
chemists with an inherent and paradoxical challenge of developing reagents and catalysts that are 
reactive enough to cleave these strong and inert C—H bonds, while still being able to 
functionalize in a selective and predictable manner. 
Nature has evolved powerful metalloenzymes based on earth abundant base metals like 
iron that are capable of selectively cleaving and functionalizing C—H bonds. Cytochrome P450 
enzymes contain an iron-heme center that reacts with oxygen and water to form high-valent iron-
oxo intermediates. These species can directly and selectively convert C—H bonds into C—O 
bonds, even in complex molecule settings. However, the analogous transformation of C—H 
bonds to C—N and C—C bonds via metallonitrenes and metallocarbenes is not known in nature. 
The majority of synthetic, small molecule catalysts thus far developed for these C—H 
functionalization processes have been comprised of precious or noble metals like palladium, 
rhodium, ruthenium, and iridium. This work describes the discovery and development of two 
novel base metal catalysts for C—H amination and alkylation that proceed through high-valent 
metallonitrene and carbene intermediates. 
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First, a C—H amination catalyst, manganese tert-butylphthalocyanine [Mn(tBuPc)], is 
described. This catalyst is an outlier to the reactivity-selectivity paradigm, i.e. is capable of 
oxidizing strong aliphatic C(sp3)—H bonds while displaying chemoselectivity (i.e. tolerance of 
more oxidizable functionality). It is unique in its capacity to functionalize all types of C(sp3)—H 
bonds intramolecularly, while displaying excellent chemoselectivity in the presence of π-
functionality. Mechanistic studies indicate that [Mn(tBuPc)] transfers bound nitrenes to C(sp3)—
H bonds via a pathway that lies between concerted C—H insertion, observed with reactive noble 
metals (e.g. rhodium), and stepwise radical C—H abstraction/rebound, observed with 
chemoselective base metals (e.g. iron). Rather than achieving a blending of effects, [Mn(tBuPc)] 
aminates even 1° aliphatic and propargylic C—H bonds, reactivity and selectivity unusual for 
previously  known catalysts. 
Second, a C—H alkylation catalyst, iron phthalocyanine [FePc], is described that is 
capable of alkylating allylic, benzylic and ethereal C(sp3)—H bonds via a metallocarbene 
intermediate. The catalytic transformation of a C(sp3)—H bond to a C(sp3)—C bond via an iron 
carbene intermediate represents a long-standing challenge. Despite the success of enzymatic and 
small molecule iron catalysts to mediate challenging C(sp3)—H oxidations and aminations via 
high-valent iron oxos and nitrenes, C(sp3)—H alkylations via isoelectronic iron carbene 
intermediates have thus far been unsuccessful. Iron carbenes have been inert, or shown to favor 
olefin cyclopropanation and heteroatom-hydrogen insertion. Mechanistic investigations support 
that an electrophilic iron carbene mediates homolytic C—H cleavage and rebounds from the 
resulting organoiron intermediate to form the new C—C bond; both of these steps are tunable via 
catalyst modifications. These studies suggest that for iron carbenes, distinct from other late metal 
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CHAPTER 1: A MANGANESE CATALYST FOR HIGHLY REACTIVE YET 
CHEMOSELECTIVE INTRAMOLECULAR C(sp3)—H AMINATION 
 
Acknowledgements 
This chapter has been adapted from the research article “A manganese catalyst for highly 
reactive yet chemoselective intramolecular C(sp3)—H amination” (Paradine, S. M.; Griffin, J. 
R.; Zhao, J.; Petronico, A. L.; Miller, S. M.; White, M.C. Nature Chem. 2015, 7, 987-994). 
 This work was done in collaboration with my fellow authors. The scope of aliphatic and 
benzylic C—H bonds was established by Dr. Shauna Paradine, Jinpeng Zhao, Aaron Petronico, 
and Shannon Miller and will not be described in this thesis. 
1.1 Introduction 
High-valent metal heteroatom species (i.e. oxos and nitrenes) oxidize inert C—H bonds 
with tunable site-selectivity and stereospecificity, but typically do not tolerate more readily 
oxidizable π-functionality1-6. Intramolecular metallonitrene-based C(sp3)—H amination of 
sulfamate esters, which installs medicinally important amino alcohol motifs, showcases the 
inverse correlation between reactivity and chemoselectivity for such catalysis7-10. Noble metal 
rhodium catalysts that stereospecifically functionalize robust aliphatic C—H bonds (secondary, 2° 
and tertiary, 3°) lack chemoselectivity due to competitive oxidation of π-bonds (Fig. 1)1, 7-10.  
Conversely, base metal iron catalysts that chemoselectively aminate allylic C—H bonds over 
competing aziridination are only moderately reactive toward stronger aliphatic C—H bonds (Fig. 
1)11-15. Herein we describe the discovery of an outlier catalyst, manganese tert-
butylphthalocyanine [Mn(tBuPc)] (3), that is the first to achieve both high reactivity and 
chemoselectivity for a C—H oxidation reaction (Fig. 2).  
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Figure 1 Reactivity versus chemoselectivity in intramolecular C—H amination 
 
Catalyst [Mn(tBuPc)] preparatively aminates all C(sp3)—H bond types encompassed by 
rhodium and maintains the high chemoselectivity for allylic C—H amination observed with iron, 
all while demonstrating stereospecificity, site-selectivity, and high functional group tolerance 
(Fig. 2). Additionally, [Mn(tBuPc)] aminates primary (1°) aliphatic and propargylic C—H bonds, 
reactivity and selectivity that is typically difficult to achieve with metallonitrene-based catalysis.  
Figure 2 A highly reactive yet chemoselective catalyst for C—H amination 
 
The unique generality of [Mn(tBuPc)] can be partially attributed to its mechanistically 
distinct pathway for nitrene transfer that lies between the stepwise mechanism of iron and the 
concerted mechanism of rhodium. Discovery of an Earth-abundant base metal catalyst that is 
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precious noble metals, underscores the potential benefits in the continued development of these 
inexpensive, underexplored metals as catalysts for important synthetic reactions5, 6, 11-14, 16-19.  
1.2 Results and Discussion 
1.2.1 Reaction Development and Optimization 
Noble metal rhodium catalysts functionalize strong aliphatic C—H bonds via a concerted 
asynchronous C—H insertion mechanism1. Conversely, base metal iron catalysts access 
mechanistically distinct single electron pathways for nitrene transfer, affording excellent 
chemoselectivity with diminished reactivity for stronger C—H bond types11-14. We hypothesized 
that a metal catalyst capable of transferring bound nitrenes to C(sp3)—H bonds via a stepwise 
mechanism with attenuated radical character of the metallonitrene oxidant relative to iron would 
achieve higher reactivity while maintaining chemoselectivity20. Low reactivity observed under 
iron catalysis with aliphatic C(sp3)—H bonds coupled with reports that sulfamate ester N-
centered free radicals are unreactive towards intramolecular aminations of 3° C(sp3)—H bonds21 
suggested to us that a metallonitrene with diminished radical character would be more reactive.  
Figure 3 Divergent mechanisms for stepwise and concerted C—H amination processes 
 
Although nature rarely uses manganese metal species to mediate oxidations, early studies 
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and iron oxos react via mechanistically analogous one electron pathways, with manganese 
exhibiting significantly higher C—H hydroxylation reactivity22. Importantly, the manganese 
catalysts were found to have smaller kinetic isotope effects (KIE) than their iron counterparts, 
suggestive of attenuated radical behavior23. Moreover, well-characterized nitridomanganese(V) 
porphyrin complexes have been shown to stoichiometrically transfer nitrenes when the nitrogen 
is rendered electron deficient, much like with iron24-26.  
Figure 4 Hypothesis for more reactive catalyst (A) Catalyst with nitrene character in between iron and rhodium (B) 
C—H hydroxylation studies comparing iron and manganese porphyrins 
 
We first compared a series of manganese complexes to their iron counterparts for the C—
H amination of challenging 3° aliphatic substrate 1 (bond dissociation energy (BDE) ~96 
kcal/mol) (Table 1)27. Improved yields of aminated product 2 were observed with the manganese 
complexes across all ligand classes (Table 1, entries 1-6). The previously reported 
phthalocyanine ligand was the most effective11, and so catalyst [MnPc] was employed for further 
optimization. Notably, both iron and manganese porphyrin catalysts, among the first catalysts 
shown to be competent for metallonitrene based C—H amination28, exhibited significantly lower 
reactivity with this challenging substrate (entries 3 and 4). The enhanced reactivity for an 
electrophilic C—H amination reaction may be attributed to an electronic difference between 
Reactivity Chemoselectivity
[FePc]Cl[Ru2(hp)4]ClRh2(OAc)4Rh2(esp)2
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these ligands, as evidence suggests that phthalocyanines are significantly better π-acceptor 
ligands and may lead to enhanced electrophilicity at the metal center29,30. Addition of molecular 
sieves significantly improved reactivity with both 10 mol% and 5 mol% [MnPc], affording 60% 
and 58% of 2, respectively (entries 7, 8). [Mn(tBuPc)], in which tert-butyl groups were 
introduced into the periphery of the phthalocyanine ligand, further improved the yield to 76% 
(entry 9). The enhanced productivity of [Mn(tBuPc)] enables the catalyst loading to be reduced 
to 5 mol% (72%, entry 10). 
Table 1 Reaction discovery and development 
 
This new catalytic method was next examined across all other major sp3 C—H bond 
types (benzylic, allylic, 2° and 1° aliphatic) using unsubstituted linear sulfamate esters, among 
the most difficult substrate classes for intramolecular C—H amination (Table 2). In all cases, a 
entry              catalyst                                         additive        % yield (% rsm)
   1          [FePc]Cl + AgSbF6                                       -                     29 (32)
   2          [MnPc]Cl + AgSbF6                                                  -                     43 (27)   
   3        Fe(TPP)Cl + AgSbF6                                                  -                       4 (85)
   4        Mn(TPP)Cl + AgSbF6                                            -                     17 (55)
   5         Fe(R,R-PDP)(SbF6)2                                     -                      <1 (91)
   6         Mn(R,R-PDP)(SbF6)2                                    -                        7 (82)
   7          [MnPc]Cl + AgSbF6                          4Å MS, crushed         60 (11) 
   8         [MnPc]Cl (5 mol%) + AgSbF6            4Å MS, crushed         58 (20)
   9     [Mn(tBuPc)]Cl + AgSbF6                       4Å MS, crushed         76 (<5)
  10     [Mn(tBuPc)]Cl  (5 mol%) + AgSbF6      4Å MS, crushed         72 (11)
OSO2NH2
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significant improvement in yield was observed in switching from the iron to the manganese 
catalyst, with the benzylic and allylic substrates affording synthetically useful yields of aminated 
products 3 and 4. [Mn(tBuPc)] exhibited good reactivity across all bond types with 2° (5, BDE ~ 
98 kcal/mol) and even 1° (6, BDE ~ 101 kcal/mol) 27 C—H bonds being readily intramolecularly 
aminated. Significantly, 1° C—H bonds are at the lowest end of the reactivity spectrum under 
rhodium catalysis and amination of this bond type is rare (vide infra)31. Moreover, despite the 
high intramolecular reactivity of 4, excellent chemoselectivity (>20:1 ins./azir.) was maintained 
for allylic C—H amination, as compared to 1:1 ins./azir. observed for rhodium catalyst 
[Rh2(esp)2]31. 
Table 2 Comparison of catalysts across C—H bond types 
 
1.2.2 Allylic, Propargylic, and Ethereal C—H Bond Scope 
[Mn(tBuPc)] successfully aminates at the allylic position in a variety of molecules, in all 
cases maintaining the excellent chemoselectivity previously observed with [FeIIIPc] for olefin-
containing substrates (Fig. 5)11. For example, with a challenging linear terminal olefin substrate, 
[Mn(tBuPc)] affords C—H amination product 7 in 50% yield and in 7:1 excess over the aziridine. 
[FePc] exhibits similarly high chemoselectivity (7:1 ins./azir.) but poor reactivity (22%), whereas 
a noble metal ruthenium catalyst [Ru2(hp)4] designed to be highly chemoselective is less 
R
OSO2NH2H
catalyst · AgSbF6 (5 mol%)
PhI(OPiv)2 (2 equiv)
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selective for insertion (2:1 ins./azir.)15 and Rh2(esp)2 favors π-functionalization (1:1.5 ins./azir.)31. 
Additionally, [Mn(tBuPc)] exhibits diminished sensitivity to electronics relative to its iron 
predecessor with weaker C(sp3)—H bond types. [Mn(tBuPc)] readily functionalizes C—H bonds 
proximal to an α,β-unsaturated ester (8, 77%), while other chemoselective catalysts [FePc] and 
[Ru2(hp)4] are less reactive (12% and 25%, respectively)11,15. This electronic insensitivity is 
further highlighted by the tolerance of electron-withdrawing nitrogen functionality (9, 73%) 
introduced via palladium-catalyzed intermolecular allylic C—H amination32. A cyclohexene 
derivative readily cyclizes to form bicycle 10 in 69% yield with excellent diastereoselectivity  
Figure 5 Scope of allylic, propargylic, and ethereal substrates
 
(>20:1 anti/syn). The high chemoselectivity for allylic C—H amination over aziridination with 
[Mn(tBuPc)] is maintained even in cases where aziridination is geometrically accessible. 
Homoallylic sulfamate derivative of terpene (-)-nopol undergoes facile allylic C—H amination 
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observed aziridine. This bias of [Mn(tBuPc)] toward allylic C—H amination versus aziridination 
persists even in an acyclic styrenyl homoallylic sulfamate ester substrate (12, 62%, 7:1 ins./azir.). 
In contrast, both reactivity and chemoselectivity are lower with typically chemoselective chiral 
rhodium catalysts ([Rh2(S-nap)4], 48%, 2:1 ins./azir.), and formation of the aziridine product is 
strongly favored (1:20 ins./azir.) with standard Rh2(OAc)4.1,33 
Although chemoselective propargylic C—H amination with carbamates to furnish 1,2-
amino alcohols is precedented34, amination using sulfamate esters to afford the 1,3-amino 
alcohol motif is challenging as the alkyne typically undergoes alternate oxidation pathways35. 
Instead, two-step sequences have been developed that involve amination of activated ethereal 
C—H bonds to furnish N,O-acetals followed by Lewis acid-promoted alkylations to generate 
propargylic amines1. Further underscoring the high chemoselectivity achieved with manganese 
catalysis, a TMS-protected terminal alkyne sulfamate ester readily undergoes propargylic C—H 
amination (13, 64%). α-Substituted alkyne 14 functionalizes in moderate yields and serves as a 
viable intermediate for a streamlined synthesis of saxitoxin36. Alternatively, ethereal C—H 
amination can be performed in good yield and diastereoselectivity (64%; >20:1 d.r.) with 
[Mn(tBuPc)] to furnish the sensitive oxathiazinane N,O-acetal 15, a known precursor to alkyne 
14.  
The reactivity, site- and chemoselectivity trends observed with [Mn(tBuPc)] on relatively 
simple molecules are maintained in more topologically and functionally complex natural product 
settings (Fig. 6). Allylic C—H amination of sulfamate ester derived steroids stigmasterol and 
pregnenolone furnished five-membered heterocycles 16 and 17 in 55% and 66% yields, 
respectively, as single diastereomers.  
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Figure 6 Examples of C—H amination in complex molecules 
 
1.2.3 Mechanistic Studies 
We sought to investigate our hypothesis that the unique generality of catalyst 
[Mn(tBuPc)] can be attributed to the attenuated radical character of the manganese 
metallonitrene oxidant relative to iron (Fig. 7).  
Figure 7 Mechanistic hypothesis for manganese-catalyzed C—H amination 
 
Intramolecular competition experiments were conducted to probe the C—H amination 
steps of the catalytic cycle independently from the reaction kinetics (Fig. 8). The electronic 
nature of the transition state for C—H cleavage was assessed by way of Hammett analysis with a 
series of sulfamate ester substrates having two electronically dissimilar benzylic sites (Fig. 8A). 
Plotting log(kAr/kH) against substituent parameter σ+ furnished linear correlations, with 
manganese showing less sensitivity to the electronics of the C—H bond relative to iron (ρ = –











































































	   10 
catalysts (ρ = –0.55)1,15. This data is consistent with the reactivity trends observed between 
manganese and iron with electronically deactivated substrates and suggests a transition structure 
in which C—H cleavage for manganese is less pronounced than for iron but more so than the 
related transition structure for the concerted rhodium-catalyzed process15.  
Figure 8 Intramolecular competition mechanistic studies (A) Hammett analysis (B) C—H bond reactivity trends (C) 
Kinetic isotope effect 
 
We also systematically compared the C—H bond reactivity trends for γ 3° aliphatic C—
H bonds relative to other bond types (γ’) (18-21, Fig. 8B). The reactivity trends correlate with 
the homolytic C—H BDEs for both manganese and iron, but manganese shows less 
discrimination between the different bond types, consistent with diminished electrophilic radical 
character in the C—H cleavage transition state. Additionally, benzylic amination of 
monodeuterated substrate 22 provides an intramolecular KIE for [Mn(tBuPc)] (4.2 ± 0.1) that lies 
between [FePc] (4.8 ± 0.1) and Rh2(OAc)4 catalyst (3.8 ± 0.1) (Fig. 8C). Taken together, these 
data support our hypothesis that [Mn(tBuPc)] proceeds through a stepwise mechanism with a 
transition structure in which C—H bond breakage occurs to a lesser extent than with iron15. 
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with the exception that a slightly smaller intramolecular KIE was observed with [Mn(tBuPc)]  
(4.2) relative to [MnPc] (4.5), suggesting that this ligand modification results in further 
attenuation of radical character. 
We next evaluated the recombination step for [Mn(tBuPc)]. In the allylic C—H amination 
of Z-olefin substrate 23 (>20:1 Z/E), olefin isomerization was observed with [Mn(tBuPc)] to the 
same degree as with [FePc], affording a 10:1 Z/E mixture of 4 (Fig. 9A). Characteristic of a 
reaction proceeding via a concerted C—H amination mechanism, an analogous substrate has 
been reported to proceed with no isomerization under rhodium catalysis11. Importantly, C—H 
amination at a defined aliphatic stereocenter in 24 proceeds with complete stereoretention for 
manganese phthalocyanine catalysts as well as for the iron analog  (25, 99% ee, Fig. 9B). 
Figure 9 Radical rebound probes (A) Cis/trans isomerization study (B) C—H amination of a stereodefined center 
 
These data further support a stepwise mechanism for manganese that proceeds through H–atom 
abstraction followed by rapid radical rebound from the base metal catalyst. In contrast to 
aminations that proceed via free radical intermediates21,37,38, this mechanistic feature of 
metallonitrene chemistry allows C—H amination reactions to proceed stereospecifically with 
high functional group tolerance, and enables the prospect of tuning the catalyst to control 
selectivity during functionalization6.  
In order to gain further mechanistic insight, we investigated the influence of [Mn(tBuPc)] 
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rate enhancement with [Mn(tBuPc)] relative to both [FePc] and [MnPc], resulting in significantly 
higher product yields with [Mn(tBuPc)] (Fig. 10). Initial rate measurements for both 2° and 
benzylic C—H amination with [Mn(tBuPc)] quantitatively support catalyst involvement in the 
rate-determining step of the reaction, as changes in catalyst concentration (5 mol% to 10 mol%) 
result in proportional changes in the initial rate. This is in contrast to rhodium catalysis where 
there is no rate dependence on catalyst concentration and iminoiodinane formation is 
hypothesized to be rate-determining1.  
Figure 10 Reaction profile of 2˚ C—H amination using iron and manganese catalysts 
 
 
Moreover, measuring initial rates on parallel reactions with benzylic substrate 26 and 26-
d2 revealed a primary KIE of 1.7 for [Mn(tBuPc)]  and 1.9 for [MnPc]. Consistent with this, an 
intermolecular competition experiment with one equivalent of each 26 and 26-d2 gave a KIE of 
1.6 for [Mn(tBuPc)] and 1.9 for [MnPc] from isolated product ratios (Fig. 11). These two KIE 
experiments with the two manganese phthalocyanine catalysts provide values that are larger than 
would be expected for a rate-determining step that did not involve C—H cleavage (kH/kD ~1), but 
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Figure 11 Kinetic isotope effect studies (A) Parallel rates experiment (B) Intermolecular competition experiment 
 
Ligand modification on the manganese catalyst results in small differences in KIE (Fig. 11), 
providing support for a manganese bound nitrene species in the C—H cleavage step.  
Collectively, these data suggest that the C—H cleavage step contributes significantly to the 
overall reactivity and selectivity observed with [Mn(tBuPc)], a mechanistic feature that enables 
tunable control over selectivity in oxidation. These mechanistic studies were conducted in 
collaboration with my fellow authors. Jinpeng Zhao and Aaron Petronico performed the 
Hammett analysis, and Dr. Shauna Paradine conducted the intramolecular KIE experiment, 
stereoretention experiment, and some of the C—H bond reactivity trends.  
1.3 Conclusion 
We have reported a novel manganese C—H amination catalyst, readily synthesized in 
one step from commercial materials, that is ten million times more abundant than its noble metal 
predecessor40. While further development of this reaction remains, [Mn(tBuPc)] is unique in its 
capacity to intramolecularly functionalize all types of C(sp3)—H bonds, including 1° aliphatic 
and propargylic, while maintaining stereospecificity and broad functional group tolerance in 
complex molecule settings. Studies indicate that the mechanism of metallonitrene insertion into 
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insertion observed with rhodium and the stepwise radical C—H abstraction/rebound observed for 
iron. Rather than demonstrating reactivity and selectivity in between the two, [Mn(tBuPc)] 
promotes intramolecular C—H amination with higher reactivity than rhodium while maintaining 
the high chemoselectivity observed with iron. This finding challenges the bounds of the 
reactivity/selectivity paradigm and informs an approach to discover other highly reactive and 
selective C—H oxidation reactions with catalysts that access tunable high valent metal-
heteroatom species. 
 
1.4 Experimental Information 
General Information	  
The following commercially obtained reagents were used as received: iron(III) phthalocyanine 
chloride ([FePc]Cl, Sigma-Aldrich), manganese(III) phthalocyanine chloride ([MnPc]Cl, Sigma-
Aldrich), 5,10,15,20-Tetraphenyl-21H,23H-porphine iron(III) chloride (Fe(TPP)Cl, Strem), 
5,10,15,20-Tetraphenyl-21H,23H-porphine manganese(III) chloride (Mn(TPP)Cl, Strem), 
Mn(R,R-salen)Cl (Sigma-Aldrich), silver hexafluoroantimonate (AgSbF6, Strem), and bis (tert-
butylcarbonyloxy)iodobenzene (PhI(OPiv)2, Sigma-Aldrich).41 All reactions were run in flame- 
or oven-dried glassware under an atmosphere of N2 or Ar gas with dry solvents unless otherwise 
stated. All products were filtered through a glass wool plug prior to obtaining a final weight. 
Solid reagents were stored in a dessicator or glovebox, and anhydrous solvents were purified by 
passage through a bed of activated alumina immediately prior to use (Glass Countour, Laguna 
Beach, California). Chloroform-d was stored over 3Å molecular sieves in a secondary container 
with drierite. Fe(R,R-PDP)(SbF6)2,5 Mn(R,R-PDP)(SbF6)2, and Fe(R,R-salen)Cl42 were prepared 
according to methods described in the literature and stored at 4oC. Chlorosulfonyl isocyanate 
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(ClSO2NCO, Sigma-Aldrich or TCI America) was transferred to a Schlenk-type flask and stored 
at 4oC under an inert atmosphere.43 4Å MS beads were crushed with a mortar and pestle until 
fine, then activated in a 180°C oven for at least 48h and stored in a dessicator or glovebox. Thin-
layer chromatography (TLC) was conducted with E. Merck silica gel 60 F254 pre-coated plates 
(0.25 mm) and visualized with UV and ethanolic anisaldehyde or potassium permanganate stains. 
Flash chromatography was performed as described by Still44 using American International 
ZEOprep 60 ECO silica gel (230-400 mesh). Achiral gas chromatographic (GC) analysis was 
performed on an Agilent 6890N Series instrument equipped with FID detectors using a HP-5 
(5%-Phenyl)-methylpolysiloxane column (30m, 0.32mm, 0.25mm), and chiral GC analysis using 
a CycloSil-B column (30m, 0.25mm, 0.25mm).  
1H-NMR spectra were recorded on a Varian Inova-500 (500 MHz) or Varian Unity-500 
(500 MHz) spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 
7.26 ppm). Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sxt = 
sextet, spt = septet, m = multiplet, br = broad, app = apparent; coupling constant(s) in Hz; 
integration. Proton-decoupled 13C-NMR spectra were recorded on a Varian Unity-500 (125 
MHz) spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 
77.16 ppm). Kinetic isotope effect analyses were recorded on a Varian Inova-600 (600 MHz) 
spectrometer. IR spectra were recorded as thin films on NaCl plates or by ATR on a Perkin 
Elmer Frontier FTIR and are reported in frequency of absorption (cm-1). Optical rotations were 
measured using a 1 mL cell with a 50 mm path length on a Jasco P-1020 polarimeter. Optical 
rotations were obtained with a sodium lamp and are reported as follows: [α]λToC (c = g/100 mL, 
solvent). High-resolution mass spectra were obtained at the University of Illinois Mass 
Spectrometry Laboratory. Electrospray ionization (ESI) spectra were performed on a Waters Q-
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Tof Ultima spectrometer, and electron ionization (EI) and field desorption (FD) spectra were 
performed on a Micromass 70-VSE spectrometer. Elemental analysis was performed by 
Robertson Microlit Laboratories. 
 
Preparation of [MnIII(tBuPc)] 
[Mn(tBuPc)]Cl from ligand: The following procedure was adapted from a literature 
preparation.45 2,9,16,23-Tetra-tert-butyl-29H,31H-phthalocyanine (250 mg, 0.338 mmol, 1.0 
equiv, Sigma-Aldrich) was taken up in degassed DMF (16 mL) in a 50 mL round-bottom flask 
equipped with stir bar and septum (the flask and stir bar should be free of trace metal impurities). 
Mn(OAc)2 (58.5 mg, 0.338 mmol, 1.0 equiv, Sigma-Aldrich) was added under a stream of N2, 
then reaction was warmed to 60°C and stirred for 12h. Upon completion, the reaction cooled to rt, 
then was diluted with water (10 mL), transferred to a separatory funnel, and the aqueous layer 
was washed with hexanes (20 mL) to remove unreacted ligand. Brine (15 mL) was added, and 
then complex was extracted with chloroform (3x30 mL). The combined organic layers were 
dried over Na2SO4 and filtered. Neutral alumina (15 mL) was added to the solution of crude 
complex and concentrated to dryness. The adsorbed catalyst-alumina powder was then applied to 
a flash column with dry neutral alumina (45 mm column, 100 mm Al2O3). Remaining 
uncomplexed ligand, which is a bright turquoise color, was eluted with 9:1 hex/EtOAc (ca. 1.5L). 
Once ligand fully eluted, 3, which is a dark evergreen color, was eluted with neat EtOAc (ca. 1L). 
Pure product was isolated as a flaky dark green solid in 89% yield. 
[Mn(tBuPc)]Cl from phthalonitrile: A flame dried 100 mL round-bottom flask equipped with a 
stir bar and reflux condenser (the flask and stir bar should be free of trace metal impurities) was 
sequentially charged with 4-tert-butyl-phthalonitrile (2.211 g, 12.0 mmol, 4.0 equiv, TCI 
	  
	   17 
America), 1-hexanol (24 mL, freshly distilled over MgSO4 and degassed), Mn(OAc)2 (519 mg, 
3.00 mmol, 1.0 equiv, Sigma-Aldrich) and DBU (3.59 mL, 24.0 mmol, 8.0 equiv, Sigma-
Aldrich). Reaction flask was evacuated under vacuum and refilled with N2 three times, then 
heated to 155ºC. The reaction mixture changed from colorless to turquoise green over 10 min. 
After stirring at 155ºC overnight (12-15h), the heat was ceased and the condenser was removed. 
Brine (15 mL) was cautiously added into the reaction dropwise via a pasteur pipette while the 
reaction temperature was maintained over 100ºC, then the reaction was stirred open to air while 
cooling to room temp for 1h. Brine and chloroform were added to the flask and the mixture was 
extracted with chloroform 3 times. The combined organic layer was dried over Na2SO4, filtered, 
and concentrated by rotatory evaporation. The remaining solution was transferred to a round-
bottom flask equipped with stir bar and short path distillation head, placed under high vac, and 
then heated to ~60-80ºC until crude material was a sticky solid (~2-3 days). The crude catalyst 
was taken up in CH2Cl2 with 50 mL neutral alumina (Brockmann Type I, Alfa Aesar), then 
concentrated to dryness and applied to a plug of 200 mL neutral Al2O3 (50 mm fritted glass 
column) pre-wetted with 5% EtOAc/hexanes. Nonpolar impurities were eluted with 10% 
EtOAc/hexanes à 20% EtOAc/hexanes (~2L) until eluting solution turned green. 
[Mn(tBuPc)]Cl was eluted as a separate dark green fraction by flushing with EtOAc (~2-4L). The 
solution was concentrated by rotatory evaporation and was dried under high vac overnight to 
afford 971 mg (1.17 mmol) of 3 as a dark green powder (39% yield). Catalyst obtained by this 
method contains a minor unknown impurity (visible in IR at 1711 cm-1), which has no 
observable impact on reactivity or reaction rate for any of the substrate classes examined. Due to 
the convenience and economy of this procedure, this was the standard method for preparing the 
catalyst used in this report. [Mn(tBuPc)]Cl prepared in this way can be made analytically pure by 
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column chromatography on silica using a gradient of 10% à 20% à 30% à 50% à 100% 
EtOAc/hexanes. 
UV-Vis (CHCl3, λmax = nm, ε = M-1cm-1): 729 (ε = 73400), 662 (ε = 15900), 531 (ε = 10100), 
369 (ε = 32400), 280 (ε = 39200); IR (ATR, cm-1) 2955, 2865, 1612, 1506, 1482, 1459, 1394, 
1363, 1328, 1280, 1255, 1199, 1147, 1075, 932, 893, 828, 763, 746; HRMS (ESI) m/z calculated 
for C48H48MnN8 [M-Cl]+: 791.3382, found 791.3380. LRMS (FD) m/z 792.9 (Mn(tBuPc)+H), 
827.8 (M+). Anal. calculated for C48H48ClMnN8 (FW = 827.36), C 69.68, H 5.85, N 13.54, Mn 
6.64; found C 70.07, H 6.05, N 13.21, Mn 6.62. 
UV-Vis Studies: 4.2 mg (0.005 mmol) of [MnIII(tBuPc)] was taken up in CHCl3 to 5 mL 
solution (1.0 mM). 100 µL of this solution was diluted to 10 mL (10.0 µM). UV-Vis was taken 
from 850-250 nm in a quartz cuvette (path length = 1 cm). 
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Preparation of Sulfamate Ester Starting Materials 
General procedure for preparation of sulfamate ester substrates11,46 
Method A: 
Preparation of ClSO2NH2 solution (2M in MeCN): A round-bottom flask equipped with stir bar 
and rubber septum was charged with ClSO2NCO (1.5 equiv) and MeCN (2M relative to 
isocyanate). The flask was cooled to 0oC, and then neat formic acid (1.5 equiv) was added 
dropwise. The reaction stirred vigorously at 0oC (1 h) then room temp (~20oC) overnight.  
Sulfamate ester formation: A 50 mL round-bottom flask equipped with stir bar and rubber 
septum was charged with 95% NaH (1.1 equiv) and 5 mL DMF (1M relative to starting material) 
and cooled to 0oC. The alcohol starting material (1.0 equiv) in DMF was slowly added. The 
reaction was stirred at room temp for 1h, after which it was cooled again to 0oC. The freshly 
prepared 2M MeCN solution of ClSO2NH2 (vide supra) was then added dropwise via syringe, 
and the reaction stirred at room temp. for 2-4 h. Upon complete consumption of starting material 
as monitored by TLC, the reaction was quenched with H2O until the mixture turned clear (~8 
mL). The reaction mixture was partitioned between H2O (15 mL) and Et2O (60 mL) and 
separated. The aqueous layer was then extracted with Et2O (2x30 mL). The organic layers were 
combined, dried over MgSO4, filtered, and concentrated under reduced pressure. Although the 
sulfamate esters were generally pure by NMR after a single column, as a precaution they were 
subjected to a second column to remove minor NMR-silent impurities that have been shown to 
inhibit the amination reaction. Following purification, sulfamate esters were thrice dissolved in 
benzene and concentrated under reduced pressure to remove trace H2O, then stored in a 
dessicator until use. 
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Method B: 
A round-bottom flask equipped with stir bar and rubber septum was charged with ClSO2NCO 
(2.0 equiv) and CH2Cl2 (2M relative to isocyanate). The flask was cooled to 0oC, and then neat 
formic acid (2.0 equiv) was added dropwise. The reaction stirred vigorously at 0oC (1 h) then 
room temp (~20oC) overnight. After cooling the reaction flask back to 0oC, the alcohol starting 
material (1.0 equiv) with Et3N (2.0 equiv) in CH2Cl2 (0.75M relative to starting material) was 
slowly added via syringe. After complete addition, the reaction warmed back to room temp. and 
stirred for 4-6 h. If conversion is low after 3-4 h, additional Et3N (1-2 equiv) can be added. Upon 
complete consumption of starting material as monitored by TLC, the reaction was quenched with 
H2O until the mixture turned clear (~8 mL). The reaction mixture was partitioned between H2O 
(15 mL) and CH2Cl2 (30 mL) and separated. The aqueous layer was then extracted with CH2Cl2 
(2x30 mL). The organic layers were combined, dried over MgSO4, filtered, and concentrated 
under reduced pressure. Although the sulfamate esters were generally pure by NMR after a 
single column, as a precaution they were subjected to a second column to remove minor NMR-
silent impurities that have been shown to inhibit the amination reaction. Following purification, 
sulfamate esters were thrice dissolved in benzene and concentrated under reduced pressure to 
remove trace H2O, then stored in a dessicator until use. 
Method C: 
A round-bottom flask equipped with stir bar and rubber septum was charged with ClSO2NCO 
(1.5 equiv). The flask was cooled to 0ºC, and then neat formic acid (1.5 equiv) was added 
dropwise. After vigorously stirring for 5 min at 0ºC, MeCN (2M relative to isocyanate) was 
added, and the reaction stirred vigorously at 0ºC (1 h) then room temp (~20ºC) overnight. After 
cooling the reaction flask back to 0ºC, the phenol (1.0 equiv) in N,N-dimethylacetamide (DMA, 
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1.6M) was slowly added via syringe. After complete addition, the reaction warmed back to room 
temp and stirred for 4-6 h. Upon complete consumption of starting material as monitored by TLC, 
the reaction was quenched with H2O (~5 mL). The reaction mixture was partitioned between 
H2O (15 mL) and Et2O (30 mL) and separated. The aqueous layer was then extracted with Et2O 
(2x30 mL). The organic layers were combined, dried over MgSO4, filtered, and concentrated 
under reduced pressure. Following purification of the crude product via flash column 
chromatography, the pure product was dissolved in CH2Cl2 and filtered through a short silica 
plug, then twice dissolved in benzene and concentrated under reduced pressure to remove trace 
H2O, then stored in a desiccator until use. 
NOTE: Some sulfamate esters exhibited suboptimal reactivity after storing for more than a 
month (although some are bench stable for much longer); repurification usually restored 
reactivity in these cases. 
 
(±)-3,7-dimethyloctyl sulfamate [1]. 
Prepared according to method A. 4.75 g (30.0 mmol) of (±)-3,7-
dimethyloctanol were used, along with NaH (834 mg, 33.0 mmol, 1.1 equiv), DMF (30 + 15 mL), 
ClSO2NCO (3.92 mL, 45.0 mmol, 1.5 equiv), formic acid (1.70 mL, 45.0 mmol, 1.5 equiv) and 
MeCN (23 mL). Flash column chromatography on silica (45 mm fritted glass column, 200 mm 
SiO2) using 4:1 hexanes/EtOAc as eluent gave 5.835 g (24.6 mmol) of pure product as a 
colorless oil (82% yield). 
1H-NMR (500 MHz, CDCl3) δ 4.71 (br. s, 2H), 4.29-4.22 (m, 2H), 1.82-1.76 (m, 1H), 1.64-1.48 
(m, 3H), 1.34-1.22 (m, 3H), 1.20-1.10 (m, 3H), 0.92 (d, J = 6.5 Hz, 3H), 0.87 (d, J = 6.5 Hz, 
6H); 13C-NMR (125 MHz, CDCl3) δ 70.3, 39.3, 37.1, 35.8, 29.5, 28.1, 24.7, 22.8, 22.7, 19.4; IR 
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(film, cm-1) 3392, 3294, 2953, 2870, 1556, 1468, 1367, 1180, 1034, 953, 766; HRMS (ESI) m/z 
calculated for C10H23NO3SNa [M+Na]+: 260.1296, found 260.1297. 
(E)-hex-4-en-1-yl sulfamate. 
Prepared according to method A. 500 mg (5.00 mmol) of (E)-hex-4-en-1-ol 
were used, along with NaH (138 mg, 5.50 mmol, 1.1 equiv), DMF (8.9 mL), ClSO2NCO (651 
µL, 7.50 mmol, 1.5 equiv), formic acid (283 µL, 7.50 mmol, 1.5 equiv) and MeCN (3.8 mL). 
Flash column chromatography on silica (100 mL SiO2) using 4:1 hexanes/EtOAc à 3:1 
hexanes/EtOAc as eluent gave 613 mg (3.40 mmol) of pure product as a colorless oil (68% 
yield). 
1H-NMR (500 MHz, CDCl3) δ 5.52-5.45 (m, 1H), 5.42-5.35 (m, 1H), 4.73 (s, 2H), 4.21 (t, J = 
6.5 Hz, 2H), 2.13-2.08 (m, 2H), 1.80 (tt, J = 7.3, 6.6 Hz, 2H), 1.65 (ddd, J = 6.3, 2.3, 1.2 Hz, 
3H); 13C-NMR (125 MHz, CDCl3) δ 129.3, 126.7, 71.1, 28.7, 28.4, 18.0.  These data are in 
agreement with that previously reported in the literature.31 
 
Pent-4-en-1-yl sulfamate. 
Prepared according to method A. 1.03 g (12.0 mmol) of 4-penten-1-ol were 
used, along with NaH (333 mg, 13.2 mmol, 1.1 equiv), DMF (21.4 mL), 
ClSO2NCO (2.2 mL, 25.5 mmol, 1.5 equiv), formic acid (959 µL, 25.5 mmol, 1.5 equiv) and 
MeCN (12.8 mL). Flash column chromatography on silica (45 mm fritted glass column, 170 mm 
SiO2) using 3:1 hexanes/EtOAc as eluent gave 1.60 g (9.70 mmol) of pure product as a colorless 
oil (81% yield). 
1H-NMR (500 MHz, CDCl3) δ 5.79 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.07 (dd, J = 17.2, 1.7 Hz, 
1H), 5.03 (dd, J = 10.2, 1.3 Hz, 1H), 4.81 (s, 2H), 4.23 (t, J = 6.5 Hz, 2H), 2.23 - 2.14 (m, 2H), 
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1.86 (tt, J = 7.4, 6.5 Hz, 2H); 13C-NMR (125 MHz, CDCl3) δ 137.0, 116.2, 71.0, 29.7, 28.1.  
These data are in agreement with that previously reported in the literature.15 
 
Ethyl (E)-6-(sulfamoyloxy)hex-2-enoate. 
Prepared according to method B. 949 mg (6.00 mmol) of ethyl (E)-6-
hydroxyhex-2-enoate were used, along with Et3N (1.74 mL, 9.00 
mmol, 1.5 equiv), ClSO2NCO (783 µL, 9.00 mmol, 1.5 equiv), formic acid (340 µL, 9.00 mmol, 
1.5 equiv) and CH2Cl2 (4.5 + 8.6 mL). Flash column chromatography on silica (45 mm fritted 
glass column, 200 mm SiO2) using 25% acetone/hexanes à 30% acetone/hexanes as eluent gave 
968 mg (4.08 mmol) of pure product as a colorless oil (68% yield).  
1H-NMR (500 MHz, CDCl3) δ 6.93 (dt, J = 15.6, 7.0 Hz, 1H), 5.87 (dt, J = 15.7, 1.6 Hz, 1H), 
4.93 (br. s, 2H), 4.23 (t, J = 6.2 Hz, 2H), 4.19 (q, J = 7.1 Hz, 2H), 2.36 (qd, J = 7.2, 1.6 Hz, 2H), 
1.93 (tt, J = 7.5, 6.2 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 166.7, 
147.0, 122.7, 70.3, 60.6, 28.2, 27.3, 14.4.  These data are in agreement with that previously 
reported in the literature.15  
 
(E)-6-((N-(methoxycarbonyl)-4-methylphenyl)sulfonamido)hex-4-en-1-yl sulfamate. 
Prepared according to method B. 1.15 g (3.50 mmol) of methyl 
(E)-(6-hydroxyhex-2-en-1-yl)(tosyl)carbamate were used, along 
with Et3N (731 µL, 5.3 mmol, 1.5 equiv), ClSO2NCO (461 µL, 5.3 
mmol, 1.5 equiv), formic acid (198 µL, 5.3 mmol, 1.5 equiv) and CH2Cl2 (5 + 2.6 mL). Flash 
column chromatography on silica (45 mm fritted glass column, 150 mm SiO2) using 4:1 
hexanes/acetone as eluent gave 810 mg (1.99 mmol) of pure product as a white solid (57% yield).  
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1H-NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.5 Hz, 2H), 5.77 (dt, J = 
15.2, 7.0 Hz, 1H), 5.67-5.61 (m, 1H), 4.82 (s, 2H), 4.41 (d, J = 6.1 Hz, 2H), 4.21 (t, J = 6.3 Hz, 
2H), 3.70 (s, 3H), 2.44 (s, 3H), 2.23 (dd, J = 13.6, 7.0 Hz, 2H), 1.88 (p, J = 6.6 Hz, 3H); 13C-
NMR (125 MHz, CDCl3) δ152.7, 144.9, 136.1, 133.3, 129.4, 128.3, 126.1, 70.0, 54.0, 48.6, 27.9, 
27.7, 21.6; IR (film, cm-1) 3378, 3283, 2959, 1736, 1596, 1559, 1495, 1447, 1359, 1244, 1127, 
974, 928, 816, 768, 737, 677, 578, 547; HRMS (ESI) m/z calculated for C15H23N2O7S2 [M+H]+: 
407.0947, found 407.0941. 
 
(±)-cyclohex-3-en-1-ylmethyl sulfamate. 
Prepared according to method A. 841 mg (875 µL, 7.50 mmol) of 3-cyclohexene -1-
methanol were used, along with Et3N (1.57 mL, 11.3 mmol, 1.5 equiv), ClSO2NCO 
(984 µL, 11.3 mmol, 1.5 equiv), formic acid (426 µL, 11.3 mmol, 1.5 equiv) and CH2Cl2 (5.7 + 
10.7 mL). Flash column chromatography on silica (45 mm fritted glass column, 200 mm SiO2) 
using 4:1 hexanes/EtOAc à 3:1 hexanes/EtOAc as eluent gave 1.07 g (5.60 mmol) of pure 
product as a colorless oil (75% yield).  
1H-NMR (500 MHz, CDCl3) δ 5.71-5.64 (m, 2H), 4.80 (br. s, 2H), 4.11 (d, J = 6.6 Hz, 2H), 2.19-
2.03 (m, 1H), 2.11-2.04 (m, 3H), 1.86-1.78 (m, 2H), 1.37 (dddd, J = 12.9, 10.8, 8.8, 7.0 Hz, 1H); 
13C-NMR (125 MHz, CDCl3) δ 127.2, 125.1, 75.4, 33.2, 27.7, 24.9, 24.2.  These data are in 
agreement with that previously reported in the literature.15 
 
(-)-2-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethyl sulfamate. 
Prepared according to method A. 1.25 g (1.3 mL, 7.50 mmol) of (-)-(1R)-
nopol were used, along with NaH (208 mg, 8.30 mmol, 1.1 equiv), DMF 
	  
	   25 
(13.4 mL), ClSO2NCO (984 µL, 11.3 mmol, 1.5 equiv), formic acid (426 µL, 11.3 mmol, 1.5 
equiv) and MeCN (5.6 mL). Flash column chromatography on silica (35 mm fritted glass column, 
170 mm SiO2) using 4:1 hexanes/EtOAc as eluent gave 1.30 g (5.30 mmol) of pure product as a 
white solid (71% yield). 
1H-NMR (500 MHz, CDCl3) δ 5.36 (app tt, J = 3.0, 1.5 Hz, 1H), 4.71 (br. s, 2H), 4.21 (td, J = 7.2, 
1.9 Hz, 2H), 2.54-2.36 (m, 3H), 2.29-2.17 (m, 2H), 2.10 (app tdt, J = 6.9, 4.0, 1.9 Hz, 1H), 2.04 
(td, J = 5.6, 1.5 Hz, 1H), 1.28 (s, 3H), 1.15 (d, J = 8.6 Hz, 1H), 0.83 (s, 3H).; 13C-NMR (125 
MHz, CDCl3) δ142.8, 119.9, 69.7, 45.7, 40.7, 38.2, 36.1, 31.7, 31.5, 26.3, 21.3; IR (film, cm-1) 
3371, 3288, 2989, 2928, 2875, 1542, 1467, 1443, 1341, 1190, 1067, 1056, 969, 955, 912, 837, 
769, 698; [α]D25 = -25.0° (c = 1.0, CHCl3); HRMS (ESI) m/z calculated for C11H19NO3SNa 
[M+Na]+: 268.0983, found 268.0987. 
 
(E)-4-phenylbut-3-en-1-yl sulfamate. 
Prepared according to method B. 727 mg (4.90 mmol) of (E)-4-phenylbut-
3-en-1-ol were used, along with Et3N (1.03 mL, 7.36 mmol, 1.5 equiv), 
ClSO2NCO (639 µL, 7.36 mmol, 1.5 equiv), formic acid (278 µL, 7.36 mmol, 1.5 equiv) and 
CH2Cl2 (3.7 + 7.0 mL). Flash column chromatography on silica (150 mL SiO2) using 3:1 
hexanes/EtOAc as eluent gave 830 mg (3.65 mmol) of pure product as a white solid (75% yield).  
1H-NMR (500 MHz, CDCl3) δ 7.37-7.28 (m, 4H), 7.26-7.21 (m, 1H), 6.52 (d, J = 16.0 Hz, 1H), 
6.17 (dt, J = 15.8, 7.0 Hz, 1H), 4.71 (br. s, 2H), 4.32 (t, J = 6.7 Hz, 2H), 2.67 (qd, J = 6.7, 1.5 Hz, 
2H); 13C-NMR (125 MHz, CDCl3) δ 137.0, 133.5, 128.7, 127.7, 126.3, 124.1, 70.6, 32.5. These 
data are in agreement with that previously reported in the literature.47 
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(±)-5-(trimethylsilyl)pent-4-yn-1-yl sulfamate [S21]. 
 Prepared according to method B. 782 mg (5.00 mmol) of 5-
(trimethylsilyl)pent-4-yn-1-ol were used, along with Et3N (1.05 mL, 
7.50 mmol, 1.5 equiv), ClSO2NCO (653 µL, 7.50 mmol, 1.5 equiv), formic acid (283 µL, 7.50 
mmol, 1.5 equiv) and CH2Cl2 (3.8 + 7.1 mL). Flash column chromatography on silica (45 mm 
fritted glass column, 150 mm SiO2) using 5% Et2O/hexanes à 10% Et2O/hexanes à 15% 
Et2O/hexanes as eluent gave 605 mg (2.57 mmol) of pure product as a clear oil (51% yield).  
1H-NMR (500 MHz, CDCl3) δ 4.82 (br. s, 2H), 4.34 (t, J = 6.1 Hz, 2H), 2.39 (t, J = 6.9 Hz, 2H), 
1.95 (p, J = 6.4 Hz, 2H), 0.15 (s, 9H); 13C-NMR (125 MHz, CDCl3) δ 105.0, 86.4, 69.9, 27.8, 
16.3, 0.2; IR (film, cm-1) 3383, 3284, 2960, 2175, 1557, 1359, 1249, 1177, 1070, 1017, 979, 929, 
759, 698; HRMS (ESI) m/z calculated for C8H18O3SSi [M+H]+: 236.0777, found 236.0779. 
 
(+)-(S)-2-((tert-butyldimethylsilyl)oxy)-7-(tosyloxy)hept-4-yn-1-yl sulfamate. 
Prepared according to method B. 940 mg (2.30 mmol) of (S)-6-
((tert-butyldimethylsilyl)oxy)-7-hydroxyhept-3-yn-1-yl 4-
methylbenzene sulfonate were used, along with Et3N (488 µL, 3.50 mmol, 1.5 equiv), 
ClSO2NCO (304 µL, 3.50 mmol, 1.5 equiv), formic acid (132 µL, 3.50 mmol, 1.5 equiv) and 
CH2Cl2 (1.75 + 3.3 mL). Flash column chromatography on silica (35 mm fritted glass column, 
150 mm SiO2) using 3:1 hexanes/EtOAc à 2:1 hexanes/EtOAc as eluent gave 688 mg (1.40 
mmol) of pure product as a pale yellow oil (61% yield).  
1H-NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8.3 Hz, 2H), 7.36 (d, J = 7.9 Hz, 2H), 5.03 (s, 2H), 
4.33 (dd, J = 10.2, 3.7 Hz, 1H), 4.15 (dd, J = 10.2, 5.9 Hz, 1H), 4.08-4.01 (m, 3H), 2.51 (tt, J = 
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3H); 13C-NMR (125 MHz, CDCl3) δ 145.3, 132.7, 130.1, 128.1, 78.1, 77.5, 73.3, 69.3, 68.4, 
25.8, 24.5, 21.8, 20.0, 18.2, -4.6, -4.8; IR (film, cm-1) 3378, 3288, 2929, 2857, 1598, 1558, 1463, 
1358, 1255, 1120, 1096, 971, 903, 808, 775, 663; [α]D25 = +8.21° (c = 0.56, CHCl3); HRMS 
(ESI) m/z calculated for C20H34NO7S2Si [M+H]+: 492.1546, found 492.1542. 
 
(-)-(S)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate. 
Prepared according to method B. 661 mg (622 µL, 5.00 mmol) of (R)-glycerol 
acetonide were used, along with Et3N (1.05 mL, 7.50 mmol, 1.5 equiv), 
ClSO2NCO (651 µL, 7.50 mmol, 1.5 equiv), formic acid (282.9 µL, 7.5 mmol, 1.5 equiv) and 
CH2Cl2 (3.8 + 7.1 mL). Flash column chromatography on silica (150 mL SiO2) using 2:1 
hexanes/EtOAc as eluent gave 704 mg (3.30 mmol) of pure product as a clear oil (67% yield).  
1H-NMR (500 MHz, CDCl3) δ 5.20 (s, 2H), 4.41 (p, J = 5.7 Hz, 1H), 4.23 (dd, J = 10.7, 6.1 Hz, 
1H), 4.18 (dd, J = 10.7, 4.8 Hz, 1H), 4.11 (dd, J = 8.8, 6.5 Hz, 1H), 3.83 (dd, J = 8.8, 5.4 Hz, 
1H), 1.45 (s, 3H), 1.37 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 110.4, 73.2, 70.6, 65.7, 26.6, 
25.2. These data are in agreement with that previously reported in the literature.36 
 
(-)-stigmasteryl sulfamate. 
Prepared according to method B. 2.06 g (5.00 mmol) of (-)-
stigmasterol were used, along with Et3N (1.38 mL, 10.0 mmol, 2.0 
equiv), ClSO2NCO (870 µL, 10.0 mmol, 2.0 equiv), formic acid (377 
µL, 10.0 mmol, 2.0 equiv) and CH2Cl2 (5.0 mL + 7.1 mL). Flash 
column chromatography on silica (45 mm fritted glass column, 170 mm SiO2) using 4:1 
hexanes/acetone as eluent gave 1.40 g (2.85 mmol) of pure product as a white solid (57% yield).  
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1H-NMR (500 MHz, CDCl3) δ 5.42-5.40 (m, 1H), 5.15 (dd, J = 15.2, 8.6 Hz, 1H), 5.02 (dd, J = 
15.2, 8.5 Hz, 1H), 4.83 (br. s, 2H), 4.43 (tt, J = 11.0, 5.3 Hz, 1H), 2.56-2.46 (m, 2H), 2.11-1.95 
(m, 4H), 1.91 (dt, J = 13.5, 3.7 Hz, 1H), 1.81-1.67 (m, 2H), 1.56-1.40 (m, 9H), 1.28-0.91 (m, 
13H), 0.85-0.79 (m, 9H), 0.70 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 138.9, 138.4, 129.5, 
123.8, 83.5, 56.9, 56.1, 51.4, 50.1, 42.3, 40.7, 39.7, 38.9, 37.1, 36.6, 32.0, 31.9, 29.1, 28.7, 25.6, 
24.5, 21.4, 21.3, 21.2, 19.4, 19.1, 12.4, 12.2; IR (film, cm-1) 3323, 3262, 2962, 2937, 2893, 2866, 
1569, 1458, 1381, 1328, 1189, 968, 869, 807, 737; [α]D25 = -50.8° (c = 0.5, CHCl3); HRMS (ESI) 
m/z calculated for C29H49NO3SNa [M+Na]+: 514.3331, found 514.3333. 
 
(+)-pregnenolyl sulfamate. 
Prepared according to method B. 1.58 g (5.00 mmol) of (+)-pregnenolone 
were used, along with Et3N (1.05 mL, 7.50 mmol, 1.5 equiv), ClSO2NCO 
(653 µL, 7.50 mmol, 1.5 equiv), formic acid (283 µL, 7.50 mmol, 1.5 equiv) 
and CH2Cl2 (3.8 mL + 7.1 mL).  Flash column chromatography on silica (45 
mm fritted glass column, 170 mm SiO2) using 3:1 hexanes/EtOAc as eluent gave 967 mg (2.44 
mmol) of pure product as a white solid (49% yield).  
1H-NMR (500 MHz, CDCl3) δ 5.42 (dt, J = 5.0, 2.0 Hz, 1H), 4.72 (br. s, 2H), 4.44 (tt, J = 11.2, 
5.3 Hz, 1H), 2.57-2.45 (m, 3H), 2.22- 1.99 (m, 7H), 1.92 (dt, J = 13.6, 3.7 Hz, 1H), 1.80-1.44 
(m, 8H), 1.26-1.12 (m, 3H), 1.02 (s, 3H), 0.98 (dd, J = 11.3, 4.9 Hz, 1H), 0.63 (s, 3H); 13C-NMR 
(125 MHz, CDCl3) δ 209.9, 139.0, 123.5, 83.1, 63.8, 56.9, 49.9, 44.1, 38.8, 38.8, 37.0, 36.5, 
31.9, 31.7, 28.6, 24.6, 22.9, 21.2, 19.3, 13.4; IR (film, cm-1) 3421, 3239, 3102, 2937, 1683, 1580, 
1470, 1451, 1376, 1352, 1174, 978, 937, 857, 820, 729; [α]D25 = +19.4° (c = 0.62, CHCl3); 
HRMS (ESI) m/z calculated for C21H34NO4S [M+H]+: 396.2209, found 396.2208. 
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Optimization of Mn-catalyzed Intramolecular C—H Amination 
General procedure for catalyst and optimization studies (entries 1-10) 
Into a 10 mL round-bottom flask was added AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), catalyst 
(0.040 mmol, 0.10 equiv), crushed 4Å MS (100 mg, if using) and a stir bar in a glovebox. The 
flask was then sealed with a rubber septum, covered in aluminum foil (when AgSbF6 was used), 
and taken out of the box. (±)-3,7-dimethyloctyl sulfamate 4 (94.9 mg, 0.400 mmol, 1.0 equiv) 
dissolved in 9:1 C6H6/MeCN (800 µL, 0.5M) was added via syringe, followed by PhI(OPiv)2 
(325 mg, 0.800 mmol, 2.0 equiv) in a single portion. The reaction stirred for 8h at room temp 
(~23oC), and then was applied directly to a silica column (35 mm fritted glass column, 150 mm 
SiO2). The product and starting material were eluted with 5:1 hexanes/EtOAc and isolated 
separately. 
 
(±)-4-methyl-4-(4-methylpentyl)-1,2,3-oxathiazinane 2,2-dioxide [2]. 
Isolated as a colorless oil. 1H-NMR (500 MHz, CDCl3) δ 4.71-4.61 (m, 2H), 
4.29 (br. s, 1H), 1.82-1.67 (m, 3H), 1.54 (app. spt, J = 7.0 Hz, 1H), 1.45-1.41 (m, 
2H), 1.38 (s, 3H), 1.30-1.24 (m, 1H), 1.20-1.15 (m, 2H), 0.87 (d, J = 6.5 Hz, 6H); 13C-NMR (125 
MHz, CDCl3) δ 69.1, 59.1, 41.3, 39.1, 34.7, 27.3, 24.7, 22.7, 22.6, 20.8; IR (film, cm-1) 3271, 
2954, 2872, 1466, 1421, 1360, 1252, 1188, 1155, 1113, 1070, 1014, 987, 933, 870, 783; HRMS 
(ESI) m/z calculated for C10H22NO3S [M+H]+: 236.1320, found 236.1315. 
 
Entry 1. (±)-3,7-dimethyloctyl sulfamate (94.9 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24 mg, 
0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (800 µL, 0.5M) were used.  
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Run 1: (27.1 mg, 0.115 mmol, 29%), (12.3 mg alcohol, 0.078 mmol, 19%), (24.9 mg rsm, 0.262 
mmol, 26%). Run 2: (28.0 mg, 0.119 mmol, 30%), (32.8 mg rsm, 0.138 mmol, 35%). Run 3: 
(26.6 mg, 0.113 mmol, 28%), (33.7 mg rsm, 0.142 mmol, 36%).  Average: 29% yield ± 0.8, 
32% rsm ± 4.5. 
 
Entry 2. (±)-3,7-dimethyloctyl sulfamate (94.9 mg, 0.400 mmol, 1.0 equiv), [MnPc]Cl (24 mg, 
0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (800 µL, 0.5M) were used.  
Run 1: (39.2 mg, 0.167 mmol, 42%), (22.3 mg rsm, 0.094 mmol, 23%). Run 2: (39.4 mg, 0.167 
mmol, 42%), (27.1 mg rsm, 0.114 mmol, 29%). Run 3: (41.8 mg, 0.178 mmol, 44%), (26.7 mg 
rsm, 0.113 mmol, 28%).  Average: 43% yield ± 0.9, 27% rsm ± 2.6. 
 
Entry 3. (±)-3,7-dimethyloctyl sulfamate (94.9 mg, 0.400 mmol, 1.0 equiv), Fe(TPP)Cl (28.2 
mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (800 µL, 0.5M) were used.  
Run 1: (4.0 mg, 0.017 mmol, 4%), (80.1 mg rsm, 0.338 mmol, 84%). Run 2: (2.9 mg, 0.012 
mmol, 3%), (82.3 mg rsm, 0.347 mmol, 87%). Run 3: (3.5 mg, 0.015 mmol, 4%), (79.5 mg rsm, 
0.335 mmol, 84%).  Average: 4% yield ± 0.5, 85% rsm ± 1.4. 
 
Entry 4. (±)-3,7-dimethyloctyl sulfamate (94.9 mg, 0.400 mmol, 1.0 equiv), Mn(TPP)Cl (28.2 
mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (800 µL, 0.5M) were used.  
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Run 1: (15.6 mg, 0.066 mmol, 17%), (51.8 mg rsm, 0.218 mmol, 55%). Run 2: (16.8 mg, 0.072 
mmol, 18%), (63.1 mg rsm, 0.266 mmol, 67%). Run 3: (17.4 mg, 0.074 mmol, 18%), (61.4 mg 
rsm, 0.259 mmol, 65%).  Average: 18% yield ± 0.5, 62% rsm ± 5.3. 
 
Entry 5. (±)-3,7-dimethyloctyl sulfamate (94.9 mg, 0.400 mmol, 1.0 equiv), Fe(R,R-
PDP)(SbF6)2 (33.6 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) 
and 9:1 C6H6/MeCN (800 µL, 0.5M) were used.  
Run 1: <1% yield, (87.9 mg rsm, 0.370 mmol, 93%). Run 2: <1% yield, (87.7 mg rsm, 0.370 
mmol, 92%). Run 3: <1% yield, (84.7 mg rsm, 0.357 mmol, 89%).  Average: <1% yield, 91% 
rsm ± 1.7. 
 
Entry 6. (±)-3,7-dimethyloctyl sulfamate (94.9 mg, 0.400 mmol, 1.0 equiv), Mn(R,R-
PDP)(SbF6)2 (33.6 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) 
and 9:1 C6H6/MeCN (800 µL, 0.5M) were used.  
Run 1: (7.0 mg, 0.030 mmol, 7%), (78.3 mg rsm, 0.330 mmol, 83%). Run 2: (6.2 mg, 0.026 
mmol, 7%), (73.7 mg rsm, 0.311 mmol, 78%). Run 3: (6.7 mg, 0.028 mmol, 7%), (79.4 mg rsm, 
0.335 mmol, 84%).  Average: 7% yield ± 0.0, 82% rsm ± 2.2. 
 
Entry 7. (±)-3,7-dimethyloctyl sulfamate (94.9 mg, 0.400 mmol, 1.0 equiv), [MnPc]Cl (24.0 mg, 
0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were used.  
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Run 1: (56.1 mg, 0.238 mmol, 60%), (10.6 mg rsm, 0.045 mmol, 11%). Run 2: (54.3 mg, 0.231 
mmol, 58%), (10.5 mg rsm, 0.044 mmol, 11%). Run 3: (58.2 mg, 0.247 mmol, 62%), (10.9 mg 
rsm, 0.046 mmol, 11%).  Average: 60% yield ± 1.6, 11% rsm ± 0.1. 
 
Entry 8. (±)-3,7-dimethyloctyl sulfamate (94.9 mg, 0.400 mmol, 1.0 equiv), [MnPc]Cl (12.0 mg, 
0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 0.800 
mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were used.  
Run 1: (56.3 mg, 0.239 mmol, 60%), (21.6 mg rsm, 0.091 mmol, 23%). Run 2: (51.3 mg, 0.218 
mmol, 55%), (15.0 mg rsm, 0.063 mmol, 16%). Run 3: (56.0 mg, 0.238 mmol, 59%), (20.3 mg 
rsm, 0.086 mmol, 21%).  Average: 58% yield ± 2.2, 20% rsm ± 2.9. 
 
Entry 9. (±)-3,7-dimethyloctyl sulfamate (94.9 mg, 0.400 mmol, 1.0 equiv), [Mn(tBuPc)]Cl 
(33.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 
mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were 
used.  
Run 1: (71.3 mg, 0.303 mmol, 76%), <5% rsm. Run 2: (70.4 mg, 0.299 mmol, 75%), <5% rsm. 
Run 3: (70.1 mg, 0.298 mmol, 74%), <5% rsm.  Average: 75% yield ± 0.8, <5% rsm. 
 
Entry 10. (±)-3,7-dimethyloctyl sulfamate (94.9 mg, 0.400 mmol, 1.0 equiv), [Mn(tBuPc)]Cl 
(16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 
mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were 
used.  
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Run 1: (68.1 mg, 0.289 mmol, 72%), (12.2 mg rsm, 0.051 mmol, 12%). Run 2: (68.8 mg, 0.292 
mmol, 73%), (16.6 mg rsm, 0.070 mmol, 17%). Run 3: (67.8 mg, 0.288 mmol, 72%), (13.1 mg 
rsm, 0.055 mmol, 14%).  Average: 72% yield ± 0.5, 14% rsm ± 2.1. 
 
Substrate Scope for Mn-catalyzed Intramolecular C—H Amination 
General procedure for [MnPc] and [Mn(tBuPc)]-mediated C—H amination 
Into a 10 mL round-bottom flask was added AgSbF6 (0.05 equiv or 0.10 equiv), [Mn(tBuPc)]Cl 
(0.05 equiv or 0.10 equiv), crushed 4Å MS, and a stir bar in a glovebox. The flask was then 
sealed with a rubber septum, covered in aluminum foil, and taken out of the box. Sulfamate ester 
(1.0 equiv), 9:1 C6H6/MeCN (0.5M), and, lastly, PhI(OPiv)2 (2.0 equiv) were then added under 
an inert atmosphere; if sulfamate ester was an oil, it was taken up in the solvent mixture and 
added to the flask via syringe. After addition of oxidant, the dark red solution gradually turned 
dark brown. The reaction stirred for 8h at room temperature unless otherwise specified (~20°C). 
Upon completion, the reaction mixture was applied directly to a silica column for purification. 
Alternatively, the reaction can be concentrated under reduced pressure, and the remaining dark 
brown residue suspended in Et2O and filtered through a small pad of Celite. Upon removal of 
solvent under reduced pressure, the brown residue was taken up in minimal CH2Cl2 and applied 
to a column. Any variation of these reaction conditions is noted for individual substrates. 
 
General procedure for [FePc]-mediated intramolecular C—H amination11 
Into a 10 mL round-bottom flask was added AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
[FePc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), and a stir bar in a glovebox. The flask was then 
sealed with a rubber septum, covered in aluminum foil, and taken out of the box. 4:1 
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PhMe/MeCN (800 µL, 0.5M), sulfamate ester (0.400 mmol, 1.0 equiv), and PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv) were then added sequentially; if sulfamate ester was an oil, it was taken 
up in the solvent mixture and added to the flask via syringe. After addition of oxidant, the deep 
violet solution gradually turned dark brown. The reaction stirred for 8h at room temperature 
unless otherwise specified (~20°C). Upon completion, the reaction mixture was applied directly 
to a silica column (35 mm fritted glass column, 150 mm SiO2) for purification. Alternatively, the 
reaction can be concentrated under reduced pressure, and the remaining dark brown residue 
suspended in Et2O and filtered through a small pad of Celite. Upon removal of solvent under 
reduced pressure, the brown residue was taken up in minimal CH2Cl2 and applied to a column. 
Any variation of these reaction conditions is noted for individual substrates. 
 
(±)-4-phenyl-1,2,3-oxathiazinane 2,2-dioxide [3]. 
In all cases, material was purified via flash column chromatography on silica (25 
mm fritted glass column, 150 mm SiO2) using 4:1 hexanes/EtOAc as eluent, 
affording oxathiazinane product and starting material separately.  
FePc conditions: 3-phenylpropyl sulfamate (86.5 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (12.0 
mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were used. 
Run 1: (18.5 mg, 0.086 mmol, 22%), (54.9 mg rsm, 0.254 mmol, 63%). Run 2: (19.0 mg, 0.089 
mmol, 22%), (58.2 mg rsm, 0.269 mmol, 67%). Run 3: (17.8 mg, 0.083 mmol, 21%), (56.2 mg 
rsm, 0.260 mmol, 65%). Average: 22% yield ± 0.5, 65% rsm ± 1.6.  
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MnPc conditions: 3-phenylpropyl sulfamate (86.5 mg, 0.400 mmol, 1.0 equiv), [MnPc]Cl (12.0 
mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were used. 
Run 1: (59.1 mg, 0.276 mmol, 69%), (<5% rsm). Run 2: (59.8 mg, 0.279 mmol, 70%), (<5% 
rsm). Run 3: (62.6 mg, 0.292 mmol, 73%), (<5% rsm). Average: 71% yield ± 1.7, <5% rsm.  
Mn(tBuPc) conditions: 3-phenylpropyl sulfamate (86.5 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. 
Run 1: (63.0 mg, 0.294 mmol, 74%), (<5% rsm). Run 2: (65.2 mg, 0.304 mmol, 76%), (<5% 
rsm). Run 3: (61.5 mg, 0.287 mmol, 72%), (<5% rsm). Average: 74% yield ± 1.6, <5% rsm.  
Pure product was isolated as a white solid. 1H-NMR (500 MHz, CDCl3) δ 7.43-7.35 (m, 5H), 
4.90-4.85 (m, 2H), 4.66 (ddd, J = 11.5, 5.0, 1.5 Hz, 1H), 4.35 (br. d, J = 9.0 Hz, 1H), 2.30-2.21 
(m, 1H), 2.05-2.00 (m, 1H); 13C-NMR (125 MHz, CDCl3) δ 137.7, 129.0, 128.7, 126.1, 71.8, 
58.7, 30.0. These data are in agreement with that previously reported in the literature.11  
 
(±)-(E)-4-(prop-1-en-1-yl)-1,2,3-oxathiazinane 2,2-dioxide [4]. 
In all cases, material was purified via flash column chromatography on silica (35 
mm fritted glass column, 150 mm SiO2) using 3:1 hexanes/EtOAc, affording a 
mixture of product and starting material; yields were determined based on 1H NMR ratios. Pure 
product could be obtained by eluting with 10% hexanes/CH2Cl2 à CH2Cl2 à 2% Et2O/CH2Cl2. 
Ins./azir. ratios determined by 1H NMR of the crude reaction mixture. Pure product was isolated 
as a white solid. 
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FePc conditions: (E)-hex-4-en-1-yl sulfamate (71.7 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (12.1 
mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were used. 
Run 1: (8.2  mg, 0.046 mmol, 11%), (54.3 mg rsm, 0.303 mmol, 76%). Run 2: (7.6 mg, 0.043 
mmol, 11%), (55.0 mg rsm, 0.307 mmol, 77%). Run 3: (6.7 mg, 0.038 mmol, 9%), (54.8 mg rsm, 
0.306 mmol, 76%).  Average: 10% yield ± 0.9 (ins./azir. crude = >20:1), 76% rsm ± 0.5. 
MnPc conditions: (E)-hex-4-en-1-yl sulfamate (71.7 mg, 0.400 mmol, 1.0 equiv), [MnPc]Cl 
(12.1 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 
mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were 
used.  
Run 1: (43.1 mg, 0.243 mmol, 61%). Run 2: (43.6 mg, 0.246 mmol, 61%). Run 3: (42.7 mg, 
0.241 mmol, 60%) Average: 61% yield ± 0.5 (ins./azir. crude = >20:1). 
Mn(tBuPc) conditions: (E)-hex-4-en-1-yl sulfamate (71.7 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used.  
Run 1: (45.0 mg, 0.254 mmol, 63%). Run 2: (40.9 mg, 0.231 mmol, 58%). Run 3: (44.3 mg, 
0.250 mmol, 62%) Average: 61% yield ± 2.2 (ins./azir. crude = >20:1). 
1H-NMR (500 MHz, CDCl3) δ 5.78 (dqd, J = 14.3, 6.5, 1.3 Hz, 1H), 5.43 (dd, J = 15.4, 5.9 Hz, 
1H), 4.74 (dt, J = 12.0, 2.7 Hz, 1H), 4.55 (dd, J = 11.6, 5.0 Hz, 1H), 4.30-4.24 (m, 1H), 4.00 (br. 
d, J = 10.0 Hz, 1H), 1.91-1.77 (m, 2H), 1.73 (dd, J = 6.5, 1.4 Hz, 3H); 13C-NMR (125 MHz, 
CDCl3) δ 129.6, 128.1, 71.8, 56.9, 29.8, 17.9; 13C-NMR (125 MHz, CDCl3) δ 129.6, 128.1, 71.8, 
56.9, 29.8, 17.9. These data are in agreement with that previously reported in the literature.31  
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(±)-4-propyl-1,2,3-oxathiazinane 2,2-dioxide [5]. 
In all cases, material was purified via flash column chromatography on silica (35 
mm fritted glass column, 150 mm SiO2) using 3:1 hexanes/EtOAc, affording a 
mixture of product and starting material; yields were determined based on 1H NMR ratios. Pure 
product could be obtained by eluting with CH2Cl2 à 2% Et2O/CH2Cl2. 
FePc conditions: Hexyl sulfamate (72.5 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.0 mg, 0.040 
mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 0.800 
mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were used. 
Run 1: (3.7 mg, 0.021 mmol, 5%), (53.3 mg rsm, 0.294 mmol, 74%). Run 2: (3.3 mg, 0.018 
mmol, 5%), (56.2 mg rsm, 0.310 mmol, 77%). Run 3: (2.7 mg, 0.015 mmol, 4%), (55.6 mg rsm, 
0.307 mmol, 77%).  Average: 5% yield ± 0.8, 76% rsm ± 1.4. 
MnPc conditions: Hexyl sulfamate (72.5 mg, 0.400 mmol, 1.0 equiv), [MnPc]Cl (24.0 mg, 
0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were used. 
Run 1: (26.1 mg, 0.146 mmol, 36%), (27.2 mg rsm, 0.150 mmol, 38%). Run 2: (29.1 mg, 0.162 
mmol, 41%), (23.9 mg rsm, 0.132 mmol, 33%). Run 3: (28.1 mg, 0.157 mmol, 39%), (23.9 mg 
rsm, 0.132 mmol, 33%).  Average: 39% yield ± 2.1, 35% rsm ± 2.4. 
Mn(tBuPc) conditions: Hexyl sulfamate (72.5 mg, 0.400 mmol, 1.0 equiv), [Mn(tBuPc)]Cl 
(33.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 
mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were 
used. 
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Run 1: (40.8 mg, 0.228 mmol, 57%), (14.5 mg rsm, 0.080 mmol, 20%). Run 2: (42.2 mg, 0.235 
mmol, 59%), (11.2 mg rsm, 0.062 mmol, 16%). Run 3: (40.1 mg, 0.224 mmol, 56%), (13.2 mg 
rsm, 0.073 mmol, 18%).  Average: 57% yield ± 1.2, 18% rsm ± 1.6. 
Product was isolated as a white solid. 1H-NMR (500 MHz, CDCl3) δ 4.74-4.66 (m, 1H), 4.52 (dt, 
J = 11.0, 3.3 Hz, 1H), 4.20 (br. d, J = 10.5 Hz, 1H), 3.74-3.66 (m, 1H), 1.73-1.69 (m, 2H), 1.53-
1.35 (m, 4H), 0.92 (t, J = 7.3 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 72.2, 55.9, 37.2, 29.9, 
18.4, 13.7; IR (ATR, cm-1) 3367, 3285, 2919, 2858, 1539, 1470, 1343, 1178, 1063, 1032, 973, 
922, 850, 792, 742, 717; HRMS (ESI) m/z calculated for C6H14NO3S [M+H]+: 180.0694, found 
180.0698. 
 
5,5-dimethyl-1,2,3-oxathiazinane 2,2-dioxide [6]. 
In all cases, the reaction was stirred at rt for 24h. The crude reaction mixture was 
purified via flash column chromatography on silica (35 mm fritted glass column, 150 
mm SiO2) using 15% EtOAc/hexanes à 20% EtOAc/hexanes with 0.5% AcOH as eluent. 
FePc conditions: Neopentyl sulfamate (66.9 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 
0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv) and 4:1 PhMe/MeCN (800 µL) were used. Product and recovered 
starting material were isolated as a mixture after column purification.   
Run 1: (2.0 mg, 0.012 mmol, 3% yield), (50.2 mg, 0.300 mmol, 75% rsm). Run 2: (2.4 mg, 0.015 
mmol, 4% yield), (48.0 mg, 0.287 mmol, 72% rsm). Run 3: (2.1 mg, 0.013 mmol, 3% yield), 
(52.2 mg, 0.312 mmol, 78% rsm). Average: 3% yield ± 0.6, 75% rsm ± 3.0. 
MnPc conditions: Neopentyl sulfamate (66.9 mg, 0.400 mmol, 1.0 equiv), [MnPc]Cl (24.2 mg, 
0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), crushed 4Å MS (100 mg), 
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PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (800 µL) were used. Product 
and starting material were isolated separately. 
Run 1: (24.8 mg, 0.150 mmol, 38% yield), (25.9 mg, 0.155 mmol, 39% rsm). Run 2: (22.1 mg, 
0.134 mmol, 33% yield), (27.0 mg, 0.161 mmol, 40% rsm). Run 3: (26.8 mg, 0.162 mmol, 41% 
yield), (29.5 mg, 0.176 mmol, 44% rsm). Average: 37% yield ± 4.0, 41% rsm ± 2.6. 
Mn(tBuPc) conditions: Neopentyl sulfamate (66.9 mg, 0.400 mmol, 1.0 equiv), [Mn(tBuPc)]Cl 
(33.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), crushed 4Å MS 
(100 mg), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (800 µL) were used. 
Product and starting material were isolated separately. 
Run 1: (42.6 mg, 0.258 mmol, 64% yield), (6.0 mg, 0.036 mmol, 9% rsm). Run 2: (41.3 mg, 
0.250 mmol, 63% yield), (10.4 mg, 0.062 mmol, 16% rsm). Run 3: (42.6 mg, 0.258 mmol, 64% 
yield), (8.6 mg, 0.051 mmol, 13% rsm). Average: 64% yield ± 0.6, 13% rsm ± 3.5. 
Product was isolated as a white solid. 1H-NMR (500 MHz, CDCl3) δ 4.69 (br. s, 1H), 4.27 (s, 
2H), 3.27 (d, J = 7.5 Hz, 2H), 1.07 (s, 6H); 13C-NMR (125 MHz, CDCl3) δ 81.7, 55.4, 29.1, 
21.9; IR (ATR, cm-1): 3315, 2967, 1425, 1399, 1350, 1336, 1314, 1282, 1183, 1046, 954, 930, 
922, 910, 844; HRMS (ESI) m/z calculated for C5H12NO3S [M+H]+: 166.0538, found 166.0535. 
 
(±)-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide [7]. 
In both cases, product was purified via flash column chromatography on silica (35 
mm fritted glass column, 120 mm SiO2) using 3:1 hexanes/EtOAc and collected as a 
mixture of sulfamate ester and product and yields determined by 1H NMR. Additional column 
purification using 10% hexanes/CH2Cl2 à CH2Cl2 à 2% Et2O/CH2Cl2 affords pure product as a 
pale yellow oil. Ins./azir. ratios determined by 1H NMR of the crude reaction mixture. 
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FePc conditions: Pent-4-en-1-yl sulfamate (66.1 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.0 
mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were used. 
Run 1: (13.5 mg, 0.083 mmol, 21%), (15.7 mg rsm, 0.095 mmol, 24%). Run 2: (14.2 mg, 0.087 
mmol, 22%), (15.7 mg rsm, 0.095 mmol, 24%). Run 3: (15.5 mg, 0.095 mmol, 24%), (18.2 mg 
rsm, 0.110 mmol, 28%).  Average: 22% yield ± 1.5 (ins./azir. crude = 7:1), 25% rsm ± 2.3. 
Mn(tBuPc) conditions: Pent-4-en-1-yl sulfamate (66.1 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (33.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. 
Run 1: (33.7 mg, 0.207 mmol, 52%), (12.6 mg rsm, 0.076 mmol, 19%). Run 2: (32.0 mg, 0.196 
mmol, 49%), (10.6 mg rsm, 0.064 mmol, 16%). Run 3: (31.2 mg, 0.191 mmol, 48%), (8.1 mg 
rsm, 0.050 mmol, 12%).  Average: 50% yield ± 1.9 (ins./azir. crude = 7:1), 16% rsm ± 3.5. 
1H-NMR (500 MHz, CDCl3) δ 5.82 (ddd, J = 17.1, 10.6, 4.9 Hz, 1H), 5.36-5.25 (m, 2H), 4.81-
4.72 (m, 1H), 4.57 (ddd, J = 11.9, 4.6, 2.2 Hz, 1H), 4.38-4.30 (m, 1H), 4.19 (d, J = 8.7 Hz, 1H), 
1.94-1.80 (m, 2H); 13C-NMR (125 MHz, CDCl3) δ 135.0, 117.5, 71.8, 57.0, 29.2.  These data are 
in agreement with that previously reported in the literature.15  
 
(±)-ethyl (E)-3-(2,2-dioxido-1,2,3-oxathiazinan-4-yl)acrylate [8]. 
In both cases, reaction stirred at rt for 12 h.  Product was purified via flash 
column chromatography on silica (35 mm fritted glass column, 120 mm SiO2) 
using 20% acetone/hexanes à 30% acetone/hexanes à 40% acetone/hexanes. 
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FePc conditions: ethyl (E)-6-(sulfamoyloxy)hex-2-enoate (94.9 mg, 0.400 mmol, 1.0 equiv), 
[FePc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were used. 
Run 1: (10.4 mg, 0.044 mmol, 11%), (55.1 mg rsm, 0.232 mmol, 58%). Run 2: (14.8 mg, 0.063 
mmol, 16%), (48.4 mg rsm, 0.204 mmol, 51%). Run 3: (9.2 mg, 0.039 mmol, 10%), (66.4 mg 
rsm, 0.280 mmol, 70%).  Average: 12% yield ± 2.6, 60% rsm ± 7.8. 
Mn(tBuPc) conditions: Ethyl (E)-6-(sulfamoyloxy)hex-2-enoate (94.9 mg, 0.400 mmol, 1.0 
equiv), [Mn(tBuPc)]Cl (33.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 
equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 
C6H6/MeCN (800 µL, 0.5M) were used. 
Run 1: (71.3 mg, 0.303 mmol, 76%), <10% rsm. Run 2: (71.6 mg, 0.305 mmol, 76%) <10% rsm. 
Run 3: (72.7 mg, 0.309 mmol, 77%) <10% rsm.  Average: 77% yield ± 0.5, <10% rsm. 
Product was isolated as a yellow oil. 1H-NMR (500 MHz, CDCl3) δ 6.84 (dd, J = 15.9, 4.7 Hz, 
1H), 6.04 (dd, J = 15.6, 1.8 Hz, 1H), 4.82-4.77 (m, 1H), 4.61 (ddd, J = 11.8, 3.4, 2.5 Hz, 1H), 
4.56-4.50 (m, 1H), 4.23 (q, J = 7.1 Hz, 2H), 4.15 (br. d, J = 10.5 Hz, 1H), 1.94-1.89 (m, 2H), 
1.30 (t, J = 7.1 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 165.8, 143.1, 123.0, 71.6, 61.2, 55.8, 
28.9, 14.3.  These data are in agreement with that previously reported in the literature.15 
 
(±)-Methyl (E)-(3-(2,2-dioxido-1,2,3-oxathiazinan-4-yl)allyl)(tosyl)carbamate [9]. 
(E)-6-((N-(methoxycarbonyl)-4-methylphenyl)sulfonamido)hex-4-en-1-yl 
sulfamate (81.3 mg, 0.200 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 
0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 4:1 PhMe/MeCN 
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(400 µL, 0.5M) were used. Reaction stirred at rt for 12 h. Product was purified via flash column 
chromatography on silica (35 mm fritted glass column, 120 mm SiO2) using 2:1 hexane/EtOAc 
à1:1 hexanes/EtOAc. Pure product was isolated as a white solid. 
Run 1: (58 mg, 0.144 mmol, 72%), <5% rsm. Run 2: (59 mg, 0.146 mmol, 73%), <5% rsm. Run 
3: (60 mg, 0.149 mmol, 76%), <5% rsm. Average: 73% yield ± 1.5, <5% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.81 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 5.86 (dt, J = 
15.6, 5.7 Hz, 1H), 5.76 (dd, J = 15.6, 5.2 Hz, 1H), 4.76 (td, J = 11.7, 11.0, 4.4 Hz, 1H), 4.60- 
4.56 (m, 1H), 4.46 (d, J = 5.5 Hz, 2H), 4.38 (tt, J = 10.2, 5.0 Hz, 1H), 3.96 (d, J = 10.3 Hz, 1H), 
3.71 (s, 3H), 2.45 (s, 3H), 1.95-1.82 (m, 2H); 13C-NMR (125 MHz, CDCl3) δ 152.6, 145.1, 
136.2, 130.9, 129.6, 128.5, 128.1, 71.8, 56.3, 54.2, 47.9, 29.4, 21.8; IR (film, cm-1) 3255, 2960, 
1736, 1596, 1443, 1359, 1242, 1170, 1089, 1011, 973, 937, 910, 866, 771, 736, 673, 579, 546; 
HRMS (ESI) m/z calculated for C15H21N2O7S2 [M+H]+: 405.0790, found 405.0786. 
 
(±)-hexahydrobenzo[d][1,2,3]oxathiazine 2,2-dioxide [10]. 
(±)-cyclohex-3-en-1-ylmethyl sulfamate (76.5 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 
equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 
C6H6/MeCN (800 µL, 0.5M) were used. Product was purified via flash column chromatography 
on silica (35 mm fritted glass column, 120 mm SiO2) using 5:1 hexanes/EtOAc. Pure product 
was isolated as a white solid as a single diastereomer. 
Run 1: (50.8 mg, 0.268 mmol, 67%), <5% rsm. Run 2: (54.4 mg, 0.287 mmol, 72%), <5% rsm. 
Run 3: (51.5 mg, 0.272 mmol, 68%), <5% rsm. Average: 69% yield ± 2.2, <5% rsm. 
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1H-NMR (500 MHz, CDCl3) δ 6.06-6.02 (m, 1H), 5.75-5.72 (m, 1H), 4.96 (dd, J = 11.8, 3.1 Hz, 
1H), 4.35 (dd, J = 11.8, 1.4 Hz, 1H), 4.32-4.28 (m, 1H), 4.05 (br. d, J = 11.2 Hz, 1H), 2.31-2.12 
(m, 2H), 1.92 (tdd, J = 14.1, 11.2, 5.9 Hz, 1H), 1.72-1.67 (m, 2H); 13C-NMR (125 MHz, CDCl3) 
δ 133.6, 123.7, 76.8, 52.4, 31.1, 25.0, 20.0.  These data are in agreement with that previously 
reported in the literature.15 
 
4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)-1,2,3-oxathiazolidine 2,2-dioxide [11]. 
(-)-2-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethyl sulfamate (98.1 mg, 
0.400 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), 
AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 
equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were used. Product was 
purified via flash column chromatography on silica (35 mm fritted glass column, 120 mm SiO2) 
using 5:1 hexanes/EtOAc. Pure product was isolated as a white solid and a 2:1 mixture of 
inseparable diastereomers. 
Run 1: (57.3 mg, 0.235 mmol, 59%), <5% rsm. Run 2: (59.7 mg, 0.245 mmol, 61%), <5% rsm. 
Run 3: (58.4 mg, 0.240 mmol, 60%), <5% rsm.  Average: 60% yield ± 1.3, <5% rsm. 
1H-NMR (500 MHz, CDCl3) δ 5.72-5.70 (m, 1H-Dmaj + 1H-Dmin), 4.58-4.46 (m, 2H-Dmaj + 2H-
Dmin), 4.32 (s, 1H-Dmaj + 1H-Dmin), 4.20 (t, J = 8.4 Hz, 1H-Dmin), 4.16 (t, J = 8.1 Hz, 1H-Dmaj), 
2.48 (dq, J = 8.9, 5.7 Hz, 1H-Dmaj + 1H-Dmin), 2.40-2.22 (m, 3H-Dmaj + 3H-Dmin), 2.18-2.12 (m, 
1H-Dmaj + 1H-Dmin), 1.32 (s, 3H-Dmaj + 3H-Dmin), 1.16 (d, J = 8.9 Hz, 1H-Dmaj), 1.13 (d, J = 8.9 
Hz, 1H-Dmin), 0.83 (s, 3H-Dmin), 0.79 (s, 3H-Dmaj); 13C-NMR (125 MHz, CDCl3) δ 141.2, 141.1, 
124.7, 124.1, 72.5, 72.2, 60.1, 60.0, 41.6, 41.4, 40.6, 40.6, 38.1, 31.6, 31.4, 31.4, 26.0, 25.9, 21.3, 
21.2; IR (film, cm-1) 3281, 2918, 2832, 1721, 1469, 1384, 1347, 1287, 1064, 973, 922, 886, 796, 
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773, 658, 637, 513, 487; HRMS (ESI) m/z calculated for C11H17NO3SNa [M+Na]+: 266.0827, 
found 266.0827. 
 
(±)-(E)-4-styryl-1,2,3-oxathiazolidine 2,2-dioxide [12]. 
(E)-4-phenylbut-3-en-1-yl sulfamate (90.0 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 
mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 
9:1 C6H6/MeCN (800 µL, 0.5M) were used. Product was purified via flash column 
chromatography on silica (35 mm fritted glass column, 150 mm SiO2) using 3:1 hexanes/EtOAc. 
Pure product was isolated as a white solid. Insertion to aziridination ratio was determined from 
1H NMR of the crude mixture. 
Run 1: (57.7 mg, 0.256 mmol, 64%), <5% rsm. Run 2: (55.1 mg, 0.245 mmol, 61%), <5% rsm. 
Run 3: (54.6 mg, 0.242 mmol, 61%), <5% rsm.  Average: 62% yield ± 1.7 (ins./azir. crude = 
7:1), <5% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.42-7.30 (m, 5H), 6.75 (d, J = 15.8 Hz, 1H), 6.13 (dd, J = 15.8, 
7.8 Hz, 1H), 4.77-4.64 (m, 2H), 4.46 (br. d, J = 6.6 Hz, 1H), 4.36 (t, J = 8.0 Hz, 1H); 13C-NMR 
(125 MHz, CDCl3) δ 136.7, 135.0, 129.2, 129.0, 127.0, 122.1, 74.0, 58.7. These data are in 
agreement with that previously reported in the literature.48 
 
(±)-4-((trimethylsilyl)ethynyl)-1,2,3-oxathiazinane 2,2-dioxide [13]. 
5-(trimethylsilyl)pent-4-yn-1-yl sulfamate (94.13 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 
mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 
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9:1 C6H6/MeCN (800 µL, 0.5M) were used. Product was purified via flash column 
chromatography on silica (35 mm fritted glass column, 150 mm SiO2) using 4:1 hexanes/EtOAc. 
Pure product was isolated as a white solid. 
Run 1: (60.0 mg, 0.257 mmol, 64%), <5% rsm. Run 2: (58.2 mg, 0.249 mmol, 62%), <5% rsm. 
Run 3: (60.0 mg, 0.257 mmol, 64%), <5% rsm.  Average: 64% yield ± 1.1, <5% rsm. 
1H-NMR (500 MHz, CDCl3) δ 4.70 (ddd, J = 12.7, 11.8, 2.5 Hz, 1H), 4.58-4.51 (m, 2H), 4.30 (d, 
J = 10.1 Hz, 1H), 2.10 (dddd, J = 14.8, 12.6, 11.6, 4.9 Hz, 1H), 2.01-1.97 (m, 1H), 0.17 (s, 9H); 
13C-NMR (125 MHz, CDCl3) δ 100.1, 91.6, 71.4, 48.1, 30.9, -0.3; IR (film, cm-1) 3233, 2962, 
2901, 2193, 1717, 1463, 1430, 1358, 1254, 1190, 1170, 1077, 1061, 997, 941, 922, 876, 780, 




1-yl 4-methylbenzenesulfonate [14]. 
(S)-2-((tert-butyldimethylsilyl)oxy)-7-(tosyloxy)hept-4-yn-1-yl sulfamate (98.3 mg, 0.200 mmol, 
1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 
0.10 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 50 mg crushed 4Å MS, and 9:1 
C6H6/MeCN (800 µL, 0.5M) were used. Reaction stirred at rt for 12 hours.  Product was purified 
via flash column chromatography on silica (75 mL SiO2) using 5:1 hexanes/EtOAc à 4:1 
hexanes/EtOAc. Product was isolated as a clear oil as a 1:1 mixture of diastereomers.  Additional 
column purification using a gradient of 10% hexanes/CH2Cl2 à CH2Cl2 à 1% Et2O/CH2Cl2 
allowed separation of diastereomers. 
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Run 1: (45.7 mg, 0.093 mmol, 47%), <5% rsm. Run 2: (47.9 mg, 0.098 mmol, 49%), <5% rsm. 
Run 3: (46.5 mg, 0.095 mmol, 48%), <5% rsm. Average: 48% yield ± 1, <5% rsm. 
Syn diastereomer: 1H-NMR (500 MHz, CDCl3) δ 7.80 (d, J = 
8.3 Hz, 2H), 7.38 (d, J = 7.9 Hz, 2H), 4.65-4.54 (m, 3H), 4.28 
(dd, J = 12.3, 1.9 Hz, 1H), 4.07 (td, J = 6.9, 1.0 Hz, 2H), 3.67 
(dt, J = 2.1, 1.0 Hz, 1H), 2.58 (td, J = 6.8, 1.7 Hz, 2H), 2.47 (s, 3H), 0.92 (s, 9H), 0.14 (s, 3H), 
0.12 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 145.4, 132.8, 130.1, 128.1, 81.4, 76.9, 75.9, 67.1, 
64.0, 53.4, 25.7, 21.8, 19.8, 18.2, -4.6, -4.7; IR (film, cm-1) 3257, 2929, 2857, 1422, 1364, 1257, 
1176, 1137, 1074, 1028, 986, 904, 864, 838, 776, 664, 553, 480, 459; [α]D25= -18.2° (c = 1.28, 
CHCl3); HRMS (ESI) m/z calculated for C20H32NO7S2Si [M+H]+: 490.1389, found 490.1386. 
Anti diastereomer: 1H-NMR (500 MHz, CDCl3) δ 7.80 (d, J = 
8.3 Hz, 2H), 7.37 (d, J = 8.6 Hz, 2H), 4.55 (d, J = 8.7 Hz, 1H), 
4.45 (dd, J = 11.7, 4.0 Hz, 1H), 4.31 (dd, J = 11.6, 8.2 Hz, 1H), 
4.22 (ddt, J = 9.6, 7.8, 2.2 Hz, 1H), 4.11 (t, J = 6.6 Hz, 2H), 3.79 (td, J = 7.9, 4.0 Hz, 1H), 2.61 
(td, J = 6.7, 2.0 Hz, 2H), 2.47 (s, 3H), 0.89 (s, 9H), 0.12 (s, 3H), 0.12 (s, 3H); 13C-NMR (125 
MHz, CDCl3) δ 145.4, 132.9, 130.1, 128.0, 82.4, 77.3, 73.1, 67.3, 66.4, 53.3, 25.6, 21.8, 20.0, 
18.1, -4.5, -4.6; IR (film, cm-1) 3257, 2929, 2857, 1719, 1598, 1432, 1369, 1259, 1190, 1133, 
1046, 904, 840, 782, 664, 618, 555, 492; [α]D25 = -38.1° (c = 0.54, CHCl3); HRMS (ESI) m/z 
calculated for C20H32NO7S2Si [M+H]+: 490.1389, found 490.1388. 
 
(-)-(4R,7R)-6,6-dimethyltetrahydro-[1,3]dioxolo[4,5-d][1,2,3]oxathiazine 2,2-dioxide [15]. 
(-)-(S)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate (84.49 mg, 0.400 mmol, 1.0 
equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 
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mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 
9:1 C6H6/MeCN (800 µL, 0.5M) were used. Product was purified via flash column 
chromatography on silica (35 mm fritted glass column, 120 mm SiO2) using 3:1 hexanes/EtOAc 
à 2:1 hexanes/EtOAc. Pure product was isolated as a pale yellow solid. 
Run 1: (55.5 mg, 0.265 mmol, 66%), <5% rsm. Run 2: (52.6 mg, 0.251 mmol, 63%), <5% rsm. 
Run 3: (52.9 mg, 0.253 mmol, 63%), <5% rsm.  Average: 64% yield ± 1.4, <5% rsm. 
1H-NMR (500 MHz, CD3OD) δ 5.41 (d, J = 5.1 Hz, 1H), 4.59-4.58 (m, 2H), 4.30 (dt, J = 5.2, 1.6 
Hz, 1H), 1.54 (s, 3H), 1.34 (s, 3H); 13C-NMR (125 MHz, CD3OD) δ 111.5, 85.6, 71.7, 71.5, 
26.9, 25.6.  [α]D25= -36.7° (c = 0.71, acetone). These data are in agreement with that previously 
reported in the literature.36  
 
(-)-3,4-(2,2-dioxido-1,2,3-oxathiazinan-3-yl)-pregnenolone [16]. 
Pregenolyl sulfamate (79.1 mg, 0.200 mmol, 1.0 equiv), [Mn(tBuPc)]Cl 
(16.6 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.10 
equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å 
MS, and 4:1 C6H6/MeCN (400 µL, 0.5M) were used. Reaction stirred at rt 
for 12 h. Product was purified via flash column chromatography on silica (35 mm fritted glass 
column, 120 mm SiO2) using 20% EtOAc/hexanes à 30% EtOAc/hexanes à 40% 
EtOAc/hexanes. Pure product was isolated as a white solid. 
Run 1: (41.9 mg, 0.106 mmol, 53%), <5% rsm. Run 2: (45.5 mg, 0.116 mmol, 58%), <5% rsm. 
Run 3: (42.3 mg, 0.107 mmol, 54%), <5% rsm.  Average: 55% yield ± 2.2, <5% rsm. 
1H-NMR (500 MHz, CDCl3) δ 5.82 (dd, J = 4.8, 2.3 Hz, 1H), 4.75 (dt, J = 11.5, 6.0 Hz, 1H), 
4.54 (t, J = 5.5 Hz, 1H), 4.38 (d, J = 5.0 Hz, 1H), 2.53 (t, J = 8.8 Hz, 1H), 2.33-2.14 (m, 3H), 
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2.13 (s, 3H), 2.11-2.04 (m, 2H), 1.92 (dt, J = 14.0, 4.0 Hz, 1H), 1.71-1.57 (m, 5H), 1.49-1.41 (m, 
2H), 1.28-1.22 (m, 2H), 1.21 (s, 3H), 1.20-1.09 (m, 2H), 1.02-0.96 (m, 1H), 0.64 (s, 3H); 13C-
NMR (125 MHz, CDCl3) δ 209.5, 135.9, 133.3, 84.0, 63.6, 62.1, 56.9, 49.2, 44.0, 38.6, 36.2, 
33.6, 32.1, 31.6, 31.5, 24.5, 23.8, 22.9, 21.2, 20.7, 13.4; IR (film, cm-1) 3252, 2944, 1698, 1454, 
1339, 1291, 1174, 966, 941, 754, 667, 587, 479; [α]D25 = -23.6° (c = 0.68, CHCl3); HRMS (ESI) 
m/z calculated for C21H32NO4S [M+H]+: 394.2052, found 394.2053. 
 
(-)-3,4-(2,2-dioxido-1,2,3-oxathiazinan-3-yl)-stigmasterol [17].  
Stigmasteryl sulfamate (98.4 mg, 0.200 mmol, 1.0 equiv), 
Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 
0.020 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 
equiv), 100 mg crushed 4Å MS, and 4:1 C6H6/MeCN (400 µL, 
0.5M) were used. Reaction stirred for 12 h. Product was purified via flash column 
chromatography on silica (35 mm fritted glass column, 120 mm SiO2) using 10% 
acetone/hexanes à 15% acetone/hexanes. Pure product was isolated as a white solid. 
Run 1: (61 mg, 0.125 mmol, 63%), <5% rsm. Run 2: (64 mg, 0.131 mmol, 66%), <5% rsm. Run 
3: (67 mg, 0.137 mmol, 69%), <5% rsm. Average: 66% yield ± 2.1, <5% rsm. 
1H-NMR (500 MHz, CDCl3) δ 5.82 (dd, J = 4.7, 2.2 Hz, 1H), 5.15 (dd, J = 15.1, 8.6 Hz, 1H), 
5.02 (dd, J = 15.1, 8.6 Hz, 1H), 4.74 (dt, J = 10.7, 6.0 Hz, 1H), 4.53 (t, J = 5.6 Hz, 1H), 4.29 (d, 
J = 5.3 Hz, 1H), 2.27 (tdd, J = 13.9, 10.8, 3.5 Hz, 1H), 2.14 (dt, J = 17.2, 4.5 Hz, 1H), 2.08-1.99 
(m, 3H), 1.91 (dt, J = 14.0, 4.0, 1H), 1.72 (dtd, J = 13.6, 9.4, 5.9 Hz, 1H), 1.63-1.39 (m, 10H), 
1.28-1.25 (m, 2H), 1.23- 0.99 (m, 10H), 0.93-0.90 (m, 2H), 0.88-0.75 (m, 9H), 0.71 (s, 3H); 13C-
NMR (125 MHz, CDCl3) δ 138.3, 135.9, 133.9, 129.7, 84.4, 62.4, 57.1, 56.1, 51.5, 49.5, 42.4, 
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40.7, 39.6, 36.3, 33.7, 32.3, 32.1, 31.7, 29.1, 27.3, 25.6, 24.5, 23.9, 21.4, 21.3, 20.8, 19.2, 12.5, 
12.3; IR (film, cm-1) 3326, 2955, 2867, 1456, 1369, 1321, 1190, 1173, 1021, 987, 940, 925, 820, 
790, 752, 688; [α]D25 = -60.1° (c = 0.62, CHCl3); HRMS (ESI) m/z calculated for C29H48NO3S 
[M+H]+: 490.3355, found 490.3362. 
 
C—H Bond Reactivity Trends 
(±)-5-methyl-1-phenylhexan-3-yl sulfamate [19]. 
Prepared according to method A. 1.600 g (8.56 mmol) of (±)-5-methyl-1-
phenylhexan-3-ol were used, along with NaH (237 mg, 9.4 mmol, 1.1 equiv), 
DMF (8.5 mL + 6.8 mL), ClSO2NCO (1.11 mL, 12.8 mmol, 1.5 equiv), formic acid (483 µL, 
12.8 mmol, 1.5 equiv) and MeCN (6.5 mL). Flash column chromatography on silica (35 mm 
fritted glass column, 150 mm SiO2) using 9:1 hexanes/EtOAc à 4:1 hexanes/EtOAc as eluent 
gave 1.720 g (6.34 mmol) of pure product as a white solid (74% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.31-7.28 (m, 2H), 7.22-7.19 (m, 3H), 4.76-4.69 (m, 3H), 2.75 (td, 
J = 8.5, 3.0 Hz, 2H), 2.11-2.00 (m, 2H), 1.79-1.72 (m, 2H), 1.51 (ddd, J = 16.0, 10.0, 5.5 Hz, 
1H), 0.95 (d, J = 6.0 Hz, 3H), 0.93 (d, J = 6.5 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 141.3, 
128.6, 128.5, 126.2, 83.5, 43.3, 36.2, 31.1, 24.6, 22.9, 22.6. These data are in agreement with that 
previously reported in the literature.31  
 
(±)-2-methyl-8-(trimethylsilyl)oct-7-yn-4-yl sulfamate [20].  
Prepared according to method B. 2.655 g (12.5 mmol) of (±)-2-methyl-8-
(trimethylsilyl)oct-7-yn-4-ol were used, along with Et3N (3.5 mL, 25 mmol, 
2.0 equiv), CH2Cl2 (13 mL + 36 mL), ClSO2NCO (2.18 mL, 25 mmol, 2.0 
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equiv), formic acid (943 µL, 25 mmol, 2.0 equiv). Flash column chromatography on silica (35 
mm fritted glass column, 150 mm SiO2) using 9:1 hexanes/EtOAc à 4:1 hexanes/EtOAc as 
eluent gave 2.290 g (7.85 mmol) of pure product as a white solid (63% yield).  
1H-NMR (500 MHz, CDCl3) δ 4.84-4.80 (m, 2H), 2.40 (t, J = 6.8 Hz, 2H), 1.92-1.88 (m, 2H), 
1.77-1.71 (m, 2H), 1.53-1.47 (m, 1H), 0.96 (d, J = 6.0 Hz, 3H), 0.94 (d, J = 6.5 Hz, 3H), 0.16 (s, 
9H); 13C-NMR (125 MHz, CDCl3) δ 106.0, 86.7, 82.5, 43.6, 33.0, 24.6, 22.7, 22.6, 16.9, 0.2; IR 
(ATR, cm-1) 3370, 3284, 2960, 2873, 2175, 1559, 1470, 1359, 1250, 1183, 923, 844, 761; 
HRMS (ESI) m/z calculated for C12H26NO3SSi [M+H]+: 292.1403, found 292.1406. 
 
(±)-2-methyloctan-4-yl sulfamate [21]. 
Prepared according to method A. 1.863 g (12.9 mmol) of (±)-2-methyloctan-4-ol 
were used, along with NaH (359 mg, 14.2 mmol, 1.1 equiv), DMF (13 mL + 10 
mL), ClSO2NCO (1.69 mL, 19.4 mmol, 1.5 equiv), formic acid (731 µL, 19.4 mmol, 1.5 equiv) 
and MeCN (10 mL). Flash column chromatography on silica (45 mm fritted glass column, 170 
mm SiO2) using 9:1 hexanes/EtOAc à 4:1 hexanes/EtOAc as eluent gave 2.017 g (9.03 mmol) 
of pure product as a colorless oil (70% yield). This sulfamate ester generated precipitate rapidly 
and was repurified if not used within a week. 
1H-NMR (500 MHz, CDCl3) δ 4.75 (br. s, 2H), 4.67 (app. dq, J = 7.5, 5.5 Hz, 1H), 1.79-1.66 (m, 
4H), 1.47-1.29 (m, 5H), 0.95 (d, J = 7.0 Hz, 3H), 0.93 (d, J = 6.5 Hz, 3H), 0.91 (t, J = 7.0 Hz, 
3H); 13C-NMR (125 MHz, CDCl3) δ 84.3, 43.3, 34.3, 26.9, 24.5, 23.0, 22.7, 22.5, 14.1; HRMS 
(ESI) m/z calculated for C9H21NO3SNa [M+Na]+: 246.1140, found 246.1139. 
 
Tertiary C—H versus Allylic C—H.  
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In all cases, flash column chromatography on silica (35 mm fritted glass column, 150 mm SiO2) 
using 6:1 hexanes:EtOAc + 1% AcOH as eluent gave pure syn and anti oxathiazinanes 
separately; the olefin maintained a >20:1 E/Z geometry in each case. Data for [FePc]Cl has been 
previously reported.11  
MnPc conditions: (±)-(E)-2-methylnon-7-en-4-yl sulfamate (94.0 mg, 0.400 mmol, 1.0 equiv), 
[MnPc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. By 1H-NMR analysis of the crude product, γ:γ’ was <1:20, ins./azir. was 
>20:1, and d.r. was 3:1 syn:anti.  
Run 1: (54.6 mg syn + 12.1 mg anti (4.5:1 d.r.), 0.286 mmol, 72%), <5% rsm. Run 2: (56.0 mg 
syn + 11.1 mg anti (5:1 d.r.), 0.288 mmol, 72%), <5% rsm. Run 3: (56.3 mg syn + 11.2 mg anti 
(5:1 d.r.), 0.290 mmol, 73%), <5% rsm. Average: 72% yield allylic ± 0.5 (γ:γ’ crude = <1:20), 
<5% rsm. 
Mn(tBuPc) conditions: (±)-(E)-2-methylnon-7-en-4-yl sulfamate (94.0 mg, 0.400 mmol, 1.0 
equiv), Mn(tBuPc)Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 
equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 
C6H6/MeCN (800 µL, 0.5M) were used. By 1H-NMR analysis of the crude product, γ:γ’ was 
<1:20, ins./azir. was >20:1, and d.r. was 4:1 syn:anti. 
Run 1: (55.0 mg syn + 13.8 mg anti (4:1 d.r.), 0.296 mmol, 74%), 0% rsm. Run 2: (51.9 mg syn 
+ 14.0 mg anti (3.7:1 d.r.), 0.284 mmol, 71%), 0% rsm. Run 3: (55.6 mg syn + 15.9 mg anti 
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Tertiary C—H versus Benzylic C—H. 
In all cases, material was purified via flash column chromatography on silica (35 mm fritted 
glass column, 150 mm SiO2) using 10% EtOAc/hexanes à 15% EtOAc/hexanes à 20% 
EtOAc/hexanes, isolating the 3° and benzylic products and starting material separately. 
FePc conditions: 5-methyl-1-phenylhexan-3-yl sulfamate (109 mg, 0.400 mmol, 1.0 equiv), 
[FePc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were used. 
By 1H-NMR analysis of the crude product, γ:γ’ was 1:14. 
Run 1: (56.2 mg benzylic, 0.208 mmol, 52%), (5.5 mg 3° (10:1 benzylic/3°), 0.020 mmol, 5%), 
(14.5 mg rsm, 0.053 mmol, 13% rsm). Run 2: (53.9 mg benzylic, 0.200 mmol, 50%), (5.7 mg 3° 
(10:1 benzylic/3°), 0.021 mmol, 5%), (12.4 mg rsm, 0.046 mmol, 11%). Run 3: (55.5 mg 
benzylic, 0.206 mmol, 51%), (5.8 mg 3° (10:1 benzylic/3°), 0.021 mmol, 5%), (13.4 mg rsm, 
0.049 mmol, 12%). Average: 51% yield benzylic ± 0.8 (γ:γ’ crude = 1:14), 12% rsm ± 0.8. 
MnPc conditions: 5-methyl-1-phenylhexan-3-yl sulfamate 42 (109 mg, 0.400 mmol, 1.0 equiv), 
[MnPc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. By 1H-NMR analysis of the crude product, γ:γ’ was 1:3. 
Run 1: (66.8 mg benzylic, 0.247 mmol, 62%), (23.0 mg 3° (2.9:1 benzylic/3°), 0.085 mmol, 
21%), 0% rsm. Run 2: (65.6 mg benzylic, 0.242 mmol, 61%), (19.9 mg 3° (2.8:1 benzylic/3°), 
0.073 mmol, 18%), 0% rsm. Run 3: (64.7 mg benzylic, 0.240 mmol, 60%), (20.5 mg 3° (2.8:1 
benzylic/3°), 0.076 mmol, 19%), 0% rsm. Average: 61% yield benzylic ± 0.8 (γ:γ’ crude = 
1:3), 0% rsm. 
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Mn(tBuPc) conditions: 5-methyl-1-phenylhexan-3-yl sulfamate (109 mg, 0.400 mmol, 1.0 
equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 
equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 
C6H6/MeCN (800 µL, 0.5M) were used. By 1H-NMR analysis of the crude product, γ:γ’ was 1:3.  
Run 1: (66.0 mg benzylic, 0.244 mmol, 61%), (22.8 mg 3° (2.9:1 benzylic/3°), 0.084 mmol, 
21%), 0% rsm. Run 2: (62.6 mg benzylic, 0.232 mmol, 58%), (18.0 mg 3° (2.7:1 benzylic/3°), 
0.067 mmol, 17%), 0% rsm. Run 3: (63.0 mg benzylic, 0.233 mmol, 58%), (20.7 mg 3° (2.8:1 
benzylic/3°), 0.077 mmol, 19%), 0% rsm. Average: 59% yield benzylic ± 1.4 (γ:γ’ crude = 
1:3), 0% rsm. 
4,4-dimethyl-6-phenethyl-1,2,3-oxathiazinane 2,2-dioxide. 1H-NMR (500 
MHz, CDCl3) δ 7.31 (dd, J = 12.5, 7.5 Hz, 2H), 7.23-7.19 (m, 3H), 4.84-4.82 
(m, 1H), 4.34 (br. s, 1H), 2.84 (ddd, J = 15.5, 9.5, 5.0 Hz, 1H), 2.78-2.72 (m, 
1H), 2.06 (dtd, J = 14.5, 9.0, 5.5 Hz, 1H), 1.89 (dddd, J = 13.5, 9.5, 7.5, 4.0 Hz, 1H), 1.68-1.60 
(m, 2H), 1.47 (s, 3H), 1.30 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 140.6, 128.7, 128.6, 126.4, 
80.4, 56.0, 41.5, 37.2, 31.9, 30.9, 25.2. These data agree with that previously reported in the 
literature.31 
6-isobutyl-4-phenyl-1,2,3-oxathiazinane 2,2-dioxide. 1H-NMR (500 MHz, 
CDCl3) δ 7.42-7.33 (m, 5H), 4.95 (dddd, J = 11.5, 9.0, 4.5, 2.0 Hz, 1H), 4.81 
(ddd, J = 12.0, 9.0, 3.0 Hz, 1H), 4.21 (br. d, J = 9.0 Hz, 1H), 2.04 (dt, J = 14.5, 
3.0 Hz, 1H), 1.94-1.86 (m, 2H), 1.79 (ddd, J = 9.0, 6.0 Hz, 1H), 1.44 (ddd, J = 12.5, 8.5, 4.0 Hz, 
1H), 0.97 (d, J = 6.5 Hz, 3H), 0.95 (d, J = 6.5 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 138.2, 
129.3, 129.0, 126.4, 83.9, 58.4, 44.3, 36.8, 23.9, 23.0, 22.0. These data agree with that previously 
reported in the literature.31 
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Tertiary C—H versus Propargylic C—H.  
In all cases, material was purified via flash column chromatography on silica (35 mm fritted 
glass column, 150 mm SiO2) using 10% EtOAc/hexanes à 15% EtOAc/hexanes, isolating 
product and starting material separately. 
FePc conditions: 2-methyl-8-(trimethylsilyl)oct-7-yn-4-yl sulfamate (116.6 mg, 0.400 mmol, 
1.0 equiv), [FePc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 
equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were 
used. By 1H-NMR analysis of the crude product, γ:γ’ was 1:3. 
Run 1: (61.1 mg propargylic, 0.211 mmol, 53%), (21.7 mg 3°, 0.075 mmol, 19%), 0% rsm. Run 
2: (64.7 mg propargylic, 0.223 mmol, 56%), (23.6 mg 3°, 0.081 mmol, 20%), 0% rsm. Run 3: 
(61.7 mg propargylic, 0.213 mmol, 53%), (26.1 mg 3°, 0.090 mmol, 23%), 0% rsm. Average: 
54% yield ± 1.7 propargylic (γ:γ’ crude = 1:3), 0% rsm. 
MnPc conditions: 2-methyl-8-(trimethylsilyl)oct-7-yn-4-yl sulfamate (116.6 mg, 0.400 mmol, 
1.0 equiv), [MnPc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 
equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 
C6H6/MeCN (800 µL, 0.5M) were used. By 1H-NMR analysis of the crude product, γ:γ’ was 1:2. 
Run 1: (61.0 mg propargylic, 0.210 mmol, 53%), (34.8 mg tertiary, 0.120 mmol, 30%). Run 2: 
(69.9 mg propargylic, 0.241 mmol, 60%), (36.4 mg tertiary, 0.126 mmol, 31%). Run 3: (65.1 mg 
propargylic, 0.225 mmol, 56%), (37.9 mg tertiary, 0.131 mmol, 33%). Average: 56% yield ± 
3.5 propargylic (γ:γ’ crude = 1:2), 0% rsm. 
Mn(tBuPc) conditions: 2-methyl-8-(trimethylsilyl)oct-7-yn-4-yl sulfamate (116.6 mg, 0.400 
mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 
mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 
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9:1 C6H6/MeCN (800 µL, 0.5M) were used. By 1H-NMR analysis of the crude product, γ:γ’ was 
1:2. 
Run 1: (81.6 mg propargylic, 0.282 mmol, 70%), (30.8 mg tertiary, 0.106 mmol, 27%). Run 2: 
(78.4 mg propargylic, 0.271 mmol, 68%), (28.7 mg tertiary, 0.099 mmol, 25%). Run 3: (80.0 mg 
propargylic, 0.276 mmol, 69%), (32.5 mg tertiary, 0.112 mmol, 28%). Average: 69% yield ± 
0.8 propargylic (γ:γ’ crude = 1:2), 0% rsm. 
4,4-dimethyl-6-(4-(trimethylsilyl)but-3-yn-1-yl)-1,2,3-oxathiazinane 2,2-dioxide. 
1H-NMR (500 MHz, CDCl3) δ 5.00-4.96 (m, 1H), 4.28 (br. s, 1H), 2.40 (t, 
J = 7.0 Hz, 2H), 1.99-1.92 (m, 1H), 1.84-1.77 (m, 1H), 1.70-1.59 (m, 2H), 
1.50 (s, 3H), 1.30 (s, 3H), 0.14 (s, 9H); 13C-NMR (125 MHz, CDCl3) δ 134.5, 123.7, 104.9, 86.3, 
79.8, 56.0, 41.2, 33.9, 31.9, 25.2, 15.6, 0.1; (ATR, cm-1) 3269, 2960, 1730, 1423, 1389, 1374, 
1354, 1250, 1194, 1164, 944, 908, 844, 873, 760; HRMS (ESI) m/z calculated for C12H24NO3SSi 
[M+H]+: 290.1246, found 290.1238. 
6-isobutyl-4-((trimethylsilyl)ethynyl)-1,2,3-oxathiazinane 2,2-dioxide. 
Syn diastereomer:  1H-NMR (500 MHz, CDCl3) δ 4.77 (dddd, J = 11.6, 9.0, 
4.3, 2.1 Hz, 1H), 4.50 (ddd, J = 12.0, 10.4, 3.0 Hz, 1H), 4.12 (d, J = 10.4 
Hz, 1H), 2.02 (dt, J = 14.6, 2.6 Hz, 1H), 1.90-1.81 (m, 1H), 1.82-1.66 (m, 2H), 1.38 (ddd, J = 
14.2, 8.5, 4.4 Hz, 1H), 0.94 (d, J = 4.5 Hz, 3H), 0.93 (d, J = 4.8 Hz, 3H), 0.17 (s, 9H); 13C-NMR 
(125 MHz, CDCl3) δ 100.4, 91.5, 82.4, 47.6, 44.1, 37.2, 23.9, 23.0, 22.1, -0.2; (ESI) m/z 
calculated for C12H24NO3SSi [M+H]+: 290.1246, found 290.1244. 
 
Anti diastereomer:  1H-NMR (500 MHz, CDCl3) δ 5.19-5.14 (m, 1H), 4.67 
(d, J = 6.0 Hz, 1H), 4.49-4.46 (m, 1H), 2.02-1.77 (m, 4H), 1.44-1.39 (m, 
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1H), 0.97 (d, J = 6.4 Hz, 3H), 0.95 (d, J = 6.5 Hz, 3H), 0.18 (s, 9H); 13C-NMR (125 MHz, 
CDCl3) δ 101.1, 91.6, 81.4, 46.1, 43.3, 35.2, 24.1, 22.7, 22.0, 0.0; (ATR, cm-1) 3278, 2960, 2874, 
1470, 1422, 1371, 1251, 1189, 1097, 1015, 867, 845, 791, 761; (ESI) m/z calculated for 
C12H24NO3SSi [M+H]+: 290.1246, found 290.1252. 
 
Tertiary C—H versus Secondary C—H.  
In all cases, material was purified via flash column chromatography on silica (35 mm fritted 
glass column, 150 mm SiO2) using 4:1 hexanes/EtOAc, isolating product and starting material 
separately. The 3° + 2° products could not be separated by any column conditions and were thus 
isolated as a mixture. 
FePc conditions: (±)-2-methyloctan-4-yl sulfamate (89.3 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl 
(24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 
mg, 0.800 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were used. By 1H-NMR 
analysis of the crude product, γ:γ’ was >20:1. 
Run 1: (26.5 mg 3°, 0.120 mmol, 30%), (27.5 mg rsm, 0.123 mmol, 31%). Run 2: (28.3 mg 3°, 
0.128 mmol, 32%), (33.6 mg rsm, 0.151 mmol, 38%). Run 3: (27.1 mg 3°, 0.122 mmol, 31%), 
(33.4 mg rsm, 0.150 mmol, 37%). Average: 31% yield 3° ± 0.8 (γ:γ’ crude = >20:1), 35% rsm 
± 3.1. 
MnPc conditions: (±)-2-methyloctan-4-yl sulfamate (89.3 mg, 0.400 mmol, 1.0 equiv), 
[MnPc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. By 1H-NMR analysis of the crude product, γ:γ’ was 5:1. 
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Run 1: (55.8 mg 3°, 0.252 mmol, 63%), 0% rsm. Run 2: (57.2 mg 3°, 0.259 mmol, 65%), 0% rsm. 
Run 3: (59.0 mg 3°, 0.267 mmol, 67%), 0% rsm. Average: 65% yield 3° ± 1.6 (γ:γ’ crude = 
5:1), 0% rsm. 
Mn(tBuPc) conditions: (±)-2-methyloctan-4-yl sulfamate (89.3 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. By 1H-NMR analysis of the isolated product, γ:γ’ was 5:1. 
Run 1: (70.6 mg 3°, 0.319 mmol, 80%), 0% rsm. Run 2: (71.1 mg 3°, 0.321 mmol, 80%), 0% rsm. 
Run 3: (74.3 mg 3°, 0.336 mmol, 84%), 0% rsm. Average: 81% yield 3° ± 1.9 (γ:γ’ = 5:1), 0% 
rsm. 
6-butyl-4,4-dimethyl-1,2,3-oxathiazinane 2,2-dioxide. Product was isolated as 
a white solid. 1H-NMR (500 MHz, CDCl3) δ 4.84-4.79 (m, 1H), 4.06 (s, 1H), 
1.77-1.71 (m, 1H), 1.66-1.56 (m, 3H), 1.51-1.31 (m, 4H), 1.48 (s, 3H), 1.30 (s, 3H), 0.91 (t, J = 
7.0 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 81.4, 56.0, 41.7, 35.1, 32.1, 26.8, 25.3, 22.4, 14.0; 
IR (ATR, cm-1) 3264, 2974, 2953, 2931, 2874, 1472, 1456, 1429, 1418, 1388, 1374, 1345, 1271, 
1190, 1179, 1152, 1043, 1008, 988, 952, 890, 822, 766, 728; HRMS (ESI) m/z calculated for 
C9H19NO3SNa [M+Na]+: 244.0983, found 244.0982. 
Intramolecular Kinetic Isotope Effect Study 
 
 
Method for KIE Determination: The column-purified product mixture (ca. 30 mg in 700 µL 
CDCl3) was analyzed by 13C-NMR (600 MHz instrument).11,15,49 Cr(acac)3 (15 mg) was added 
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directly to the solution in the NMR tube immediately prior to running the NMR study; this helps 
to significantly reduce delay times needed to obtain accurate integrations. The experiment was 
run under inverse-gated decoupling conditions without sample spinning. The following 
parameters were used for the experiment, listed as Varian commands: 
temp=23 
dm=’nny’ (inverse-gated decoupling) 
d1=5 (initial delay) 
at=0.5 (acquisition time) 
setsw(180,0) (spectral width, in ppm) 
bs=64 (block size for FID) 
nt=2944 (number of scans) 
pw=pw90=7.0 (pulse width, 90° pulse width) 
The KIE was reported as the area of the deuterated peak over that of the protonated peak. Three 
identical NMR experiments were run and an average value was calculated with error reported as 
a standard deviation. 
[FePc]Cl: C—H/C—D = 4.8 ± 0.1 (5.0, 4.6, 4.8)  
[MnPc]Cl: C—H/C—D = 4.5 ± 0.1 (4.6, 4.4, 4.4) 
[Mn(tBuPc)]Cl: C—H/C—D = 4.2 ± 0.1 (4.2, 4.1, 4.4) 
Rh2(OAc)4: C—H/C—D = 3.8 ± 0.1 (3.8, 4.0, 3.7) 
(±)-4-deuterio-4-phenyl-tetrahydro-1,2,3-oxathiazine-2,2-dioxide. 
(±)-3-deuterio-3-phenylprop-1-yl sulfamate (86.5 mg, 0.400 mmol, 1.0 equiv), 
[MnPc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 
equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 9:1 C6H6:MeCN (800 µL) were used. 
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Flash column chromatography on silica (35 mm fritted glass column, 150 mm SiO2) using 3:1 
hexanes/EtOAc as eluent gave the deuterated and protonated oxathiazinanes as a mixture.  
Run 1: (58.4 mg, 0.1273 mmol, 68%), <5% rsm. Run 2: (55.7 mg, 0.260 mmol, 65%), <5% rsm. 
Run 3: (55.1 mg, 0.257 mmol, 64%), <5% rsm. Average: 66% yield ± 1.7, <5% rsm. 
Characterization data are in agreement with that previously reported in the literature.11  
 
Olefin Isomerization Study 
 
(Z)-hex-4-en-1-yl sulfamate [23]. 
Prepared according to method A. 500 mg (584 µL, 5.0 mmol) of cis-4-
hexene-1-ol were used, along with NaH (138 mg, 5.5 mmol, 1.1 equiv), DMF (8.9 mL), 
ClSO2NCO (651 µL, 7.5 mmol, 1.5 equiv), formic acid (283 µL, 7.5 mmol, 1.5 equiv) and 
MeCN (3.8 mL). Flash column chromatography on silica (100 mL SiO2) using 4:1 
hexanes/EtOAc à 3:1 hexanes/EtOAc as eluent gave 756 mg (4.2 mmol) of pure product as a 
colorless oil (84% yield). 
1H-NMR (500 MHz, CDCl3) δ 5.56-5.49 (m, 1H), 5.38-5.32 (m, 1H), 4.79 (br. s, 2H), 4.22 (t, J = 
6.5 Hz, 2H), 2.18 (q, J = 7.3 Hz, 2H), 1.82 (tt, J = 7.3, 6.6 Hz, 2H), 1.62 (ddd, J = 6.8, 1.7, 0.9 
Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 128.6, 125.9, 71.2, 28.8, 22.9, 13.0.  These data are in 
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Procedure for olefin isomerization experiments: 
In all cases, crude material was purified via flash column chromatography on silica (35 mm 
fritted glass column, 120 mm SiO2) using 9:1 CH2Cl2/hexanes à 19:1 CH2Cl2/hexanes as eluent, 
affording pure oxathiazinane as a white solid. 
[FePc] Conditions: (Z)-hex-4-en-1-yl sulfamate 23 (71.7 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl 
(24.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 
mg, 0.800 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were used. By 1H-NMR 
analysis of the crude product, Z/E was 10:1 (this ratio was confirmed by subjecting column-
purified Z/E mixtures of products to 1H-NMR analysis).  
[MnPc] Conditions: (Z)-hex-4-en-1-yl sulfamate 23 (71.7 mg, 0.400 mmol, 1.0 equiv), 
[MnPcCl (24.1 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. By 1H-NMR analysis of the crude product, Z/E was 10:1 (this ratio was 
confirmed by subjecting column-purified Z/E mixtures of products to 1H-NMR analysis). 
[Mn(tBuPc)] Conditions: (Z)-hex-4-en-1-yl sulfamate 23 (71.7 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (33.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. By 1H-NMR analysis of the crude product, Z/E was 10:1 (this ratio was 
confirmed by subjecting column-purified Z/E mixtures of products to 1H-NMR analysis). 
(Z)-4-(prop-1-en-1-yl)-1,2,3-oxathiazinane 2,2-dioxide [Z-4]. 
1H-NMR (500 MHz, CDCl3) δ 5.77 (dqd, J = 10.8, 7.0, 1.2 Hz, 1H), 5.27 (ddq, J = 
10.1, 8.1, 1.9 Hz, 1H), 4.81 (ddd, J = 12.8, 11.7, 2.4 Hz, 1H), 4.66-4.60 (m, 1H), 4.57 
(ddd, J = 11.7, 5.0, 1.7 Hz, 1H), 4.01 (br. d, J = 9.3 Hz, 1H), 1.90 (dddd, J = 14.6, 12.8, 11.7, 5.0 
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Hz, 1H), 1.80-1.71 (m, 4H); 13C-NMR (125 MHz, CDCl3) δ 130.8, 127.1, 71.9, 52.8, 30.1, 13.8. 
These data are in agreement with that previously reported in the literature.31  
Stereoretention Study 
(+)-(R)-3-methylpentyl sulfamate [24]. 
Prepared according to method A. 1.00 mL (8.12 mmol) of (+)-(R)-3-methyl-
1-pentanol were used, along with NaH (226 mg, 8.93 mmol, 1.1 equiv), DMF 
(8 mL + 6 mL), ClSO2NCO (1.06 mL, 12.2 mmol, 1.5 equiv), formic acid (460 µL, 12.2 mmol, 
1.5 equiv) and MeCN (6 mL). Flash column chromatography on silica (35 mm fritted glass 
column, 150 mm SiO2) using 3:1 hexanes/EtOAc as eluent gave 1.385 g (7.64 mmol) of pure 
product as a colorless oil (94% yield). 
1H-NMR (500 MHz, CDCl3) δ 4.96 (br. s, 2H), 4.28-4.21 (m, 2H), 1.83-1.74 (m, 1H), 1.57-1.49 
(m, 2H), 1.41-1.33 (m, 1H), 1.20 (dp, J = 14.0, 7.0 Hz, 1H), 0.91 (d, J = 6.5 Hz, 3H), 0.88 (t, J = 
7.5 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 70.3, 35.3, 31.0, 29.4, 18.9, 11.3; [α]25D = +5.8o (c = 
2.0, CHCl3). These data agree with that previously reported in the literature.46  
 
(+)-(R)-4-ethyl-4-methyl-1,2,3-oxathiazinane 2,2-dioxide [25]. 
In all cases, material was purified via flash column chromatography on silica (35 mm 
fritted glass column, 150 mm SiO2) using CH2Cl2 à 2% Et2O/CH2Cl2, affording pure 
product (starting material was not collected). Enantiopurity was established by chiral GC 
analysis using a CycloSil-B column with an isocratic method at 160°C.  
Racemic product: tr (R) = 22.51 min, tr (S) = 24.35 min 
Enantioenriched product: tr (R) = 22.51 min 
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FePc conditions: (+)-(R)-3-methylpentyl sulfamate 24 (72.5 mg, 0.400 mmol, 1.0 equiv), 
[FePc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were used. 
By chiral GC analysis, product was 99% ee. 
Run 1: (14.2 mg product, 0.079 mmol, 20%). Run 2: (13.7 mg product, 0.076 mmol, 19%). Run 
3: (13.6 mg product, 0.076 mmol, 19%). Average: 19% yield ± 0.5. 
MnPc conditions: (+)-(R)-3-methylpentyl sulfamate 24 (72.5 mg, 0.400 mmol, 1.0 equiv), 
[MnPc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. By chiral GC analysis, product was 99% ee. 
Run 1: (33.3 mg product, 0.186 mmol, 46%). Run 2: (36.4 mg product, 0.203 mmol, 51%). Run 
3: (34.4 mg product, 0.192 mmol, 48%).  Average: 48% yield ± 2.1. 
Mn(tBuPc) conditions: (+)-(R)-3-methylpentyl sulfamate 24 (72.5 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (33.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. By chiral GC analysis, product was 99% ee. 
Run 1: (44.3 mg product, 0.247 mmol, 62%). Run 2: (43.2 mg product, 0.241 mmol, 60%). Run 
3: (40.4 mg product, 0.225 mmol, 56%).  Average: 59% yield ± 2.5. 
Pure product is isolated as a white solid. 1H-NMR (500 MHz, CDCl3) δ 4.77-4.63 (m, 2H), 4.10 
(br. s, 1H), 1.86 (dq, J = 14.5, 7.5 Hz, 1H), 1.79 (ddd, J = 14.5, 8.0, 4.0 Hz, 1H), 1.71 (ddd, J = 
15.0, 6.5, 4.0 Hz, 1H), 1.52 (dq, J = 14.0, 7.3 Hz, 1H), 1.37 (s, 3H), 0.97 (t, J = 7.3 Hz, 3H); 13C-
NMR (125 MHz, CDCl3) δ 69.1, 59.2, 34.4, 33.7, 24.3, 7.6; [α]26D = +7.6o (c = 1.8, CHCl3). 
These data agree with that previously reported in the literature.46 
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Kinetic Analysis of C—H Amination Reactions 
 
(±)-pentan-2-yl sulfamate. 
Prepared according to method A. 1.30 g (1.63 mL, 15.0 mmol) of pentan-2-ol were 
used, along with NaH (417 mg, 16.5 mmol, 1.1 equiv), DMF (27 mL), ClSO2NCO 
(1.95 mL, 22.5 mmol, 1.5 equiv), formic acid (850 µL, 22.5 mmol, 1.5 equiv) and MeCN (11.3 
mL). Flash column chromatography on silica (100 mL SiO2) using 4:1 hexanes:EtOAc as eluent 
gave 2.00 g (11.7 mmol) of pure product as a colorless oil (80% yield).  
1H-NMR (500 MHz, CDCl3) δ 4.76-4.70 (m, 3H), 1.79-1.71 (m, 1H), 1.60 (ddt, J = 13.9, 9.7, 5.8 
Hz, 1H), 1.51-1.38 (m, 2H), 1.44 (d, J = 6.2 Hz, 3H), 0.97 (t, J = 7.4 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 81.7, 38.7, 20.7, 18.5, 13.9.  These data are in agreement with that previously 
reported in the literature.50 
 
(±)-4,6-dimethyl-1,2,3-oxathiazinane 2,2-dioxide. 
Syn diastereomer:  Isolated as a white sold. 1H-NMR (500 MHz, CDCl3) δ 4.89 
(dqd, J = 12.5, 6.3, 2.2 Hz, 1H), 3.87-3.78 (m, 1H), 3.65 (br. d, J = 10.6 Hz, 1H), 
1.84 (dt, J = 14.3, 2.5 Hz, 1H), 1.44 (d, J = 6.2 Hz, 3H), 1.38 (dt, J = 14.4, 11.8 Hz, 1H), 1.29 (d, 
J = 6.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 81.0, 51.2, 38.8, 21.1, 20.7. These data are in 
agreement with that previously reported in the literature.50  
Anti diastereomer: Isolated as a white solid with ~20% of syn diastereomer. 1H-
NMR (500 MHz, CDCl3) δ 5.04 (dqd, J = 9.8, 6.4, 3.3 Hz, 1H), 4.37 (d, J = 7.8 Hz, 
1H), 3.84 (dtd, J = 14.5, 7.3, 4.7 Hz, 1H), 1.87-1.78 (m, 1H), 1.71-1.66 (m, 1H), 1.50 (d, J = 6.5 
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Hz, 3H), 1.46 (d, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 78.8, 77.4, 77.2, 76.9, 49.4, 
36.0, 20.8, 19.7. These data are in agreement with that previously reported in the literature.50 
 
General procedure for reaction profile studies: Into a 1 dram vial was added AgSbF6 (6.9 mg, 
0.020 mmol, 0.10 equiv), catalyst (0.020 mmol, 0.10 equiv), and a stir bar in a glovebox. The 
vial was then sealed with a septum-lined cap, covered in aluminum foil, taken out of the box, and 
topped with a balloon of argon. Pentan-2-yl sulfamate (33.4 mg, 0.200 mmol, 1.0 equiv) was 
taken up in 9:1 C6H6/MeCN (400 µL, 0.5M) and added via syringe, followed by internal standard 
(decane, 19.5 µL, 0.500 equiv). After stirring for 10-15 min, a 10 µL aliquot was removed (as a 
t0 timepoint), then PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) was added under an inert 
atmosphere and reaction stirred at room temp (~23oC) for 8h. 10 µL aliquots were removed by 
syringe at 15 min, 30 min, 1h, 1.5h, 2h, 3h, 4h, 6h, and 8h; aliquots were filtered through a short 
plug of silica (glass wool lined pipette, 1-2 mm SiO2) with 1 mL Et2O directly into a GC vial. 
Yields were established by GC analysis based on a standard curve. Each catalyst was run in 
triplicate; reported values are averages of three runs with error bars denoting standard deviation. 
 
General Procedure for Initial Rate Analysis 
5 mol% Conditions: 
In order to obtain accurate initial rate data, all reactions for rate analysis were run at room 
temperature and at 0.25 M concentration. Into a flame-dried 1 dram vial was added AgSbF6 (3.4 
mg, 0.010 mmol, 0.05 equiv), [Mn(tBuPc)]Cl (8.3 mg, 0.010 mmol, 0.05 equiv), and a stir bar in 
a glovebox. The vial was then sealed with a septum-lined cap, covered in aluminum foil, taken 
out of the box, and topped with a balloon of argon. Pentan-2-yl sulfamate (33.4 mg, 0.2 mmol, 
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1.0 equiv) and internal standard decane (0.08 mmol, 40 mol%), were dissolved in 9:1 
C6H6/MeCN (400 µL, 0.5M) and added to the 1 dram vial. PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 
equiv) was dissolved in 9:1 C6H6/MeCN (400 µL, 0.5M), and added directly to the reaction. The 
vial was then sealed and placed to stir at rt. Aliquots (10 µL) were taken at the corresponding 
times from the reaction flask, and filtered through a silica pad with 600 µL of diethyl ether for 
GC analysis. The yield was determined by integration of the product peaks relative to the decane 
internal standard. Yields of S56 are reported as the average of three runs with error bars denoting 
standard deviation. 
Supplementary Figure 2: Initial rates with 5 mol% [Mn(tBuPc)] 
 
10 mol% Conditions: 
In order to obtain accurate initial rate data, all reactions for rate analysis were run at room 
temperature and 0.25 M concentration. Into a flame-dried 1 dram vial was added AgSbF6 (6.8 
mg, 0.020 mmol, 0.10 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.10 equiv), and a stir bar 
in a glovebox. The vial was then sealed with a septum-lined cap, covered in aluminum foil, taken 
out of the box, and topped with a balloon of argon. Pentan-2-yl sulfamate (33.4 mg, 0.2 mmol, 
1.0 equiv) and internal standard decane (0.08 mmol, 40 mol%.), were dissolved in 9:1 
C6H6:MeCN (400 µL, 0.5M) and added to the 1 dram vial. PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 
y = 0.0112x + 0.4213 
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equiv) was dissolved in 9:1 C6H6/MeCN (400 µL, 0.5M), and added directly to the reaction. The 
vial was then sealed and placed to stir at room temperature. Aliquots (10 µL) were taken at the 
corresponding times from the reaction flask, and filtered through a silica pad with 600 µL of 
diethyl ether for GC analysis. The yield was determined by integration of the product peaks 
relative to the decane internal standard. Yields of S56 are reported as the average of three runs 
with error bars denoting standard deviation. 
Supplementary Figure 3: Initial rates with 10 mol% [Mn(tBuPc)] 
	  
	  
Determination of Kinetic Isotope Effect via Initial Rates  
 
General Procedure for Initial Rate Analysis at 5 mol%: In order to obtain accurate initial 
rate data, all reactions for rate analysis were run at room temperature and at 0.25 M 
concentration. To a 1 dram flame-dried borosilicate vial containing a Teflon stir bar was added 
catalyst (0.010 mmol, 0.05 equiv) and AgSbF6 (3.4 mg, 0.010 mmol, 0.05 equiv). 3-
phenylpropyl sulfamate 26 or 3-phenylpropyl-3,3-d2 sulfamate 26-d2 (33.4 mg, 0.2 mmol, 1.0 
y = 0.0169x + 0.5907 
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equiv) and internal standard 1-fluoro-2-nitrobenzene (0.08 mmol, 40 mol%), were dissolved in 
9:1 C6H6/MeCN (400 µL, 0.5M) and added to the 1 dram vial. PhI(OPiv)2 (163 mg, 0.400 mmol, 
2.0 equiv) was dissolved in 9:1 C6H6/MeCN (400 µL, 0.5M), and added directly to the reaction. 
The vial was then sealed and placed to stir at rt. Aliquots (10 µL) were taken at the 
corresponding times from the reaction flask, and filtered through a silica pad with 600 µL of 
isopropanol for HPLC (Zorbax CN, 4.6 x 250 nm) analysis. The yield was determined by 
integration of the product peaks relative to the 1-fluoro-2-nitrobenzene internal standard and 
comparison to a standard curve. Yields are reported as the average of three runs with error bars 
denoting standard deviation. Initial rates were determined for formation of 3 (Figures S5 and S6). 
Error for kinetic isotopes was calculated via propagation of the standard error of the mean for 
each set of rates. 
(±)-3-phenylpropyl-3,3-d2 sulfamate [26-d2]. 
1H-NMR (500 MHz, CDCl3) δ 7.30 (t, J = 7.5 Hz, 2H), 7.23-7.19 (m, 3H), 
4.75 (br s, 2H), 4.22 (t, J = 6.5 Hz, 2H), 2.08 (dt, J = 7.5, 7.0 Hz, 2H). 
[Mn(tBuPc)]Cl: kH/kD= 0.0052 / 0.0030= 1.7 ± 0.1 
[MnPc]Cl: kH/kD= 0.0034 / 0.0018= 1.9 ± 0.2 
Supplementary Figure 4: Initial rates with 26 and 5 mol% [Mn(tBuPc)] 
 
y = 0.0052x + 0.6775 
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Supplementary Figure 5: Initial rates with 26-d2 and 5 mol% [Mn(tBuPc)] 
 
Supplementary Figure 6: Initial rates with 26 and 5 mol% [MnPc] 
 
Supplementary Figure 7: Initial rates with 26-d2 and 5 mol% [MnPc] 
 
y = 0.0030x + 0.3584 



















y = 0.0034x - 1.1695 



















y = 0.0018x - 0.6721 
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General Procedure for Initial Rate Analysis at 10 mol%:  In order to obtain accurate initial 
rate data, all reactions for rate analysis were run at room temperature and at 0.25 M 
concentration. Into a flame-dried 1 dram vial was added AgSbF6 (6.7 mg, 0.02 mmol, 0.10 
equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.02 mmol, 0.10 equiv), and a stir bar in a glovebox. The vial 
was then sealed with a septum-lined cap, covered in aluminum foil, taken out of the box, and 
topped with a balloon of argon. 3-phenylpropyl sulfamate 26 (43.1 mg, 0.2 mmol, 1.0 equiv) and 
internal standard 1-fluoro-2-nitrobenzene (0.08 mmol, 40 mol%), were dissolved in 9:1 
C6H6/MeCN (400 µL, 0.5M) and added to the 1 dram vial. PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 
equiv) was dissolved in 9:1 C6H6/MeCN (400 µL, 0.5M), and added directly to the reaction. The 
vial was then sealed and placed to stir at rt. Aliquots (10 µL) were taken at the corresponding 
times from the reaction flask, and filtered through a silica pad with 600 µL of isopropanol for 
HPLC (Zorbax CN, 4.6 x 250 nm) analysis. The yield was determined by integration of the 
product peaks relative to the 1-fluoro-2-nitrobenzene internal standard and comparison to a 
standard curve. Yields are reported as the average of three runs with error bars denoting standard 
deviation. 
Supplementary Figure 8: Initial rates with 26 and 10 mol% [Mn(tBuPc)] 
 
y = 0.0090x + 0.2804 
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Intermolecular Kinetic Isotope Effect Study 
 
Method for KIE Determination: The column-purified product mixture (ca. 30 mg in 700 µL 
CDCl3) was analyzed by 13C-NMR (600 MHz instrument).11,15,49 Cr(acac)3 (15 mg) was added 
directly to the solution in the NMR tube immediately prior to running the NMR study; this helps 
to significantly reduce delay times needed to obtain accurate integrations. The experiment was 
run under inverse-gated decoupling conditions without sample spinning. The following 
parameters were used for the experiment, listed as Varian commands: 
temp=23 
dm=’nny’ (inverse-gated decoupling) 
d1=5 (initial delay) 
at=0.5 (acquisition time) 
setsw(180,0) (spectral width, in ppm) 
bs=64 (block size for FID) 
nt=4416 (number of scans) 
pw=7.0 (pulse width) 
pw90=7.0 (90° pulse width) 
The KIE was reported as the area of the protonated peak over that of the deuterated peak. The 
experiment was run in triplicate and each was analyzed by NMR.  An average value was 
calculated with error reported as a standard deviation. 
[Mn(tBuPc)]Cl: kH/kD = 1.62 ± 0.06 (1.56, 1.67, 1.64). 
[MnPc]Cl: kH/kD= 1.90 ± 0.09 (2.00, 1.81, 1.90). 
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(±)-4-deuterio-4-phenyl-tetrahydro-1,2,3-oxathiazine-2,2-dioxide. 
3-phenylpropyl sulfamate 26 (43.1 mg, 0.200 mmol, 1.0 equiv), 3-phenylpropyl-3,3-
d2 sulfamate 26-d2 (43.5 mg, 0.200 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 
0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.10 equiv), PhI(OPiv)2 (162.5 mg, 
0.400 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (400 µL, 0.5M) were used. Flash column 
chromatography on silica (35 mm fritted glass column, 150 mm SiO2) using 3:1 hexanes/EtOAc 
as eluent gave the deuterated and protonated oxathiazinanes as a mixture. Characterization data 
are in agreement with that previously reported in the literature.11 
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This chapter has been adapted with permission from the research communication 
“Catalytic C(sp3)—H Alkylation via an Iron Carbene Intermediate” (Griffin, J. R.; Wendell, C. 
I.; Garwin, J. A.; White, M.C. J. Am. Chem. Soc. 2017). Copyright 2017 American Chemical 
Society. 
 This work was done in collaboration with my fellow authors. The majority of the scope 
of benzylic C—H bonds was established by Chloe Wendell and will not be described in this 
thesis. 
2.1 Introduction 
 Iron is one of the most abundant elements, totaling one-third of the Earth’s mass, and is 
emerging as an important metal for homogenous catalysis5,11,12,51-53. Iron is utilized by nature in 
enzymes (e.g. cytochrome P450s) and by synthetic chemists in small molecule catalysis to 
mediate challenging oxidation reactions, selectively transforming strong C(sp3)—H bonds 
directly into C—O bonds via high-valent iron oxo intermediates5,53. Recently, these enzymes and 
related small molecule catalysts have been modified to form high-valent iron nitrene 
intermediates capable of transforming C—H bonds into C—N bonds11,12,54. Despite this ability 
of iron to readily support high-valent metal oxidants that can functionalize even very strong 
aliphatic C—H bonds, no iron catalyst has been demonstrated to generate isoelectronic 
metallocarbenes capable of alkylating C(sp3)—H bonds.  
 Naturally occurring P450 enzymes have been shown to form iron carbenes during drug 
metabolism. However, unlike their oxygen counterparts, metallocarbene formation results in 
very stable, inert organometallic species (Fig. 12)55. Iron P450 enzymes have been engineered to 
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support catalytically active high-valent iron carbenes, but they have only been shown to catalyze 
 
Figure 12 Iron oxos versus iron carbenes in nature 
 
the cyclopropanation of olefins or insertion into heteroatom-hydrogen bonds, energetically more 
facile processes than C—H alkylation (Fig. 13A)56,57. Small molecule iron catalysts capable of 
forming carbenes also fail to catalyze C—H alkylation processes, instead demonstrating similar 
reactivity trends to engineered iron enzymes that favor alternative reaction pathways58,59 (Fig. 
13B). Curiously, nearly all late metals, including copper60, cobalt61, silver60, palladium62, 
rhodium63, and ruthenium64, have been shown to form catalytically active metallocarbenes for 
C—H alkylation, but alkylation of C(sp3)—H bonds via an iron carbene is not known. Previous  
Figure 13 Known reactivity of iron carbenes (A) Engineered P450 enzymes (B) Small molecule catalysts 
 
iron-mediated C—H alkylation reactions have proceeded under reductive conditions using low-






























































been demonstrated52. Herein we report an example of an iron-catalyzed alkylation of allylic and 
benzylic C(sp3)—H bonds that proceeds under oxidative conditions and provide mechanistic 
evidence that the reaction proceeds via an iron carbene intermediate where, distinct from other 
late metal carbenes, C—H cleavage is partially rate-determining and tunable via the catalyst 
ligand framework.  
 
2.2 Results and Discussion 
2.2.1 Reaction Discovery and Development  
Iron carbene complexes have been generated stoichiometrically, isolated, and 
demonstrated in a separate synthetic step to insert into C—H bonds65,66. We hypothesized that an 
underlying reason these reactions had not been rendered catalytic was due to distinct energetic 
requirements for each individual step. This is reflected in the different conditions used for each 
Figure 14 Reactivity of stoichiometric iron carbenes 
 
transformation; room temperature was sufficient to form the isolable iron carbene while elevated 
temperatures (80˚C) and solvent quantities of substrate were necessary for C—H alkylation65 
(Fig. 14). At the elevated temperatures needed to promote C—H alkylation reactivity, thermal 
decomposition of the carbene precursor into reactive free carbenes may occur. For example, 
literature reports claiming iron-catalyzed C—H alkylation with methyl phenyldiazoacetate using 
solvent quantities of cyclohexane at 80˚C are ambiguous because donor-acceptor diazoesters are 


























non-metal mediated alkylation reactivity with cyclohexane at such temperatures67,68 (Fig. 15). 
Figure 15 Thermal reactivity of donor/acceptor carbenes 
 
An additional complicating factor observed experimentally (vide infra) and supported by 
computational studies is that competitive reaction pathways with lower activation energies than 
C—H alkylation (e.g. dimerization to furnish olefins) predominate under conditions that form 
iron carbenes69 (Fig. 16A). Unlike rhodium and copper catalysis where the rate-limiting step of 
the reaction has been shown to be formation of the metallocarbene60,69,70, we hypothesized that 
under iron catalysis formation of the metallocarbene is relatively facile and the kinetic demands 
of the C—H insertion step are what limit reaction progress. Encouragingly, the reactivity and 
selectivity of metal carbenes have been shown be highly tunable via electronic and steric 
modifications to the carbene precursor and catalyst ligand framework63,71. We hypothesized that 
simultaneous steric and electronic tuning of both the iron complex and carbene precursor would 
enable us to form a metallocarbene intermediate under mild conditions that is reactive enough to 
overcome the kinetic barrier of inserting into an inert C(sp3)—H bond, while avoiding 
competitive, lower energy reaction pathways (Fig. 16B).  
We first evaluated a series of iron catalysts known to catalyze cyclopropanations and 
heteroatom-hydrogen insertion reactions, presumably via metallocarbene intermediates, for the 




















we examined a series of substituted diazo compounds (acceptor 27, donor-acceptor 28, acceptor-  
Figure 16 Challenges of developing an iron carbene C—H insertion reaction (A) Deleterious reaction pathways (B) 
Hypothesis of rate-determining C—H cleavage 
 
acceptor 29) with varying degrees of electrophilicity and steric bulk (24). Diazoester 1 was 
with the iron PyBOX complex58. However, with iron porphyrin and phthalocyanine catalysts, it 
converted to large amounts of olefin dimer (30, 93% and 84%, respectively), suggestive of iron 
carbene formation71. We hypothesized that a more bulky disubstituted diazoester may create a 
more sterically demanding environment that disfavors dimerization. Consistent with this, 
disubstituted donor-acceptor carbene precursor 28 disfavored dimerization with all three 
catalysts71. However, it was unproductive for C—H alkylation, affording large amounts of 
recovered starting material and some conversion to alternate oxidation products with Fe(TPP)Cl 
and [FeIIIPc]Cl (ketone 31, 4% and 12% respectively).  
We hypothesized that augmenting the electrophilicity of the disubstituted diazo 
compound would increase its reactivity by producing a strongly electrophilic carbene that could 
more readily engage in higher energy C—H insertion pathways. As demonstrated with rhodium 
catalysis, acceptor-acceptor diazo compounds are stable and typically require very active 
catalysts to form the metallocarbene. Once formed, however, the metallocarbene is highly 
electrophilic and reactive towards C—H insertion71. Acceptor-acceptor diazoester 29 resulted in 
























A. Deleterious Background Reactivity and Side Reactivity
B. Hypothesis
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reactivity may indicate failure to generate a metallocarbene. Alternatively, it could indicate  
Table 3 Exploration of various catalysts and carbene precursors 
 
formation of a metallocarbene that was unreactive towards not only C—H bond insertion, but 
also deleterious side reactions. Exploring this latter possibility, we endeavored to generate a 
more reactive, electrophilic iron carbene. Upon examination of the 13C shifts of the α-carbon of a 
variety of different acceptor-acceptor diazo precursors, we observed that sulfonate esters 
appeared to be the most electrophilic and thus investigated their corresponding diazoesters (32) 
for potential C—H alkylation reactivity72. Iron porphyrin and PyBOX complexes exhibited no 
reactivity for this transformation. However, the catalyst with the greatest π-accepting character, 
iron phthalocyanine chloride ([FeIIIPc]Cl), formed the C—H alkylated δ-sultone product 33 in 
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We reasoned that a cationic catalyst should provide a more electron deficient metal center 
than its neutral counterpart [FeIIIPc]Cl (3%, entry 1, Table 4) and thus generate a more 
electrophilic iron carbene with diazosulfonate ester 32. Upon examination of non-coordinating 
Table 4 Reaction development and optimization 
 
counterions, we observed a significant increase in product yield with both AgSbF6 (45%, entry 2) 
and NaBArF4 (48%, entry 3), with the latter giving slightly higher product yields and no risk of 
silver-mediated background reactivity with the diazoester60. Interestingly, catalysts with electron 
deficient, halogenated phthalocyanine ligand frameworks formed C—H alkylated product, but in 
lower yield than the unsubstituted, commercially available catalyst (entries 4-5). Adding the 
substrate to the catalyst over an hour boosted the yield of the 6-membered δ-sultone even further 





















































































6). Notably, iron porphyrin complexes and [FeIIPc], shown to be competent catalysts for 
cyclopropanation reactions, exhibited minimal or no reactivity, respectively, for this 
transformation even under our optimized conditions (7% yield, entry 7; 0% yield, entry 8)73. This 
highlights the significance of both the phthalocyanine framework and the FeIII oxidation state. 
Importantly, NaBArF4 alone did not yield any C—H alkylation product, providing initial 
evidence that this is indeed an iron-mediated allylic C—H functionalization (entry 9).  
2.2.2 Allylic, Benzylic, and Ethereal C—H Bond Scope 
Allylic C—H alkylations are rare under both noble and base metal catalysis. Specifically, 
under rhodium carbene mediated C—H alkylation processes, chemoselectivity issues arise 
wherein cyclopropanation of the olefin competes with insertion into C—H bonds63,71,72. Given 
that base metals often demonstrate orthogonal chemoselectivity to their noble metal 
counterparts11,12,51,61, we sought to investigate the scope of this new iron-catalyzed reaction 
across a range of allylic diazosulfonate esters for the formation of δ-sultone allylic C—H 
alkylated product (Fig. 17). Bulky trisubstituted olefins are tolerated as well as proximal, 
protected oxygen functionality (34-35). A range of bishomoallylic styrenyl diazosulfonate esters 
with varied electronic substitution undergoes iron-catalyzed alkylation in good to moderate 
yields (36-39, respectively). In contrast to cobalt catalysis, which is thought to be insensitive to 
substrate electronics due to a metalloradical mediated C—H cleavage, in iron catalysis electron-
withdrawing functionality on the substrate results in decreased yields (39) consistent with the 
intermediacy of an electrophilic metallocarbene61,49. Importantly, chemoselectivity for allylic 
C—H alkylation is maintained even when the olefin is made more proximal and 
cyclopropanation would form the geometrically preferred 6-membered sultone72. Homoallylic 
styrenyl and methyl olefin diazosulfonate esters readily undergo C—H alkylation under iron 
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catalysis to form the five-membered sultone without any observed cyclopropanated product (40-
41). Under iron catalysis, no cyclopropanation of the alkene is observed with any of these 
substrates. In contrast, rhodium catalysis demonstrates both lower reactivity and poor 
chemoselectivity for C—H insertion, instead forming large amounts of cyclopropanated product 
for both homoallylic substrates (40, 12%, 1:4 ins:cycloprop; 41, 19%, 1:1 ins:cycloprop). 
Figure 17 Scope of allylic, benzylic, and ethereal C—H bonds 
 
Other C(sp3)—H bond types with comparable bond strengths were also evaluated under 
these reaction conditions and shown to readily undergo alkylation (Fig. 17). Tert-
butyldiphenylsilyl protected substrate 42 is alkylated at the ethereal position in 68% yield. In 
addition, [FeIIIPc] efficiently catalyzes functionalization of benzylic C—H bonds in the presence 
of a variety of aryl and heteroaryl functionality. Substrates containing electron-rich aryl rings are 
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substrate 43. This iron-catalyzed transformation also exhibits good tolerance towards 
medicinally relevant heterocyclic functionality. Despite reactive, proximal alkene functionality, 
[FeIIIPc] promotes C—H alkylation adjacent an indole heterocycle, common in natural products 
and pharmaceuticals (44). Additionally, a substrate containing a benzodioxole moiety is readily 
alkylated under [FeIIIPc] catalysis (45), even though these heterocycles have been shown to 
irreversibly bind to iron heme complexes55 (Fig. 12). 
2.2.3 Mechanistic Studies 
We next sought to investigate the mechanism and determine the involvement of an iron 
carbene intermediate in this novel transformation. We hypothesized that iron-catalyzed C—H 
alkylation could occur via iron-mediated decomposition of the diazo to a catalytically active 
metal-bound carbene intermediate that, analogous to iron oxos5,53 and iron nitrenes11,12, promotes 
homolytic cleavage of the C—H bond followed by recombination with the resulting carbon-
centered radical to form the new C—C bond (Fig. 18A). Alternatively, [FeIIIPc] could serve as a 
Lewis acid to decompose the diazosulfonate ester to a free carbene capable of inserting into 
proximal C—H bonds. If this latter mechanistic scenario was operative, we would expect to see 
similar reactivity if we generated the free carbene using other methods. Unligated iron salts have 
been demonstrated to form reactive free carbenes from diazo species74. However, FeCl3 and 
FeCl2 failed to catalyze C—H alkylation and resulted in predominately recovered starting 
material (Fig. 18B). Additionally, we irradiated diazo sulfonate ester 32 with UV light at room 
temperature without any added catalyst, a known method of generating free carbenes from 
acceptor-acceptor diazo compounds75. Despite complete conversion of starting material, we 
isolated no intramolecular C—H alkylated product and instead observed formation of a new 
product 46 generated from intermolecular C—H insertion of the free carbene into the 
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dichloromethane solvent (Fig. 18B). Importantly, 46 has never been observed under [FeIIIPc]- 
catalyzed C—H alkylation, which is also run in dichloromethane solvent. These divergent 
 
 
Figure 18 Mechanistic studies (A) Proposed stepwise mechanism for C—H alkylation (B) Examination of free 
carbene reactivity (C) Inter- and intramolecular KIE experiements (D) Cis/trans olefin isomerization experiment 
 
reaction outcomes support the hypothesis that [FeIIIPc] is not generating a free carbene and is 
directly involved in the formation of C—H alkylated product, likely through the formation of a 
metal-bound carbene intermediate. 
We next sought to better understand the involvement of an iron-bound carbene 
intermediate in both the C—H bond cleavage and C—C bond formation steps (Fig. 18A). In 
rhodium-catalyzed C—H alkylation reactions known to proceed via metallocarbene 
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H/D [FeIIIPc]:          5.0±0.1
[FeIIICl8Pc]:     4.8±0.1
[FeIIICl16Pc]:   4.5±0.1
Rh2(OAc)4:     1.8±0.1
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B. Free carbene reactivity


































































SO Rh2(OAc)4:   > 20:1   Z:E
[FeIIIPc]:             3:1   Z:E
[FeIIICl8Pc]:        7:1   Z:E


















48: X=Y=H or 48-d2: X=Y=D
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intermediates, varying the carboxylate ligand has been shown to influence both the 
intramolecular kinetic isotope effect (KIE) of the C—H cleavage step49,69,75 and the selectivity of 
C—C bond formation76. Therefore, in order to investigate the role of an iron carbene in C—H 
cleavage, we evaluated the impact of electronic modifications to the iron phthalocyanine ligand 
framework on the intramolecular KIE for benzylic C—H alkylation of monodeuterated substrate 
47 (Fig 18C).  We observed a change in the KIE as we varied the ligand electronics with 
[FeIIIPc] giving the highest KIE (5.0), followed by [FeIIICl8Pc] (4.8) and [FeIIICl16Pc] (4.5). 
These data support involvement of the iron complex in the C—H cleavage step, with the 
unsubstituted catalyst [FeIIIPc] exhibiting the greatest degree of bond breakage in the transition 
state. Evaluation of the intramolecular KIE of the Rh2(OAc)4 catalyst, which has been shown to 
proceed through a concerted C—H insertion mechanism, gave a much lower KIE (1.8)69. The 
larger KIE values for the iron catalysts suggest a stepwise mechanism involving iron carbene 
mediated C—H abstraction to furnish an iron-alkyl intermediate and a carbon-centered substrate 
radical, followed by rebound to form the C—C bond and regenerate the catalyst. Such a 
mechanistic scenario would account for the improved chemoselectivity of iron catalysts relative 
to rhodium catalysts towards C—H insertion over cyclopropanation; the generation of a 
stabilized allylic radical is energetically preferable to a secondary aliphatic radical during 
stepwise olefin oxidation processes11,61. 
Next we probed the effect of iron phthalocyanine ligand electronic properties on the 
product configuration forged in the C—C bond formation step. We performed a study on Z-
olefin-containing substrate 49 to determine if and to what extent scrambling of the double bond 
geometry occurred during allylic C—H alkylation. Under Rh2(OAc)4 catalysis, no isomerization 
of the olefin was observed during functionalization, consistent with a concerted mechanism of 
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C—H insertion (Fig. 18D). In contrast, under [FeIIIPc] catalysis we observed scrambling of 
double bond geometry, consistent with the intermediacy of a stabilized carbon radical. 
Importantly, the extent of olefin isomerization is highly dependent on the electronic substitution 
of the phthalocyanine ligand, with the most electron deficient chlorinated iron catalysts affording 
products with less isomerization ([FeIIICl8Pc] 7:1 Z/E; [FeIIICl16Pc] 10:1 Z/E) than the 
unsubstituted phthalocyanine ([FeIIIPc] 3:1 Z:E). This finding is in accordance with the proposed 
mechanism of an iron-alkyl intermediate recombining with the substrate carbon-centered radical, 
and also suggests that electron-withdrawing ligand modifications may furnish a less stable iron-
alkyl species that undergoes recombination at a faster rate. Under cobalt catalysis, olefin 
isomerization during functionalization of Z-olefins occurs to a much greater extent, favoring the 
E-isomer, providing further support that iron-catalyzed C—H alkylation proceeds with less free 
radical character than cobalt-mediated alkylation61. 
In rhodium- and copper-carbene mediated C—H alkylations using diazo compounds, 
experimental and theoretical evidence supports that formation of the metallocarbene via 
extrusion of nitrogen is the rate-determining step of the reaction60,69,70. Conversely, for iron-
carbene mediated alkylations, we hypothesized that C—H insertion may be rate-determining. 
Intermolecular kinetic isotope effect (KIE) studies done by measuring initial rates on parallel 
reactions with benzylic substrate 48 and 48-d2 revealed a primary kinetic isotope effect of 3.1 
under [FeIIIPc] catalysis. This is consistent with C—H cleavage being part of the rate-
determining step of the reaction (Fig. 18C). Initial rate measurements with [FeIIICl16Pc], a less 
efficient C—H alkylation catalyst, indicated that it catalyzed the reaction at a much slower rate 
than [FeIIIPc] and with a significantly lower KIE of 1.4. With a more electron-deficient iron 
catalyst [FeIIICl16Pc], extrusion of nitrogen and formation of the metallocarbene, which is 
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thought to be facilitated by donation of electron density from the catalyst to the carbene carbon, 
may compete energetically with the C—H cleavage step and contribute to its sluggish reactivity 
relative to [FeIIIPc]69. The fact that ligand modifications on the iron catalyst result in substantial 
differences in overall reaction rates and KIE values49,69,75 provides even further support for an 
iron-bound carbene mediated C—H cleavage. Collectively, the C—H alkylation reaction 
described herein appears to be highly tunable via catalyst modifications at critical bond cleavage 
and forming steps of the catalytic cycle, making it an excellent platform for future reaction 
development.  
2.3 Conclusion 
We have reported an iron catalyst capable of alkylating C(sp3)—H bonds via an iron 
carbene intermediate. [FeIIIPc] is capable of alkylating allylic, benzylic, and ethereal C(sp3)—H 
bonds with good functional group tolerance, and has even been showcased in a complex 
molecule setting. Mechanistic studies have demonstrated the ability to exert catalyst control on 
the reactivity and selectivity during both the C—H cleavage and functionalization steps. We 
anticipate that with proper tuning of the catalyst ligand framework and diazocarbene precursors, 
stronger aliphatic C(sp3)—H bond types as well as intermolecular C—H alkylations with tunable 
site-selectivities will be accessible.  
 
2.4 Experimental Information 
General Information 
The following commercially obtained reagents were used as received: iron(III) phthalocyanine 
chloride ([FePc]Cl, Sigma-Aldrich), iron(II) phthalocyanine (FePc, Sigma-Aldrich), 5,10,15,20-
Tetraphenyl-21H,23H-porphine iron(III) chloride (Fe(TPP)Cl, Sigma-Aldrich), 2,6-bis[(4R)-4-
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phenyl-2-oxazolinyl]pyridine (PyBOX, Sigma-Aldrich), rhodium(II) acetate dimer (Rh2(OAc)4, 
Strem), and silver hexafluoroantimonate (AgSbF6, Strem). Sodium tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate (NaBArF4)77, MeSO2N378, and ClSO2CH2CO2Et72 were 
prepared according to literature procedures and stored at rt in the glovebox, 4˚C, and -20˚C, 
respectively. All reactions were run in flame- or oven-dried glassware under an atmosphere of N2 
or Ar gas with dry solvents unless otherwise stated. All products were filtered through a glass 
wool plug prior to obtaining a final weight. Solid reagents were stored in a dessicator or 
glovebox, and anhydrous solvents were purified by passage through a bed of activated alumina 
immediately prior to use (Glass Countour, Laguna Beach, California). Chloroform-d was stored 
over 3Å molecular sieves. Thin-layer chromatography (TLC) was conducted with E. Merck 
silica gel 60 F254 pre-coated plates (0.25 mm) and visualized with UV and potassium 
permanganate stains. Flash chromatography was performed as described by Still44 using 
American International ZEOprep 60 ECO silica gel (230-400 mesh). Achiral gas 
chromatographic (GC) analysis was performed on an Agilent 6890N Series instrument equipped 
with FID detectors using a HP-5 (5%-Phenyl)-methylpolysiloxane column (30m, 0.32mm, 
0.25mm), and chiral GC analysis using a CycloSil-B column (30m, 0.25mm, 0.25mm). 1H-NMR 
spectra were recorded on a Varian Inova-500 (500 MHz), Varian Unity-500 (500 MHz), Varian 
Unity Inova-400 (400 MHz), or Bruker (500Mz) spectrometer and are reported in ppm using 
solvent as an internal standard (CDCl3 at 7.26 ppm). Data reported as: s = singlet, d = doublet, t 
= triplet, q = quartet, p = pentet, sxt = sextet, spt = septet, m = multiplet, br = broad, app = 
apparent; coupling constant(s) in Hz; integration. Proton-decoupled 13C-NMR spectra were 
recorded on a Varian Unity-500 (126 MHz) or Bruker (126Mz) spectrometer and are reported in 
ppm using solvent as an internal standard (CDCl3 at 77.16 ppm). Kinetic isotope effect analyses 
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were recorded on a Varian Inova-600 (600 MHz) spectrometer. IR spectra were recorded by 
ATR on a Perkin Elmer Frontier FTIR and are reported in frequency of absorption (cm-1). 
Optical rotations were measured using a 1 mL cell with a 50 mm path length on a Jasco P-1020 
polarimeter. Optical rotations were obtained with a sodium lamp and are reported as follows: 
[α]λToC (c = g/100 mL, solvent). High-resolution mass spectra were obtained at the University of 
Illinois Mass Spectrometry Laboratory. Electrospray ionization (ESI) spectra were performed on 
a Waters Q-Tof Ultima spectrometer, and electron ionization (EI) and field desorption (FD) 
spectra were performed on a Micromass 70-VSE spectrometer. 
Preparation of [FeCl8Pc]Cl and [FeCl16Pc]Cl 
[FeCl8Pc]Cl: A flame dried 25 mL round-bottom flask equipped with 
a stir bar and reflux condenser (the flask and stir bar should be free of 
trace metal impurities) was sequentially charged with 4,5-
dichlorophthalonitrile (788 mg, 4.0 mmol, 4.0 equiv, TCI America), 1-
hexanol (10 mL, freshly distilled over MgSO4 and degassed), FeCl3 
(162 mg, 1.00 mmol, 1.0 equiv, Sigma-Aldrich) and DBU (597 µL, 4.0 mmol, 4.0 equiv, Sigma-
Aldrich). The reaction flask was evacuated under vacuum and refilled with N2 three times, then 
heated to 155ºC. The reaction mixture changed from brown to turquoise green over 10 min. After 
stirring at 155ºC overnight (12-15h), the heat was ceased and the condenser was removed. After 
cooling to room temperature, the reaction mixture was filtered. The remaining dark green solid 
was washed with 10 mL of 1 M HCl, 10 mL of water, and 10 mL of EtOH. The catalyst was 
dried under high vacuum overnight at 90˚C to afford 761 mg (0.867 mmol) of [FeCl8Pc]Cl as a 
dark green powder (87% yield).  



















= 107538).; IR (ATR, cm-1) 2955.86, 2353.03, 1889.14, 1767.7, 1730.25, 1602.19, 1514.22, 
1448.96, 1435.09, 1416.2, 1387.01, 1330.14, 1290.86, 1200.89, 1137.03, 1084.38, 1071.49, 
962.86, 887.52, 849.38, 824.54, 799.97, 783.39, 749.16, 708.28, 679.24, 660.94, 593.17, 550, 
504.; HRMS (EI) m/z = 839.77 (M-Cl). 
 
[FeCl16Pc]Cl: A flame dried 25 mL round-bottom flask equipped with 
a stir bar and reflux condenser (the flask and stir bar should be free of 
trace metal impurities) was sequentially charged with 
tetrachlorophthalonitrile (1.06 g, 4.0 mmol, 4.0 equiv, TCI America), 
1-hexanol (10 mL, freshly distilled over MgSO4 and degassed), FeCl3 
(162 mg, 1.00 mmol, 1.0 equiv, Sigma-Aldrich) and DBU (597 µL, 4.0 mmol, 4.0 equiv, Sigma-
Aldrich). The reaction flask was evacuated under vacuum and refilled with N2 three times, then 
heated to 155ºC. The reaction mixture changed from brown to turquoise green over 10 min. After 
stirring at 155ºC overnight (12-15h), the heat was ceased and the condenser was removed. After 
cooling to room temperature, the reaction mixture was filtered. The remaining dark green solid 
was washed with 10 mL of 1 M HCl, 10 mL of water, and 10 mL of EtOH. The catalyst was 
dried under high vacuum overnight at 90˚C to afford 638 mg (0.553 mmol) of [FeCl16Pc]Cl as a 
dark green powder (55% yield).  
UV-Vis (H2SO4, c = 8.2 µM, λmax = nm, ε = M-1cm-1): 797 (ε = 47290), 770 (ε = 47654), 317 (ε 
= 60784).; IR (ATR, cm-1) 3258.78, 2323.85, 2162.01, 2050.37, 1980.01, 1736.67, 1561.44, 
1501.78, 1391.32, 1302.37, 1273.49, 1212.62, 1156.98, 1091.91, 955.98, 856.36, 780.41, 770.26, 



























Reaction Discovery: Traditional Diazo Sources 
Preparation of diazoesters: 
 
(E)-pent-3-en-1-yl 2-diazoacetate [27]. 
364 mg (2.14 mmol) of (E)-pent-3-en-1-yl 3-oxobutanoate was added to a 100 
mL round-bottom flask, diluted with acetonitrile (21.4 mL, 0.1 M), and 
cooled to 0˚C. pABSA (617 mg, 2.57 mmol, 1.2 equiv) and DBU (384 µL, 2.57 mmol, 1.2 
equiv) were added and the reaction was allowed to warm to RT. After stirring for 12 hours, the 
reaction mixture was diluted with aq. NH4Cl and extracted with diethyl ether. The organic 
extracts were combined, dried over NaSO4, and filtered. After concentration, the crude yellow 
solid was triturated with a 50/50 mixture of pentane/ether, filtered, and the filtrate was 
concentrated. This crude mixture was then diluted with acetonitrile (10 mL) and cooled to 0˚C. 
4% aq. KOH (40 mL) was added and the reaction mixture stirred vigorously until judged 
complete by TLC (1-5 h). The reaction mixture was extracted three times with diethyl ether, 
dried over MgSO4, filtered and concentrated. Purification by flash column chromatography on 
silica using 10% EtOAc/Hex as eluent gave 191 mg (1.24 mmol) of pure product as a yellow oil 
(58% yield).  
1H NMR (500 MHz, CDCl3) δ 5.53 (dqt, J = 15.4, 6.3, 1.3 Hz, 1H), 5.38 (dtq, J = 15.2, 6.8, 1.6 
Hz, 1H), 4.73 (s, 1H), 4.15 (t, J = 6.9 Hz, 2H), 2.32 (qp, J = 6.8, 1.2 Hz, 2H), 1.66 (dq, J = 6.4, 
1.3 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 166.80, 128.08, 126.12, 64.47, 46.17, 32.18, 18.00.; 
IR (ATR, cm-1) 3121.57, 2961.99, 2919.82, 2858.19, 2105.68, 1686.59, 1453.75, 1394.35, 





Synthesized according to literature precedent79. (E)-pent-3-en-1-ol (689 
mg, 8.0 mmol, 1.0 equiv), phenyl acetyl chloride (1.26 mL, 8.0 mmol, 1.0 
equiv), pyridine (1.30 mL, 16 mmol, 2.0 equiv), DMAP (97.8 mg, 0.8 mmol, 0.1 equiv), and 
CH2Cl2 (16 mL, 0.5 M) were used. Flash column chromatography on silica using 0% à 5% 
ethyl acetate/hexanes as eluent gave 1.40 g (6.85 mmol) of pure product as a clear oil (86% 
yield). 
1H-NMR (400 MHz, CDCl3) δ 7.36 - 7.24 (m, 5H), 5.55 - 5.42 (m, 1H), 5.35 (dtq, J = 15.0, 6.6, 
1.5 Hz, 1H), 4.10 (t, J = 6.8 Hz, 2H), 3.62 (s, 2H), 2.32-2.27 (m, 2H), 1.64 (dq, J = 6.4, 1.3 Hz, 
3H).;  13C NMR (126 MHz, CDCl3) δ 171.66, 134.27, 129.39, 128.63, 128.09, 127.14, 126.32, 
64.56, 41.58, 32.05, 18.09.; HRMS (ESI) m/z calculated for C13H16O2Na [M+Na]+: 227.1048, 
found 227.1051. 
 
(E)-pent-3-en-1-yl 2-diazo-2-phenylacetate [28]. 
1.43 g (7.00 mmol) of (E)-pent-3-en-1-yl 2-phenylacetate was added to a 
100 mL round-bottom flask, diluted with acetonitrile (70 mL, 0.1 M), and 
cooled to 0˚C. pABSA (2.02 g, 8.40 mmol, 1.2 equiv) and DBU (1.57 mL, 10.5 mmol, 1.5 equiv) 
were added and the reaction was allowed to warm to RT. After stirring for 12 hours, the reaction 
mixture was diluted with aq. NH4Cl and extracted with diethyl ether. The organic extracts were 
combined, dried over Na2SO4, and filtered. After concentration, the crude orange solid was 
triturated with a 50/50 mixture of pentane/ether, filtered, and the filtrate was concentrated. Flash 
column chromatography on silica using 5% diethyl ether/pentane as eluent gave 669 mg (2.91 




1H-NMR (500 MHz, CDCl3) δ 7.48 (m, 2H), 7.38 (m, 2H), 7.20-7.16 (m, 1H), 5.57 (dqt, J = 15.2, 
6.3, 1.3 Hz, 1H), 5.42 (dtq, J = 15.3, 6.9, 1.5 Hz, 1H), 4.27 (t, J = 6.8 Hz, 2H), 2.38 (qp, J = 6.7, 
1.2 Hz, 2H), 1.68 (dq, J = 6.4, 1.3 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 165.27, 129.01, 
128.36, 126.19, 125.85, 125.72, 124.05, 64.63, 32.31, 18.12; HRMS (ESI) m/z calculated for 
C13H15O2 [M+H-N2]+: 203.1072, found 203.1073; IR (ATR, cm-1) 3060.58, 3026.28, 2960.68, 
2917.83, 2856.42, 2396.29, 2080.84, 1699.91, 1598.58, 1575.82, 1498.39, 1470.09, 1449.81, 
1385.81, 1346.9, 1336.76, 1285.9, 1241.61, 1152.23, 1078.61, 1045.13, 1017.79, 997.6, 965.2, 
904.04, 835.72, 752.9, 689.6, 666.78, 619.64, 555.99, 532.68, 493.98 
 
(E)-methyl pent-3-en-1-yl malonate. 
1.08 g (8.0 mmol) of (E)-pent-3-en-1-ol, pyridine (1.21 mL, 16.0 mmol, 
2 equiv), DMAP (97.7 mg, 0.8 mmol, 0.1 equiv) and CH2Cl2 were added 
to a flame-dried round-bottom flask and cooled to 0˚C. Methyl malonyl chloride (1.09 g, 8.0 
mmol, 1 equiv) was added dropwise. The reaction mixture was slowly warmed to room 
temperature and stirred overnight. The reaction mixture was diluted with aq. NH4Cl and 
extracted with CH2Cl2. The organic extracts were combined, dried over Na2SO4, and filtered. 
After concentration, the crude oil was purified by flash column chromatography on silica using 
15% EtOAc/hexanes as eluent, giving 939 mg (5.0 mmol) of pure product as a clear oil (63% 
yield). 
1H-NMR (500 MHz, CDCl3) δ 5.58-5.48 (m, 1H), 5.38 (dtq, J = 15.3, 6.9, 1.6 Hz, 1H), 4.14 (t, J 
= 6.9 Hz, 2H), 3.75 (s, 3H), 3.38 (s, 2H), 2.37-2.28 (m, 2H), 1.66 (dq, J = 6.4, 1.3 Hz, 3H).; 13C-
NMR (126 MHz, CDCl3) δ 167.11, 166.58, 128.28, 125.99, 65.27, 52.59, 41.46, 31.85, 18.10.; 





(E)-1-methyl 3-(pent-3-en-1-yl) 2-diazomalonate [29]. 
845 mg (4.54 mmol) of (E)-methyl pent-3-en-1-yl malonate was added 
to a 100 mL flame-dried round-bottom flask, diluted with acetonitrile (45 
mL, 0.1 M), and cooled to 0˚C. pABSA (1.31 mg, 5.44 mmol, 1.2 equiv) and DBU (815 µL, 5.44 
mmol, 1.2 equiv) were added and the reaction was allowed to warm to RT. After stirring for 12 
hours, the reaction mixture was diluted with aq. NH4Cl and extracted with diethyl ether. The 
organic extracts were combined, dried over Na2SO4, and filtered. After concentration, the crude 
yellow solid was triturated with a 50/50 mixture of pentane/ether, filtered, and the filtrate was 
concentrated. Flash column chromatography on silica using 15% EtOAc/hexanes as eluent gave 
812 mg (3.83 mmol) of pure product as a yellow oil (84% yield).  
1H-NMR (500 MHz, CDCl3) δ 5.58 – 5.50 (m, 1H), 5.38 (dtq, J = 15.3, 6.9, 1.7 Hz, 1H), 4.22 (t, 
J = 6.9 Hz, 2H), 3.84 (s, 3H), 2.38-2.33 (m, J = 6.8, 1.2 Hz, 2H), 1.66 (dq, J = 6.4, 1.2 Hz, 3H); 
13C NMR (126 MHz, CDCl3) δ 161.59, 160.70, 128.37, 125.76, 65.02, 52.48, 32.00, 17.96.; 
HRMS (ESI) m/z calculated for C9H12N2O4Na [M+Na]+: 235.0695, found 235.0698; IR (ATR, 
cm-1) 2957.88, 2857.93, 2132.69, 1759.74, 1733.99, 1692.34, 1436.48, 1387.26, 1319.59, 
1270.24, 1202.92, 1181.13, 1080.91, 1014.16, 966.47, 830.65, 758.66, 732.78, 647.42, 543.79, 
497.46. 
 
General procedure for reaction discovery studies: 
Into a 1 dram vial was added catalyst (0.040 mmol, 0.10 equiv) in a glovebox. The vial was 
sealed, taken out of the box, and the contents were added under a stream of nitrogen to a flame 
dried three neck 25 mL flask equipped with a stir bar, reflux condenser, glass stopper, and rubber 





minutes (4 hours for FeCl3•pybox conditions58). Diazoester (0.40 mmol) was taken up with 
CH2Cl2 (3.0 mL, 0.13 M) in a glass syringe and added dropwise to the refluxing catalyst solution 
over the course 2-3 minutes (final reaction concentration is 0.05 M). After complete addition of 
diazoester, the reaction refluxed until judged complete by TLC (2-24 h).  The reaction mixture 
was cooled, adsorbed onto SiO2 or florisil, and applied directly to a silica column (75 mL SiO2). 
Purification conditions are noted for individual entry. 
 
Acceptor diazoester: 
FeCl3•pybox Conditions:  (E)-pent-3-en-1-yl 2-diazoacetate (61.7 mg, 0.400 mmol, 1.0 equiv), 
FeCl3 (5.10 mg, 0.040 mmol, 0.10 equiv), 2,6-bis[(4R)-4-phenyl-2-oxazolinyl]pyridine 
(14.8 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 
(8.0 mL, 0.5 M) were used. Flash column chromatography on silica using 5% à 10% à 15% 
EtOAc/hexanes as eluent gave recovered starting material (rsm).  
Run 1: (61.6 mg, 0.399 mmol, 100% rsm). Run 2: (60.2 mg, 0.390 mmol, 98% rsm). Average: 
99% yield rsm. 
Fe(TPP)Cl Conditions: (E)-pent-3-en-1-yl 2-diazoacetate (61.7 mg, 0.400 mmol, 1.0 equiv), 
Fe(TPP)Cl (28.2 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.5 M) were used. Flash 
column chromatography on silica using 5% à 10% à 15% EtOAc/hexanes as eluent gave 
recovered starting material (rsm) and dimer di(pent-3-en-1-yl) fumarate [4] as a mixture of olefin 
isomers.  
Run 1: (47.9 mg, 0.190 mmol, 95% dimer), 0% rsm. Run 2: (45.9 mg, 0.182 mmol, 91% dimer), 
0% rsm. Average: 93% yield dimer [30], 0% rsm. 
[FePc]Cl Conditions: (E)-pent-3-en-1-yl 2-diazoacetate (61.7 mg, 0.400 mmol, 1.0 equiv), 
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[FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.5 M) were used. Flash 
column chromatography on silica using 5% à 10% à 15% EtOAc/hexanes as eluent gave 
recovered starting material (rsm) and dimer di(pent-3-en-1-yl) fumarate [4] as a mixture of olefin 
isomers. 
Run 1: (40.9 mg, 0.162 mmol, 81% dimer), 0% rsm. Run 2: (43.4 mg, 0.172 mmol, 86% dimer), 
0% rsm. Average: 84% yield dimer [30], 0% rsm. 
 
di(pent-3-en-1-yl) fumarate [30]  
1H-NMR (500 MHz, CDCl3) δ 6.23 (s, 2H), 5.54 (dqt, J = 15.4, 
6.3, 1.3 Hz, 2H), 5.39 (dtq, J = 15.2, 6.8, 1.6 Hz, 2H), 4.18 (t, J = 
7.0 Hz, 4H), 2.38-2.32 (m, 4H), 1.66 (dq, J = 6.4, 1.3 Hz, 6H); 
13C-NMR (126 MHz, CDCl3) δ 165.32, 129.88, 128.24, 126.08, 65.05, 31.80, 18.12.; HRMS 
(ESI) m/z calculated for C14H20O4Na [M+Na]+: 275.1259, found 275.1257. 
 
Donor/acceptor diazoester: 
FeCl3•pybox Conditions:  (E)-pent-3-en-1-yl 2-diazo-2-phenylacetate (92.1 mg, 0.400 mmol, 
1.0 equiv), FeCl3 (5.10 mg, 0.040 mmol, 0.10 equiv), 2,6-bis[(4R)-4-phenyl-2-
oxazolinyl]pyridine (14.8 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 
equiv), and CH2Cl2 (8.0 mL, 0.5 M) were used. Flash column chromatography on silica using 
10% EtOAc/hexanes as eluent gave recovered starting material (rsm). 
Run 1: (85.1 mg, 0.369 mmol, 92% rsm). Run 2: (80.1 mg, 0.348 mmol, 87% rsm). Average: 
90% rsm. 






FeTPPCl (28.2 mg, 0.040 mmol, 0.1 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. Flash 
column chromatography on silica using 0% petroleum ether to 10% Et2O/petroleum ether as 
eluent gave recovered starting material (rsm) and ketone (E)-pent-3-en-1-yl 2-oxo-2-
phenylacetate [5]. Yields partially determined via NMR with mesitylene as an internal standard.  
Run 1: (3.5 mg, 0.016 mmol, 4% ketone), (88.9 mg, 0.386 mmol, 97% rsm). Run 2: (2.8 mg, 
0.013 mmol, 3% ketone), (85.9 mg, 0.373 mmol, 93% rsm). Average: 4% yield ketone [31], 
95% rsm. 
[FePc]Cl Conditions: (E)-pent-3-en-1-yl 2-diazo-2-phenylacetate (92.1 mg, 0.400 mmol), 
FePcCl (24.2 mg, 0.040 mmol, 0.1 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. Flash 
column chromatography on silica using 0% to 10% Et2O/petroleum ether as eluent gave 
recovered starting material (rsm) and ketone (E)-pent-3-en-1-yl 2-oxo-2-phenylacetate [31]. 
Yields partially determined via NMR with mesitylene as an internal standard.  
Run 1: (10.4 mg, 0.048 mmol, 12% ketone), (53.4 mg, 0.232 mmol, 58% rsm). Run 2: (10.4 mg, 
0.048 mmol, 12% ketone), (53.4 mg, 0.232 mmol, 58% rsm). Average: 12% yield ketone [31], 
58% rsm. 
 
(E)-pent-3-en-1-yl 2-oxo-2-phenylacetate [31]. 
1H-NMR (500 MHz, CDCl3) δ  8.00 (dd, J = 8.4, 1.3 Hz, 2H), 7.68-7.64 
(m, 1H), 7.51 (dd, J = 8.3, 7.4 Hz, 2H), 5.65 - 5.54 (m, 1H), 5.44 (dtq, J = 
15.3, 6.8, 1.6 Hz, 1H), 4.40 (t, J = 6.8 Hz, 2H), 2.51 - 2.41 (m, 2H), 1.68 (dq, J = 6.4, 1.4 Hz, 
3H).; 13C NMR (126 MHz, CDCl3) δ 186.56, 164.01, 135.02, 132.61, 130.19, 129.00, 128.96, 








FeCl3•pybox Conditions:  (E)-1-methyl 3-(pent-3-en-1-yl) 2-diazomalonate (84.9 mg, 0.400 
mmol, 1.0 equiv), FeCl3 (5.10 mg, 0.040 mmol, 0.10 equiv), 2,6-bis[(4R)-4-phenyl-2-
oxazolinyl]pyridine(14.8 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 
equiv), and CH2Cl2 (8.0 mL, 0.5 M) were used. Flash column chromatography on silica using 
10% EtOAc/hexanes as eluent gave recovered starting material (rsm). 
Run 1: (81.9 mg, 0.386 mmol, 97% rsm). Run 2: (81.7 mg, 0.385 mmol, 96% rsm). Average: 
97% yield rsm. 
Fe(TPP)Cl Conditions: (E)-1-methyl 3-(pent-3-en-1-yl) 2-diazomalonate (84.9 mg, 0.400 mmol, 
1.0 equiv), Fe(TPP)Cl (28.2 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.5 M) were 
used. Flash column chromatography on silica using 10% EtOAc/hexanes as eluent gave 
recovered starting material (rsm). 
Run 1: (78.7 mg, 0.371 mmol, 93% rsm). Run 2: (83.0 mg, 0.391 mmol, 98% rsm). Average: 
96% rsm. 
[FePc]Cl Conditions: (E)-1-methyl 3-(pent-3-en-1-yl) 2-diazomalonate (84.9 mg, 0.400 mmol, 
1.0 equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.5 M) were used. 
Flash column chromatography on silica using 10% EtOAc/hexanes as eluent gave recovered 
starting material (rsm). 
Run 1: (78.5 mg, 0.370 mmol, 93% rsm). Run 2: (82.2 mg, 0.387 mmol, 97% rsm). Average: 
95% rsm. 
 
Acceptor/acceptor diazosulfonate ester: 
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FeCl3•pybox Conditions: Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 
0.400 mmol, 1.0 equiv), FeCl3 (5.10 mg, 0.040 mmol, 0.10 equiv), 2,6-bis[(4R)-4-phenyl-2-
oxazolinyl]pyridine(14.8 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 
equiv), and CH2Cl2 (8.0 mL, 0.5 M) were used. Flash column chromatography on silica using 
10% EtOAc/hexanes as eluent gave recovered starting material (rsm). 
Run 1: (105.6 mg, 0.382 mmol, 96% rsm). Run 2: (110.6 mg, 0.400 mmol, 100% rsm). Average: 
98% yield rsm. 
Fe(TPP)Cl Conditions: Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 
0.400 mmol, 1.0 equiv), Fe(TPP)Cl (28.2 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 
0.05 M) were used. Flash column chromatography on silica using 10% EtOAc/hexanes as eluent 
gave recovered starting material (rsm). 
Run 1: (108.1 mg rsm, 0.391 mmol, 98%). Run 2: (108.0 mg rsm, 0.391 mmol, 98%). Average: 
0% yield, 98% rsm. 
[FePc]Cl Conditions: Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 
mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) 
were used. Flash column chromatography on silica using 10% à 15% à 20% EtOAc/hexanes 
as eluent gave recovered starting material (rsm) and ethyl (E)-4-(prop-1-en-1-yl)-1,2-oxathiane-
3-carboxylate 2,2-dioxide [7] as a mixture of diastereomers. 
Run 1: (3.4 mg, 0.014 mmol, 3%), (107.1 mg rsm, 0.388 mmol, 97%). Run 2: (2.4 mg, 0.010 
mmol, 2%), (107.0 mg rsm, 0.387 mmol, 97%). Average: 3% yield [33], 97% rsm. 
 
Optimization of Fe-Catalyzed Intramolecular C—H Alkylation:  
Ethyl (E)-4-(prop-1-en-1-yl)-1,2-oxathiane-3-carboxylate 2,2-dioxide [33]. 
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The relative stereochemistry of the δ-sultones was determined via coupling constant analysis, 
and confirmed by nOe NMR experiments (500 MHz, CDCl3) in which the C3 and C4 protons for 
each diastereomer were irradiated (highlighted in red). Syn δ-sultones have a characteristic nOe 
between the C3 and C4 equatorial and pseudo-axial hydrogens. Conversely, the C3 and C4 
hydrogens in the anti δ-sultones fall on opposite sides of the ring and therefore experience no 
observable nOe. Instead, for anti allylic C—H alkylation products a weak nOe can be observed 
between the C3 pseudo-axial hydrogen and the pseudo-axial C5 hydrogen.  All products 
described in this paper are designated with the same relative stereochemistry as 7 as determined 
by coupling constant analogy. The experimental data are consistent with previously reported 
studies in the literature72,80. The syn and anti diastereomers were collected from initial 
purification of crude reaction as a mixture (d.r. 1:1-3:1 syn:anti) and subsequently purified for 
characterization. In most, but not all, cases, the syn diastereomer was less polar than the anti 
diastereomer. 
Supplementary Figure 9 
  
 
 Syn diastereomer (major): 1H-NMR (500 MHz, CDCl3) δ 5.68 (dqd, J = 15.0, 
6.5, 1.1 Hz, 1H), 5.33 (ddd, J = 15.3, 7.6, 1.7 Hz, 1H), 4.68-4.55 (m, 2H), 4.26 
(q, J = 7.2 Hz, 2H), 4.05 (d, J = 4.7 Hz, 1HC3), 3.28-3.18 (m, 1H), 2.61 (dtd, J = 
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1.30 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 164.11, 129.69, 127.73, 73.03, 64.90, 
62.37, 40.59, 25.40, 17.99, 14.10.; HRMS (ESI) m/z calculated for C10H17O5S [M+H]+: 
249.0797, found 249.0795. 
 Anti diastereomer (minor): 1H-NMR (500 MHz, CDCl3) δ 5.68 (dqd, J = 13.9, 
6.5, 0.9 Hz, 1H), 5.23 (ddd, J = 15.3, 8.3, 1.7 Hz, 1H), 4.70-4.61 (m, 1H), 4.52-
4.44 (m, 1H), 4.28 (q, J = 7.1 Hz, 2H), 3.78 (d, J = 11.6 Hz, 1H C3), 3.25 (dq, J = 
11.4, 8.2 Hz, 1H), 1.92-1.84 (m, 2H), 1.66 (dd, J = 6.4, 1.4 Hz, 3H), 1.29 (t, J = 7.1 Hz, 3H); 
13C-NMR (126 MHz, CDCl3) δ 163.35, 130.21, 127.93, 72.54, 68.19, 62.67, 41.70, 30.44, 17.98, 
14.16.; HRMS (ESI) m/z calculated for C10H17O5S [M+H]+: 249.0797, found 249.0796. 
 
General procedure for optimization studies (entries 1-11): 
Into a 1 dram vial was added catalyst (0.040 mmol, 0.10 equiv) in a glovebox. The vial was 
sealed, taken out of the box, and the contents were added under a stream of nitrogen to a flame 
dried three neck 25 mL flask equipped with a stir bar, reflux condenser, glass stopper, and rubber 
septum. CH2Cl2 (5.0 mL, 0.08 M) was added and the flask was heated to reflux (~45˚C) for 10 
minutes. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate 32 (110.5 mg, 0.400 mmol, 1.0 
equiv) was taken up with CH2Cl2 (3.0 mL, 0.13 M) in a glass syringe and added dropwise to the 
refluxing catalyst solution over the course of 2-3 minutes (final reaction concentration is 0.05 M). 
After complete addition of diazosulfonate, the reaction refluxed until judged complete by TLC 
(2-24 h).  The reaction mixture was cooled, adsorbed onto SiO2 or florisil, and applied directly to 
a silica column (75 mL SiO2) for purification to afford the desired sultone product. The 
recovered starting material (rsm) and product were eluted with 10% à 15% à 20% 









Entry 1. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 mmol, 1.0 
equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. 
Run 1: (3.4 mg, 0.014 mmol, 3%), (107.1 mg rsm, 0.388 mmol, 97%). Run 2: (2.4 mg, 0.010 
mmol, 2%), (107.0 mg rsm, 0.387 mmol, 97%). Average: 3% yield, 97% rsm. 
 
Entry 2. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 mmol, 1.0 
equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
and CH2Cl2 (8.0 mL, 0.05 M) were used. 
Run 1: (45.5 mg, 0.183 mmol, 46%). Run 2: (44.4 mg, 0.179 mmol, 45%). Average: 45% yield, 
0% rsm. 
 
Entry 3. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 mmol, 1.0 
equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 
equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. 
Run 1: (47.7 mg, 0.192 mmol, 48%). Run 2: (46.3 mg, 0.186 mmol, 47%). Average: 48% yield, 
0% rsm. 
 
Entry 4. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 mmol, 1.0 
equiv), [FeCl16Pc]Cl (46.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 
equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. 




Entry 5. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 mmol, 1.0 
equiv), [FeCl8Pc]Cl (35.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 
equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. 
Run 1: (24.3 mg, 0.098 mmol, 25%), (73.7 mg rsm, 0.267 mmol, 67%). Run 2: (26.0 mg, 0.105 
mmol, 26%), (72.6 mg rsm, 0.263 mmol, 66%). Average: 25% yield, 66% rsm. 
 
Entry 6. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 mmol, 1.0 
equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 
equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. Solution of diazo was added via syringe pump 
over the course of an hour (see General procedure for [FePc]-catalyzed C—H alkylation).  
Run 1: (53.4 mg, 0.215 mmol, 54%). Run 2: (51.9 mg, 0.209 mmol, 53%). Average: 53% yield, 
0% rsm. 
 
Entry 7. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 mmol, 1.0 
equiv), Fe(TPP)Cl (28.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 
equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. 
Run 1: (7.5 mg, 0.030 mmol, 7%), (103.2 mg rsm, 0.373 mmol, 93%). Run 2: (6.3 mg, 0.025 
mmol, 6%), (104.7 mg rsm, 0.379 mmol, 94%). Average: 7% yield, 93% rsm. 
 
Entry 8. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 mmol, 1.0 
equiv), [FeIIPc] (22.7 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. 
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Run 1: (108.9 mg rsm, 0.394 mmol, 99%). Run 2: (110.2 mg rsm, 0.399 mmol, 100%). Average: 
0% yield, 100% rsm. 
 
Entry 9. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 mmol, 1.0 
equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. 
Run 1: (105.7 mg rsm, 0.382 mmol, 96%). Run 2: (106.7 mg rsm, 0.386 mmol, 97%). Average: 
0% yield, 96% rsm. 
 
Preparation of Sulfonate Ester Starting Materials: 
General procedure for preparation of sulfonate ester substrates: 
A round-bottom flask equipped with a stir bar and rubber septum was charged with alcohol 
substrate (1 equiv), imidazole  (1.2 equiv), and THF (0.4 M). Ethyl chlorosulfonylacetate (1.5 
equiv) was dissolved in THF (0.4 M) and added slowly dropwise to the reaction over the course 
of 5 mins. The reaction was stirred at room temperature for 1-6 hours, or until complete 
consumption of starting material as monitored by TLC. The reaction was quenched with H2O 
until the mixture turned clear (10-20 mL). The reaction mixture was partitioned between H2O 
(15 mL) and CH2Cl2 (60 mL) and separated. The aqueous layer was then extracted with CH2Cl2 
(2x20 mL). The organic layers were combined, dried over MgSO4, filtered, and concentrated 
under reduced pressure. Purification by column chromatography on silica gel afforded the 
desired sulfonate ester. 
 
Ethyl (E)-2-((hex-4-en-1-yloxy)sulfonyl)acetate. 







mg, 12.0 mmol, 1.2 equiv), ClSO2CH2CO2Et (2.80 g, 15.0 mmol, 1.5 equiv), and THF (50 mL, 
0.2 M). Flash column chromatography on silica using 10% EtOAc/hexanes as eluent gave 2.30 g 
(9.20 mmol) of pure product as a pale yellow oil (92% yield). 
1H-NMR (500 MHz, CDCl3) δ 5.54-5.43 (m, 1H), 5.38 (dt, J = 15.2, 6.6 Hz, 1H), 4.33 (t, J = 6.5 
Hz, 2H), 4.28 (q, J = 7.2 Hz, 2H), 4.07 (s, 2H), 2.11 (dt, J = 7.3, 6.6 Hz, 2H), 1.82 (p, J = 6.7 Hz, 
2H), 1.65 (d, J = 6.3 Hz, 3H), 1.32 (t, J = 7.2 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 162.02, 
129.02, 126.58, 71.77, 62.60, 54.67, 28.86, 28.14, 17.84, 13.90.; HRMS (ESI) m/z calculated for 
C10H18O5SNa [M+Na]+: 273.0773, found 273.0771. 
 
Ethyl 2-(((5-methylhex-4-en-1-yl)oxy)sulfonyl)acetate. 
0.57 g (5.0 mmol) of 5-methylhex-4-en-1-ol were used, along with imidazole 
(409 mg, 6.0 mmol, 1.2 equiv), ClSO2CH2CO2Et (1.40 g, 7.5 mmol, 1.5 equiv), 
and THF (25 mL, 0.2 M). Flash column chromatography on silica using 15% 
EtOAc/hexanes as eluent gave 0.89 mg (3.40 mmol) of pure product as a clear oil (68% yield). 
1H-NMR (500 MHz, CDCl3) δ 5.08 (t, J = 7.2 Hz, 1H), 4.33 (t, J = 6.5 Hz, 2H), 4.28 (q, J = 7.1 
Hz, 2H), 4.07 (s, 2H), 2.11 (dt, J = 7.3, 7.1 Hz, 2H), 1.80 (p, J = 6.8 Hz, 2H), 1.70 (s, 3H), 1.61 
(s, 3H), 1.33 (t, J = 7.1 Hz, 3H); 13C-NMR (126 MHz, CDCl3) 162.14, 133.53, 122.37, 72.06, 
62.84, 54.97, 29.41, 25.84, 23.85, 17.84, 14.10; HRMS (ESI) m/z calculated for C11H20O5SNa 
[M+Na]+: 287.0929, found 287.0927. 
 
Ethyl (E)-2-(((7-((tert-butyldiphenylsilyl)oxy)hept-4-en-1-yl)oxy)sulfonyl)acetate. 
839 mg (2.30 mmol) of (E)-7-((tert-butyldiphenylsilyl)oxy)hept-4-en-













ClSO2CH2CO2Et (653 mg, 3.50 mmol, 1.5 equiv), and THF (12 mL, 0.2 M). Flash column 
chromatography on silica using 10% EtOAc/hexanes as eluent gave 1.20 g (2.30 mmol) of pure 
product as a pale yellow oil (100% yield). 
1H-NMR (500 MHz, CDCl3) δ7.69-7.63 (m, 4H), 7.45-7.34 (m, 6H), 5.44 (m, 2H), 4.32 (t, J = 
6.4 Hz, 2H), 4.27 (q, J = 7.1 Hz, 2H), 4.06 (s, 2H), 3.67 (t, J = 6.6 Hz, 2H), 2.25 (q, J = 6.4 Hz, 
2H), 2.11 (q, J = 6.9 Hz, 2H), 1.81 (p, J = 6.5 Hz, 2H), 1.31 (t, J = 7.3 Hz, 3H), 1.04 (s, 9H).; 
13C-NMR (126 MHz, CDCl3) δ 162.07, 135.63, 134.03, 130.11, 129.64, 128.55, 127.68, 71.83, 
63.82, 62.73, 54.85, 36.04, 28.96, 28.38, 26.93, 19.30, 14.04.; HRMS (ESI) m/z calculated for 
C27H39O6SiS [M+H]+: 519.2237, found 519.2239. 
 
Ethyl (E)-2-(((5-phenylpent-4-en-1-yl)oxy)sulfonyl)acetate. 
825 mg (5.10 mmol) of (E)-5-phenylpent-4-en-1-ol were used, along with 
imidazole (415 mg, 6.10 mmol, 1.2 equiv), ClSO2CH2CO2Et (1.40 g, 7.70 
mmol, 1.5 equiv), and THF (26 mL, 0.2 M). Flash column chromatography on silica using 10% 
EtOAc/hexanes as eluent gave 1.47 g (4.70 mmol) of pure product as a pale yellow oil (92% 
yield). 
1H-NMR (500 MHz, CDCl3) δ 7.36-7.32 (m, 2H), 7.30 (t, J = 7.6 Hz, 2H), 7.24-7.19 (m, 1H), 
6.45 (d, J = 15.8 Hz, 1H), 6.18 (dt, J = 15.9, 7.0 Hz, 1H), 4.40 (t, J = 6.4 Hz, 2H), 4.28 (q, J = 
7.2 Hz, 2H), 4.09 (s, 2H), 2.36 (dt, J = 8.3, 7.1 Hz, 2H), 1.96 (p, J = 6.6 Hz, 2H), 1.32 (t, J = 7.1 
Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 161.89, 137.15, 131.14, 131.11, 128.37, 128.24, 
128.19, 127.00, 125.86, 71.48, 62.42, 54.46, 28.57, 28.47, 13.76.; HRMS (ESI) m/z calculated 









735 mg (3.05 mmol) of (E)-hex-4-en-1-ol were used, along with 
imidazole (249 mg, 3.7 mmol, 1.2 equiv), ClSO2CH2CO2Et (854 mg, 
4.58 mmol, 1.5 equiv), and THF (15 mL, 0.2 M). Flash column chromatography on silica using 
15% à 20% à 25% EtOAc/hexanes as eluent gave 950 mg (2.42 mmol) of pure product as a 
clear oil (79% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.41 (d, J = 8.5 Hz, 2H), 7.20 (d, J = 8.4 Hz, 2H), 6.38 (d, J = 
15.8 Hz, 1H), 6.17 (dt, J = 15.8, 7.0 Hz, 1H), 4.39 (t, J = 6.3 Hz, 2H), 4.28 (q, J = 7.1 Hz, 2H), 
4.08 (s, 2H), 2.35 (dt, J = 7.7, 6.8 Hz, 2H), 1.95 (p, J = 6.5 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H); 13C-
NMR (126 MHz, CDCl3) δ 162.26, 136.47, 131.84, 130.54, 129.40, 127.84, 121.09, 71.80, 
62.99, 55.08, 28.96, 28.94, 14.23; HRMS (ESI) m/z calculated for C15H19BrO5SNa [M+Na]+: 
413.0034; found 413.0026. 
 
Ethyl (E)-2-(((5-(4-chlorophenyl)pent-4-en-1-yl)oxy)sulfonyl)acetate. 
610 mg (3.10 mmol) of (E)-5-(4-chlorophenyl)pent-4-en-1-ol were used, 
along with imidazole (253 mg, 3.72 mmol, 1.2 equiv), ClSO2CH2CO2Et 
(868 mg, 4.65 mmol, 1.5 equiv), and THF (16 mL, 0.2 M). Flash column chromatography on 
silica using 15% EtOAc/hexanes as eluent gave 846 mg (2.40 mmol) of pure product as a pale 
yellow oil (77% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.31- 7.23 (m, 4H), 6.40 (d, J = 15.9, 1H), 6.15 (dt, J = 15.6, 6.9 
Hz, 1H), 4.39 (t, J = 6.4 Hz, 2H), 4.28 (q, J = 7.1 Hz, 2H), 4.09 (s, 2H), 2.36 (dt, J = 7.4, 7.0 Hz, 
2H), 1.95 (p, J = 6.4 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 162.06, 


















890 mg (3.88 mmol) of (E)-hex-4-en-1-ol were used, along with 
imidazole (317 mg, 4.66 mmol, 1.2 equiv), ClSO2CH2CO2Et (1.09 g, 
5.82 mmol, 1.5 equiv), and THF (19 mL, 0.2 M). Flash column chromatography on silica using 
25% à 30% à 33% EtOAc/hexanes as eluent gave 772 mg (2.03 mmol) of pure product as a 
clear oil (52% yield). 
1H-NMR (500 MHz, CDCl3) δ7.55 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 8.2 Hz, 2H), 6.48 (d, J = 15.9 
Hz, 1H), 6.29 (dt, J = 15.8, 7.0 Hz, 1H), 4.41 (t, J = 6.3 Hz, 2H), 4.28 (q, J = 7.1 Hz, 2H), 4.10 
(s, 2H), 2.40 (dt, J = 7.3, 6.8 Hz, 2H), 1.97 (p, J = 6.5 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 162.27, 140.99, 131.36, 130.48, 129.20 (q, J = 32.4 Hz), 126.42, 
125.72 (q, J = 3.8 Hz), 124.47 (q, J = 272.2 Hz), 71.75, 63.01, 55.08, 28.99, 28.88, 14.20. 
HRMS (ESI) m/z calculated for C16H19F3O5SNa [M+Na]+: 403.0803, found 403.0788.  
 
Ethyl (E)-2-(((4-phenylbut-3-en-1-yl)oxy)sulfonyl)acetate. 
764 mg (5.20 mmol) of (E)-4-phenylbut-3-en-1-ol were used, along with 
imidazole (422 mg, 6.20 mmol, 1.2 equiv), ClSO2CH2CO2Et (1.46 g, 7.80 
mmol, 1.5 equiv), and THF (26 mL, 0.2 M). Flash column chromatography on 
silica using 15% EtOAc/hexanes as eluent gave 1.38 g (4.60 mmol) of pure product as a pale 
yellow oil (88% yield). 













J = 15.8 Hz, 1H), 6.16 (dt, J = 15.9, 7.0 Hz, 1H), 4.45 (t, J = 6.7 Hz, 2H), 4.26 (q, J = 7.2 Hz, 
2H), 4.10 (s, 2H), 2.69 (qd, J = 6.7, 1.5 Hz, 2H), 1.30 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, 
CDCl3) δ 162.07, 136.89, 133.68, 128.63, 127.63, 126.25, 123.66, 71.40, 62.78, 54.97, 32.90, 
14.00.; HRMS (ESI) m/z calculated for C14H18O5SNa [M+Na]+: 371.0773, found 321.0767. 
 
Ethyl (E)-2-((pent-3-en-1-yloxy)sulfonyl)acetate. 
431 mg (5.0 mmol) of (E)-pent-3-en-1-ol were used, along with imidazole (409 
mg, 6.0 mmol, 1.2 equiv), ClSO2CH2CO2Et (1.40 g, 7.50 mmol, 1.5 equiv), and 
THF (25 mL, 0.2 M). Flash column chromatography on silica using 10% EtOAc/hexanes as 
eluent gave 807 mg (3.40 mmol) of pure product as a pale yellow oil (68% yield). 
1H-NMR (500 MHz, CDCl3) δ 5.65-5.54 (m, 1H), 5.38 (dtq, J = 15.4, 6.9, 1.7 Hz, 1H), 4.32 (t, J 
= 6.8 Hz, 2H), 4.28 (q, J = 7.4 Hz, 2H), 4.08 (s, 2H), 2.45 (m, 2H), 1.68 (dq, J = 6.7, 1.4 Hz, 
3H), 1.33 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 162.05, 129.40, 124.56, 71.83, 
62.66, 54.82, 32.44, 17.98, 13.94.; HRMS (ESI) m/z calculated for C9H16O5SNa [M+Na]+: 
259.0616, found 259.0609. 
 
Ethyl 2-((3-((tert-butyldiphenylsilyl)oxy)propoxy)sulfonyl)acetate. 
1.57 g (5.0 mmol) of 3-((tert-butyldiphenylsilyl)oxy)propan-1-ol were used, 
along with imidazole (409 mg, 6.0 mmol, 1.2 equiv), ClSO2CH2CO2Et (1.4 g, 
7.5 mmol, 1.5 equiv), and THF (25 mL, 0.2 M). Flash column chromatography on silica using 
5% EtOAc/hexanes as eluent gave 1.16 g (2.50 mmol) of pure product as a sticky pale yellow oil 
(50% yield). 













4.26 (q, J = 7.2 Hz, 2H), 4.05 (s, 2H), 3.78 (t, J = 5.8 Hz, 2H), 1.98 (p, J = 6.1 Hz, 2H), 1.30 (t, J 
= 7.1 Hz, 3H), 1.05 (s, 9H).; 13C-NMR (126 MHz, CDCl3) δ 162.03, 135.55, 133.39, 129.83, 
127.81, 69.36, 62.69, 59.31, 54.75, 32.14, 26.87, 19.23, 14.01.; HRMS (ESI) m/z calculated for 
C23H33O6SiS [M-H]+: 463.1611, found 463.1601. 
 
Ethyl 2-((3-(4-methoxyphenyl)propoxy)sulfonyl)acetate. 
1.58 g (5.00 mmol) of 3-(4-methoxyphenyl)propan-1-ol were used, along 
with imidazole (408.5 mg, 6 mmol, 1.2 equiv), ClSO2CH2CO2Et (1.40 g, 
7.50 mmol, 1.5 equiv), and THF (25 mL, 0.2 M). Flash column chromatography on silica using 
10% → 20% EtOAc/hexanes as eluent gave 855 mg (2.70 mmol) of pure product as a clear oil 
(53% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.09 (d, J = 8.5 Hz, 2H), 6.82 (d, J = 8.5 Hz, 2H), 4.31 (t, J = 6.3 
Hz, 2H), 4.25 (q, J = 7.1 Hz, 2H), 4.08 (s, 2H), 3.76 (s, 3H), 2.68 (t, J = 7.6 Hz, 2H), 2.03 (p, J = 
7.6 Hz, 2H), 1.30 (t, J = 7.2, 3H).; 13C-NMR (126 MHz, CDCl3) δ 162.08, 158.15, 132.33, 
129.45, 114.05, 71.54, 62.79, 55.33, 54.86, 31.04, 30.58, 14.05.; HRMS (ESI) m/z calculated for 
C14H20O6SNa [M+Na]+: 339.0878, found 339.0872. 
 
Ethyl 2-((3-(1-(phenylsulfonyl)-1H-indol-3-yl)propoxy)sulfonyl)acetate. 
2.30 g (7.28 mmol) of 3-(1-(phenylsulfonyl)-1H-indol-3-yl)propan-1-ol was 
used, along with imidazole (595 mg, 8.74 mmol, 1.2 equiv), 
ClSO2CH2CO2Et (2.04 g, 10.9 mmol, 1.5 equiv), and THF (18 mL, 0.2 M). 
Flash column chromatography on silica using 10% → 30% EtOAc/hexanes as eluent gave 2.40 g 














an unknown impurity that did not appear to affect reactivity. 
1H-NMR (500 MHz, CDCl3) δ 8.00 (d, J = 8.3 Hz, 1H), 7.87 (d, J = 7.2 Hz, 2H), 7.53 (t, J = 7.5 
Hz, 1H), 7.49 - 7.38 (m, 4H), 7.33 (t, J = 8.0, 1H), 7.24 (m, 1H), 4.35 (t, J = 6.1 Hz, 2H), 4.28 (q, 
J = 7.1 Hz, 2H), 4.10 (s, 2H), 2.83 (t, J = 7.3 Hz, 2H), 2.14 (p, J = 7.5 Hz, 2H), 1.31 (t, J = 7.1 
Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 162.13, 138.25, 135.54, 133.88, 130.71, 129.39, 
126.87, 125.06, 123.38, 121.38, 119.46, 113.99, 71.20, 62.94, 55.03, 28.57, 20.86, 14.11. (one 




1.26 g (7.0 mmol) of 3-(benzo[d][1,3]dioxol-5-yl)propan-1-ol were used, 
along with imidazole (571 mg, 8.40 mmol, 1.2 equiv), ClSO2CH2CO2Et 
(1.90 g, 10.5 mmol, 1.5 equiv), and THF (35 mL, 0.2 M). Flash column chromatography on 
silica using 20% EtOAc/hexanes as eluent gave 1.82 g (5.50 mmol) of pure product as a pale 
yellow oil (79% yield). 
1H-NMR (500 MHz, CDCl3) δ 6.74 (d, J = 7.9 Hz, 1H), 6.68 (d, J = 1.5 Hz, 1H), 6.64 (dd, J = 
7.9, 1.8 Hz, 1H), 5.93 (s, 2H), 4.33 (t, J = 6.3 Hz, 2H), 4.28 (q, J = 7.1 Hz, 2H), 4.08 (s, 2H), 
2.68 (t, J = 7.5 Hz, 2H), 2.04 (p, J = 6.4 Hz, 2H), 1.32 (t, J = 7.2 Hz, 3H).; 13C-NMR (126 MHz, 
CDCl3) δ 162.11, 147.89, 146.12, 134.13, 121.41, 108.95, 108.43, 101.00, 71.42, 62.87, 55.00, 
31.31, 31.14, 14.11.; HRMS (ESI) m/z calculated for C14H18O7SNa [M+Na]+: 353.0671, found 
353.0672. 
Preparation of Diazosulfonate Starting Materials: 









A round-bottom flask equipped with a stir bar and rubber septum was charged with sulfonate 
ester (1 equiv) and THF (0.4 M) and cooled to -45˚C with a dry ice/acetonitrile bath. MeSO2N3 
(2.2–3.0 equiv) was then added in one portion. DBU (1.5 equiv) was then added slowly dropwise 
over 2-5 minutes and the solution turned yellow. After the reaction was stirred for 1 hour at -
45˚C, the cooling bath was removed and 15 mL of sat. aq. (NH4)2SO4 was immediately added. 
The mixture was transferred to a separatory funnel with 20 mL of CH2Cl2. The aqueous layer 
was extracted with 3 x 10 mL CH2Cl2, and the combined organic extracts were washed with 2 x 
10 mL 10% NaOH, 2 x 10 mL H2O, and sat. aq. NaCl. The organic phase was dried over Na2SO4 
or MgSO4, filtered, and concentrated under reduced pressure. Purification by chromatography on 
silica gel gave the desired diazo product. Some diazoesters were difficult to separate from the 
sulfonamide byproduct (MeSO2NH2, singlet at 3.30 ppm). In these cases, the diazoester was 
washed 3x with 20% NaOH, 2x with H2O, and 1x with brine after column chromatography. We 
found that this sulfonamide impurity (in trace quantities, <5%) did not affect the reactivity of the 
diazoesters. Following purification, the diazo compounds were stored at -20˚C under argon. The 
13C NMR signal for the diazo carbon was typically not detected; Novikov80 and Du Bois72 
noticed similar results. NOTE: Some diazosulfonate ester compounds exhibited suboptimal 
reactivity after storing for more than a month; repurification sometimes restored reactivity in 
these cases. Some diazosulfonate ester compounds decomposed during long periods under 
reduced pressure. These cases are noted below. WARNING: Although we have not experienced 
problems with the preparation and the handling of MeSO2N3 or diazosulfonate esters, sulfonyl 




Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate [32]. 
2.30 g (9.20 mmol) of ethyl (E)-2-((hex-4-en-1-yloxy)sulfonyl)acetate were 
used, along with MeSO2N3 (2.40 g, 20.2 mmol, 2.2 equiv), DBU (206  µL, 13.8 
mmol, 1.5 equiv), and THF (23 mL, 0.4 M). Flash column chromatography on 
silica using 5% EtOAc/hexanes as eluent gave 1.98 g (7.17 mmol) of pure product as a yellow 
oil (78% yield). 
1H-NMR (500 MHz, CDCl3) δ 5.53-5.43 (m, 1H), 5.37 (ddd, J = 15.2, 6.8, 5.1 Hz, 1H), 4.35 (t, J 
= 6.3 Hz, 2H), 4.33 (q, J = 7.2 Hz, 2H), 2.10 (dt, J = 7.7, 7.3 Hz, 2H), 1.81 (p, J = 6.7 Hz, 2H), 
1.65 (dd, J = 6.2, 1.3 Hz, 3H), 1.33 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 159.62, 
129.05, 126.88, 72.98, 62.80, 28.77, 28.29, 18.01, 14.39.; HRMS (ESI) m/z calculated for 
C10H16O5N2SNa [M+Na]+: 299.0678, found 299.0681; IR (ATR, cm-1) 2970, 2940, 2856, 2130, 




0.89 g (3.40 mmol) of ethyl 2-(((5-methylhex-4-en-1-yl)oxy)sulfonyl)acetate 
[S4] were used, along with MeSO2N3 (908 mg, 7.50 mmol, 2.2 equiv), DBU 
(762  µL, 5.10 mmol, 1.5 equiv), and THF (8.5 mL, 0.4 M). Flash column 
chromatography on silica using 10% EtOAc/hexanes as eluent gave 0.60 g (2.08 mmol) of pure 
product as a yellow oil (61% yield). 
1H-NMR (500 MHz, CDCl3) δ 5.07 (t, J = 7.3 Hz, 1H), 4.34 (t, J = 6.6 Hz, 2H), 4.31 (q, J = 7.2 
Hz, 2H), 2.10 (dt, J = 7.5, 7.0 Hz, 2H), 1.79 (p, J = 7.3 Hz, 2H), 1.69 (s, 3H), 1.61 (s, 3H), 1.33 












25.77, 23.81, 17.77, 14.35; IR (ATR, cm-1) 2970, 2918, 2130, 1722, 1447, 1373, 1285, 1224, 
1178, 1083, 1007, 924, 879, 843, 777, 739, 615, 558, 495; HRMS (ESI) m/z calculated for 
C11H18N2O5SNa [M+Na]+: 313.0834, found 313.0831. 
 
Ethyl (E)-2-(((7-((tert-butyldiphenylsilyl)oxy)hept-4-en-1-yl)oxy)sulfonyl)-2-diazoacetate. 
1.18 g (2.30 mmol) of ethyl (E)-2-(((7-((tert-
butyldiphenylsilyl)oxy)hept-4-en-1-yl)oxy)sulfonyl)acetate were used, 
along with MeSO2N3 (618 mg, 5.10 mmol, 2.2 equiv), DBU (524 µL, 3.50 mmol, 1.5 equiv), and 
THF (5.75 mL, 0.4 M). Flash column chromatography on silica using 5% EtOAc/hexanes as 
eluent gave 879 mg (1.61 mmol) of pure product as a yellow oil (70% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.68-7.64 (m, 4H), 7.45-7.35 (m, 6H), 5.51-5.36 (m, 2H), 4.34 (t, 
J = 6.2 Hz, 2H), 4.31 (q, J = 7.3 Hz, 2H), 3.67 (t, J = 6.6 Hz, 2H), 2.25 (q, J = 6.9 Hz, 2H), 2.10 
(dt, J = 7.7, 7.2 Hz, 2H), 1.80 (p, J = 6.5 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H), 1.04 (s, 9H).; 13C-
NMR (126 MHz, CDCl3) δ 159.59, 135.68, 134.06, 130.08, 129.68, 128.63, 127.71, 73.01, 
63.84, 62.79, 36.08, 28.78, 28.44, 26.96, 19.34, 14.40.; HRMS (ESI) m/z calculated for 
C27H37O6N2SiS [M+H]+: 545.2142, found 545.2141; IR (ATR, cm-1) 3071, 2931, 2857, 2130, 
1723, 1589, 1472, 1376, 1288, 1225, 1179, 1091, 1006, 926, 822, 783. 
 
Ethyl (E)-2-diazo-2-(((5-phenylpent-4-en-1-yl)oxy)sulfonyl)acetate. 
1.49 g (4.70 mmol) of ethyl (E)-2-(((5-phenylpent-4-en-1-
yl)oxy)sulfonyl)acetate were used, along with MeSO2N3 (1.25 g, 10.3 mmol, 
2.2 equiv), DBU (106  µL, 7.10 mmol, 1.5 equiv), and THF (12 mL, 0.4 M). Flash column 














product as a yellow oil (65% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.36-7.27 (m, 4H), 7.24- 7.19 (m, 1H), 6.43 (d, J = 15.8 Hz, 1H), 
6.16 (dt, J = 15.8, 7.0 Hz, 1H), 4.41 (t, J = 6.3 Hz, 2H), 4.31 (q, J = 7.1 Hz, 2H), 2.36 (q, J = 7.5 
Hz, 2H), 1.95 (p, J = 6.3 Hz, 2H), 1.31 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 
159.56, 137.32, 131.59, 128.65, 128.24, 127.34, 126.12, 72.81, 62.82, 28.80, 28.67, 14.39.; 
HRMS (ESI) m/z calculated for C15H18O5N2SNa [M+H]+: 361.0834, found 361.0844; IR (ATR, 
cm-1) 3024, 2997, 2970, 2946, 2513, 2127, 1715, 1598, 1576, 1492, 1471, 1447, 1372, 1287, 
1226, 1177, 1155, 1079, 1007, 986, 962, 926, 848. 
 
Ethyl (E)-2-(((5-(4-bromophenyl)pent-4-en-1-yl)oxy)sulfonyl)-2-diazoacetate. 
950 mg (2.42 mmol) of ethyl(E)-2-(((5-(4-bromophenyl)pent-4-en-1-
yl)oxy)sulfonyl)acetate were used, along with MeSO2N3 (640 mg, 5.3 
mmol, 2.2 equiv), DBU (543  µL, 3.63 mmol, 1.5 equiv), and THF (6.1 
mL, 0.4 M). Flash column chromatography on silica using 10% à 15% à 20% EtOAc/hexanes 
as eluent gave 614 mg (1.47 mmol) of pure product as a yellow oil (61% yield). 
1H-NMR (500 MHz, CDCl3) δ7.42 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.4 Hz, 2H), 6.37 (d, J = 15.9 
Hz, 1H), 6.16 (dt, J = 15.8, 7.0 Hz, 1H), 4.41 (t, J = 6.3 Hz, 2H), 4.31 (q, J = 7.2 Hz, 2H), 2.34 
(dt, J = 7.6, 7.0 Hz, 2H), 1.94 (p, J = 6.7 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, 
CDCl3) δ159.68, 136.43, 131.85, 130.61, 129.29, 127.83, 121.13, 72.89, 62.96, 28.94, 28.70, 
14.53.; HRMS (ESI) m/z calculated for C15H18N2O5SBr [M+H]+: 417.0120, found 417.0113.; IR 
(ATR, cm-1) 2982.7, 2131.1, 1717.0, 1587.7, 1487.6, 1466.0, 1445.4, 1373.3, 1285.6, 1223.1, 
1177.1, 1085.4, 1073.1, 1007.4, 962.7, 924.3, 881.7, 838.1, 823.3, 738.2, 703.5, 613.8, 564.3, 










846 mg (2.40 mmol) of ethyl (E)-2-(((5-(4-chlorophenyl)pent-4-en-1-
yl)oxy)sulfonyl)acetate were used, along with MeSO2N3 (641 mg, 5.3 
mmol, 2.2 equiv), DBU (538  µL, 3.60 mmol, 1.5 equiv), and THF (6 mL, 0.4 M). Flash column 
chromatography on silica using 20% Et2O/hexanes as eluent gave 633 mg (1.70 mmol) of pure 
product as a yellow oil (71% yield). This compound was isolated with <5% of an unknown 
impurity that did not appear to affect reactivity. 
1H-NMR (500 MHz, CDCl3) δ 7.28-7.24 (m, 4H), 6.39 (dt, J = 15.8, 1.5 Hz, 1H), 6.14 (dt, J = 
15.9, 7.0 Hz, 1H), 4.41 (t, J = 6.3 Hz, 2H), 4.31 (q, J = 7.0 Hz, 2H), 2.35 (dt, J = 7.9, 7.5 Hz, 
2H), 1.94 (p, J = 6.5 Hz, 2H), 1.32 (t, J = 7.2 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 159.41, 
135.79, 132.70, 130.26, 128.98, 128.40, 127.27, 72.67, 62.72, 28.69, 28.46, 14.28.; HRMS (ESI) 
m/z calculated for C15H17O5N2SCl [M+H]+: 395.0444, found 395.0444; IR (ATR, cm-1) 2970, 
2940, 2131, 1718, 1593, 1490, 1465, 1373, 1285, 1224, 1177, 1088, 1011, 924, 839. 
 
Ethyl (E)-2-diazo-2-(((5-(4-(trifluoromethyl)phenyl)pent-4-en-1-yl)oxy)sulfonyl)acetate. 
 772 mg (2.03 mmol) of ethyl(E)-2-(((5-(4-
(trifluoromethyl)phenyl)pent-4-en-1-yl)oxy)sulfonyl)acetate were used, 
along with MeSO2N3 (541 mg, 4.47 mmol, 2.2 equiv), DBU (456  µL, 3.05 mmol, 1.5 equiv), 
and THF (5.1 mL, 0.4 M). Flash column chromatography on silica using 10% à 15% à 20% 
EtOAc/hexanes as eluent gave 412 mg (1.02 mmol) of pure product as a yellow oil (50% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.55 (d, J = 8.1 Hz, 2H), 7.43 (d, J = 8.1 Hz, 2H), 6.47 (d, J = 














2.39 (dt, J = 7.3, 7.0 Hz, 2H), 1.97 (p, J = 6.6 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 159.67, 140.95, 131.28, 130.53, 129.24 (q, J = 32.3 Hz), 126.42, 125.73 (q, J = 
3.8 Hz), 124.46 (q, J = 273.42 Hz), 72.84, 62.96, 29.00, 28.62, 14.50. HRMS (ESI) m/z calc’d 
for C16H18N2O5F3S  [M+H]+: 407.0889, found 407.0899.; IR (ATR, neat, cm-1) 2988.19, 2143.5, 
1916.96, 1707.3, 1654.07, 1614.47, 1578.37, 1467.21, 1454.81, 1432.38, 1378.24, 1325.48, 
1299.49, 1207.47, 1177.77, 1156.31, 1113.06, 1097.62, 1066.63, 1014.63, 1001.32, 975.17, 
951.8, 924.77, 858.66, 843.86, 825.59, 799.6, 758.89, 741.11, 650.05, 615.73, 575.8, 534.59, 
523.13, 509.54, 496.94 
 
Ethyl (E)-2-diazo-2-(((4-phenylbut-3-en-1-yl)oxy)sulfonyl)acetate. 
1.38 g (4.60 mmol) of ethyl (E)-2-(((4-phenylbut-3-en-1-
yl)oxy)sulfonyl)acetate were used, along with MeSO2N3 (1.22 g, 10.1 mmol, 
2.2 equiv), DBU (1.00  mL, 6.90 mmol, 1.5 equiv), and THF (12 mL, 0.4 M). 
Flash column chromatography on silica using 5% EtOAc/hexanes as eluent gave 1.11 g (3.42 
mmol) of pure product as a yellow oil (74% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.37-7.33 (m, 2H), 7.33-7.28 (m, 2H), 7.25-7.21 (m, 1H), 6.52 
(dt, J = 15.9, 1.4 Hz, 1H), 6.15 (dt, J = 15.8, 7.0 Hz, 1H), 4.47 (t, J = 6.6 Hz, 2H), 4.27 (q, J = 
7.1 Hz, 2H), 2.68 (qd, J = 6.7, 1.5 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, 
CDCl3) δ 159.49, 136.88, 133.74, 128.65, 127.68, 126.27, 123.59, 72.69, 62.78, 32.66, 14.32.; 
HRMS (ESI) m/z calculated for C14H16O5N2SNa [M+Na]+: 347.0678, found 347.0672; IR (ATR, 
cm-1) 3424, 3082, 3059, 3027, 2984, 2939, 2908, 2385, 2131, 1947, 1716, 1598, 1577, 1494, 









807 mg (3.40 mmol) of ethyl (E)-2-((pent-3-en-1-yloxy)sulfonyl)acetate were 
used, along with MeSO2N3 (908 mg, 7.50 mmol, 2.2 equiv), DBU (762  µL, 5.10 
mmol, 1.5 equiv), and THF (8.50 mL, 0.4 M). Flash column chromatography on 
silica using 5% EtOAc/hexanes as eluent gave 777 mg (3.0 mmol) of pure product as a yellow 
oil (87% yield). 
1H-NMR (500 MHz, CDCl3) δ 5.59 (dqt, J = 15.5, 6.4, 1.4 Hz, 1H), 5.38 (dtq, J = 15.3, 6.8, 1.7 
Hz, 1H), 4.37-4.31 (m, 4H), 2.44 (qp, J = 6.8, 1.2 Hz, 2H), 1.67 (dq, J = 6.5, 1.4 Hz, 3H), 1.34 (t, 
J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 159.66, 129.66, 124.59, 73.14, 62.82, 32.36, 
18.14, 14.43.; HRMS (ESI) m/z calculated for C9H14O5SNa [M+Na]+: 285.0521, found 
285.0515; IR (ATR, cm-1) 3424, 2969, 2940, 2919, 2859, 2388, 2130, 1717, 1466, 1448, 1372, 
1285, 1223, 1178, 1083, 1009, 961, 914, 842, 787, 739, 614, 560, 540, 491, 463. 
 
Ethyl 2-((3-((tert-butyldiphenylsilyl)oxy)propoxy)sulfonyl)-2-diazoacetate. 
1.16 g (2.50 mmol) of ethyl 2-((3-((tert-butyldiphenylsilyl)oxy)propoxy) 
sulfonyl)acetate were used, along with MeSO2N3 (666 mg, 5.50 mmol, 2.2 
equiv), DBU (561  µL, 3.80 mmol, 1.5 equiv), and THF (6.30 mL, 0.4 M). Flash column 
chromatography on silica using 2% EtOAc/hexanes as eluent gave 829 mg (1.69 mmol) of pure 
product as a pale yellow solid (68% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.67-7.62 (m, 4H), 7.49-7.33 (m, 6H), 4.54 (t, J = 6.3 Hz, 2H), 
4.29 (q, J = 7.1 Hz, 2H), 3.77 (t, J = 5.8 Hz, 2H), 1.97 (p, J = 6.1 Hz, 2H), 1.29 (t, J = 7.1 Hz, 
3H), 1.05 (s, 9H).; 13C-NMR (126 MHz, CDCl3) δ 159.54, 135.62, 133.47, 129.90, 127.88, 














[M+H]+: 491.1672, found 491.1685; IR (ATR, cm-1) 3071, 2998, 2962, 2938, 2891, 2860, 2136, 
1728, 1588, 1471, 1428, 1419, 1373, 1281, 1224, 1179, 1159, 1102, 1090, 1068, 1010, 994. 
 
Ethyl 2-diazo-2-((3-(4-methoxyphenyl)propoxy)sulfonyl)acetate [48]. 
855 mg (2.70 mmol) of ethyl 2-((3-(4-methoxyphenyl)propoxy)-
sulfonyl)acetate were used, along with MeSO2N3 (761 mg, 8.11 mmol, 3 
equiv), DBU (605 µL, 4.06 mmol, 1.5 equiv), and THF (6.8 mL, 0.4 M). Flash column 
chromatography on silica using 10% → 20% EtOAc/hexanes as eluent gave 721 mg (2.11 mmol) 
of pure product as a yellow oil (78% yield). Note: the reactivity of this diazoester deteriorated 
after one week and could not be restored by additional purification. 
1H-NMR (500 MHz, CDCl3) δ 7.10 (d, J = 8.4 Hz, 2H), 6.84 (d, J = 8.5 Hz, 2H), 4.38 - 4.28 (m, 
4H), 3.79 (s, 3H), 2.69 (t, J = 7.5 Hz, 2H), 2.04 (p, J = 7.2 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H).; 13C-
NMR (126 MHz, CDCl3) δ 159.62, 158.25, 132.31, 129.52, 114.13, 72.66, 62.86, 55.42, 30.85, 
30.66, 14.43.; HRMS (ESI) m/z calculated for C14H19O6N2S [M+H]+: 343.0964, found 343.0956; 
IR (ATR, cm-1) 2938.6, 2837.84, 2132.38, 1717.58, 1612.33, 1584.04, 1512.66, 1465.72, 
1373.33, 1285.65, 1244.79, 1224.31, 1176.21, 1084.54, 1033.1, 996.13, 830.05, 811.04, 738.66, 
698.12, 614.07, 569.25, 554.06, 509.88. 
 
Ethyl 2-((3-(1-(phenylsulfonyl)-1H-indol-3-yl)propoxy)sulfonyl)acetate. 
2.30 g (7.28 mmol) of ethyl 2-((3-(1-(phenylsulfonyl)-1H-indol-3-
yl)propoxy)sulfonyl)acetate was used, along with imidazole (595 mg, 8.74 
mmol, 1.2 equiv), ClSO2CH2CO2Et (2.04 g, 10.9 mmol, 1.5 equiv), and 















EtOAc/hexanes as eluent gave 2.40 g (5.16 mmol) of pure product as a clear oil (71% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.99 (d, J = 8.4 Hz, 1H), 7.90 - 7.85 (m, 2H), 7.56 - 7.50 (m, 1H), 
7.45 (q, J = 8.7 Hz, 3H), 7.39 (s, 1H), 7.33 (t, J = 9.8 Hz, 1H), 7.25 - 7.21 (m, 1H), 4.38 (t, J = 
6.0 Hz, 3H), 4.33 (q, J = 7.1 Hz, 3H), 2.82 (t, J = 7.4 Hz, 3H), 2.13 (p, J = 6.5 Hz, 3H), 1.31 (t, J 
= 7.1 Hz, 4H).; 13C-NMR (126 MHz, CDCl3) δ 159.47, 138.30, 135.54, 133.85, 130.70, 129.36, 
126.84, 125.04, 123.36, 123.33, 121.33, 119.42, 113.96, 72.44, 62.87, 28.36, 20.85, 14.37.; 
HRMS (ESI) m/z calculated for C21H21NO7S2 [M+H]+: 514.0719, found 514.0769. IR (ATR, cm-
1) 2138.67, 1723.8, 1463.45. 1446.28, 1376.14, 1362.96, 1287.43, 1274.42, 1229.7, 1202.13, 
1174.21, 1129.69, 1120.47, 1095.71, 1078.09, 1017.77, 970.87, 943.64, 869.67, 860.01, 821.95, 
789.11, 766.62, 748.94, 737.16, 723.89, 685.23, 626.35, 602.94, 591.1, 578.54, 570.31, 549.73, 
536.17, 501.85, 478.29. 
 
Ethyl 2-((3-(benzo[d][1,3]dioxol-5-yl)propoxy)sulfonyl)-2-diazoacetate. 
1.82 g (5.50 mmol) of ethyl 2-((3-(benzo[d][1,3]dioxol-5-
yl)propoxy)sulfonyl)acetate were used, along with MeSO2N3 (1.47 g, 12.1 
mmol, 2.2 equiv), DBU (1.23 mL, 8.3 mmol, 1.5 equiv), and THF (13.9 mL, 0.4 M). Flash 
column chromatography on silica using 5% à 10% EtOAc/hexanes as eluent gave 1.47 g (4.13 
mmol) of pure product as a yellow oil (75% yield). Note: the reactivity of this diazoester 
deteriorated after one week and could not be restored by additional purification. 
1H-NMR (500 MHz, CDCl3) δ 6.73 (d, J = 7.9 Hz, 1H), 6.67 (d, J = 1.4 Hz, 1H), 6.63 (dd, J = 
7.9, 1.4 Hz, 1H), 5.93 (s, 2H), 4.38-4.29 (m, 4H), 2.67 (t, J = 7.5 Hz, 2H), 2.03 (p, J = 6.4 Hz, 
2H), 1.33 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 159.50, 147.85, 146.07, 134.00, 









for C14H16O7N2SNa [M+Na]+: 379.0576, found 379.0574; IR (ATR, cm-1) 2970, 2941, 2132, 
1717, 1608, 1503, 1488, 1442, 1371, 1286, 1243, 1226, 1177, 1121, 1091, 1036, 999, 922, 838, 
808, 770.  
 
Substrate Scope for Fe-Catalyzed Intramolecular C—H Alkylation: 
General procedure for [FePc]-catalyzed C—H alkylation: 
Into a 1 dram vial was added [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv) and NaBArF4 (35.4 
mg, 0.040 mmol, 0.10 equiv) in a glovebox. The vial was sealed, taken out of the box, and the 
contents were added under a stream of nitrogen to a flame-dried three neck 25 mL flask equipped 
with a stir bar, reflux condenser, glass stopper, and rubber septum. CH2Cl2 (5.0 mL, 0.08 M) was 
added and the flask was heated to reflux (~45˚C) for 10 minutes.  Diazosulfonate ester (0.40 
mmol, 1 equiv) was taken up with CH2Cl2 (3.0 mL, 0.13 M) in a 5 mL glass syringe and added to 
the refluxing catalyst solution over the course of an hour (rate of 3 mL/h) via syringe pump (final 
reaction concentration is 0.05 M). After complete addition of diazosulfonate, the reaction 
refluxed until judged complete by TLC (2-12 h).  The reaction mixture was cooled, adsorbed 
onto SiO2 or florisil, and applied directly to a silica column for purification to afford the desired 
sultone product. Yields were calculated from a mixture of diastereomers. Subsequent purification 
afforded the separation of diastereomers for characterization. Relative stereochemistry was 
assigned via coupling constant analysis and analogy from 33. Some substrates demonstrated 
improved yields with the addition of activated powdered 3Å molecular sieves. In these cases, the 
molecular sieves were added to the reaction flask at the same time as [FePc]Cl and NaBArF4. 
Any further variation of these reaction conditions is noted for individual substrates.  
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General procedure for Rh2(OAc)4-mediated intramolecular C—H alkylation: 
The following procedure was adapted from literature precedent72,80. Into a 1 dram vial was added 
Rh2(OAc)4 (3.5 mg, 0.008 mmol, 0.02 equiv) in a glovebox. The vial was sealed, taken out of the 
box, and the contents were added under a stream of nitrogen to a flame dried three neck 25 mL 
flask equipped with a stir bar, reflux condenser, glass stopper, and rubber septum. CH2Cl2 (5.0 
mL, 0.08 M) was added and the flask was heated to reflux (~45˚C).  Diazosulfonate was taken up 
with CH2Cl2 (3.0 mL, 0.13 M) and added to the refluxing catalyst solution over the course of one 
minute. Transfer of the starting material was made quantitative with an additional 1 mL of 
CH2Cl2.  After complete addition of diazosulfonate, the reaction refluxed until judged complete 
by TLC (1-12 h). The solution was cooled to RT, filtered through a small pad of celite with 30 
mL of CH2Cl2, and concentrated under reduced pressure. Purification by silica gel 
chromatography afforded the desired sultone product. 
 
 (±)-Ethyl 4-(2-methylprop-1-en-1-yl)-1,2-oxathiane-3-carboxylate 2,2-dioxide [34]. 
Ethyl 2-diazo-2-(((5-methylhex-4-en-1-yl)oxy)sulfonyl)acetate (116.1 mg, 0.400 
mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 
mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. Product was purified via 
flash column chromatography on silica (75 mL SiO2) using 10% à 15% à 20% EtOAc in 
hexanes. Pure product was isolated as a white solid and a 2:1 syn:anti mixture of diastereomers. 
Subsequent purification using 5% à 10% à 15% EtOAc/hexanes allowed for separation of 
diastereomers. 
Run 1: (63.5 mg, 0.242 mmol, 61%), 0% rsm. Run 2: (57.4 mg, 0.219 mmol, 55%), 0% rsm. Run 
3: (57.8 mg, 0.220 mmol, 55%), 0% rsm.  Average: 57% yield ± 2.8, 0% rsm. 







12.3, 2.6 Hz, 1H), 4.58 (ddd, J = 11.6, 5.1, 2.1 Hz, 1H), 4.27 (q, J = 7.2 Hz, 2H), 3.98 (d, J = 4.9 
Hz, 1H), 3.44 (ddd, J = 12.0, 9.0, 4.6 Hz, 1H), 2.57 (dtd, J = 14.5, 12.3, 5.2 Hz, 1H), 1.71 (s, 
3H), 1.70 (s, 3H), 1.61-1.50 (m, 1H), 1.30 (t, J = 7.1 Hz, 3H); 13C-NMR (126 MHz, CDCl3) δ 
164.40, 137.36, 121.37, 73.30, 64.50, 62.50, 36.85, 26.21, 25.92, 18.43, 14.25. 
Anti diastereomer (minor): 1H-NMR (500 MHz, CDCl3) δ 4.84 (dd, J = 9.7, 1.4 Hz, 1H), 4.72-
4.62 (m, 1H), 4.47 (ddd, J = 11.6, 4.4, 2.5 Hz, 1H), 4.30-4.18 (m, 2H), 3.74 (d, J = 11.4 Hz, 1H), 
3.50 (qd, J = 10.1, 5.7 Hz, 1H), 1.84-1.75 (m, 2H), 1.70 (s, 3H), 1.69 (s, 3H), 1.27 (t, J = 7.1 Hz, 
3H); 13C-NMR (126 MHz, CDCl3) δ 163.56, 137.45, 121.76, 72.57, 68.37, 62.65, 38.12, 30.68, 
25.90, 18.49, 14.13. 





yl)oxy)sulfonyl)-2-diazoacetate (108.9 mg, 0.200 mmol, 1.0 equiv), 
[FePc]Cl (12.1 mg, 0.020 mmol, 0.10 equiv), NaBArF4 (17.7 mg, 0.020 mmol, 0.10 equiv), and 
CH2Cl2 (4.0 mL, 0.05 M) were used. Product was purified via flash column chromatography on 
silica (75 mL SiO2) using 10% EtOAc/hexanes. Pure product was isolated as a clear, thick oil 
and a 1.5:1 syn:anti mixture of diastereomers. Subsequent purification using 5% à 10% à 15% 
EtOAc/hexanes allowed for separation of diastereomers. 
Run 1: (55.6 mg, 0.108 mmol, 54%), 0% rsm. Run 2: (57.4 mg, 0.111 mmol, 56%), 0% rsm. Run 
3: (51.9 mg, 0.100 mmol, 50%), 0% rsm.  Average: 53% yield ± 2.2, 0% rsm. 







5.68 (td, J = 15.2, 6.9 Hz, 1H), 5.35 (dd, J = 15.4, 7.6 Hz, 1H), 4.66-4.56 (m, 2H), 4.28-4.11 (m, 
2H), 4.02 (d, J = 4.6 Hz, 1H), 3.67 (t, J = 6.4 Hz, 2H), 3.20 (ddt, J = 12.4, 8.5, 4.6 Hz, 1H), 2.60 
(dtd, J = 14.6, 12.2, 5.5 Hz, 1H), 2.26 (q, J = 6.4 Hz, 2H), 1.63-1.56 (m, 1H), 1.24 (t, J = 7.2 Hz, 
3H), 1.04 (s, 9H).; 13C-NMR (126 MHz, CDCl3) δ 164.09, 135.67, 133.87, 131.75, 129.82, 
128.58, 127.80, 73.02, 64.85, 63.37, 62.44, 40.78, 35.89, 26.98, 25.46, 19.36, 14.14. 
Anti diastereomer (minor): 1H-NMR (500 MHz, CDCl3) δ 7.70-7.60 (m, 4H), 7.46-7.34 (m, 6H), 
5.67 (dt, J = 14.4, 6.9 Hz, 1H), 5.26 (dd, J = 15.4, 8.2 Hz, 1H), 4.68-4.58 (m, 1H), 4.47 (dt, J = 
11.5, 3.6 Hz, 1H), 4.27-4.15 (m, 2H), 3.75 (d, J = 11.6 Hz, 1H), 3.64 (t, J = 6.5 Hz, 2H), 3.29-
3.19 (m, 1H), 2.23 (q, J = 6.5 Hz, 2H), 1.94-1.78 (m, 2H), 1.23 (t, J = 7.2 Hz, 3H), 1.04 (s, 9H).; 
13C-NMR (126 MHz, CDCl3) δ 163.25, 135.66, 133.83, 131.99, 129.82, 128.72, 127.89, 72.48, 
68.11, 63.29, 62.73, 41.60, 35.86, 30.33, 26.96, 19.34, 14.16.; HRMS (ESI) m/z calculated for 
C27H37O6SSi [M+H]+: 517.2080, found 517.2062. 
 
Ethyl (E)-4-styryl-1,2-oxathiane-3-carboxylate 2,2-dioxide [36]. 
Ethyl (E)-2-diazo-2-(((5-phenylpent-4-en-1-yl)oxy)sulfonyl)acetate (135.4 
mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), 
NaBArF4 (35.4 mg, 0.040 mmol, 0.10 equiv), 100 mg activated powdered 3Å mol sieves, and 
CH2Cl2 (8.0 mL, 0.05 M) were used. Product was purified via flash column chromatography on 
silica (75 mL SiO2) using 15% EtOAc/hexanes. Pure product was isolated as a white solid and a 
1:1 syn:anti mixture of diastereomers. Subsequent purification using 15% à 20% à 25% 
EtOAc/hexanes allowed for separation of diastereomers. A trace impurity (<5%) was isolated 
with this product and was factored into yield calculations. The anti diastereomer was isolated 







Run 1: (89.1 mg, 0.287 mmol, 72%), 0% rsm. Run 2: (94.0 mg, 0.303 mmol, 75%), 0% rsm. Run 
3: (87.3 mg, 0.281 mmol, 70%), 0% rsm.  Average: 73% yield ± 2.3, 0% rsm. 
Syn diastereomer (major): 1H-NMR (500 MHz, CDCl3) δ 7.36-7.27 (m, 5H), 6.58 (dd, J = 15.9, 
1.1 Hz, 1H), 6.06 (dd, J = 15.9, 7.8 Hz, 1H), 4.76-4.62 (m, 2H), 4.33-4.19 (m, 2H), 4.17 (d, J = 
4.7 Hz, 1H), 3.51-3.41 (m, 1H), 2.77 (dtd, J = 14.5, 12.0, 5.5 Hz, 1H), 1.78 (ddt, J = 14.5, 4.3, 
2.4 Hz, 1H), 1.26 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 164.03, 135.99, 133.46, 
128.79, 128.34, 126.51, 125.86, 72.92, 64.65, 62.54, 40.90, 25.40, 14.09. 
Anti diastereomer (minor): 1H-NMR (500 MHz, CDCl3) δ 7.35-7.24 (m, 5H), 6.58 (dd, J = 15.7, 
0.9 Hz, 1H), 5.94 (dd, J = 15.8, 8.5 Hz, 1H), 4.76-4.65 (m, 1H), 4.54 (ddd, J = 11.7, 4.2, 2.6 Hz, 
1H), 4.30-4.19 (m, 2H), 3.91 (d, J = 11.5 Hz, 1H), 3.54-3.42 (m, 1H), 2.08-1.98 (m, 2H), 1.23 (t, 
J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 163.23, 135.97, 134.07, 128.81, 128.40, 126.55, 
125.91, 72.45, 67.94, 62.88, 42.06, 30.41, 14.16. 
HRMS (ESI) m/z calculated for C15H19O5S [M+H]+: 311.0943, found 311.0953. 
 
Ethyl (E)-4-(4-bromostyryl)-1,2-oxathiane-3-carboxylate 2,2-dioxide [37]. 
Ethyl (E)-2-(((5-(4-bromophenyl)pent-4-en-1-yl)oxy)sulfonyl)-2-diazo-
acetate (167 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 
0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 equiv), 100 mg activated powdered 3Å mol 
sieves, and CH2Cl2 (8.0 mL, 0.5 M) were used. Product was purified via flash column 
chromatography on silica (75 mL SiO2) using 20%à25%à30% EtOAc/hexanes. Pure product 
was isolated as a yellow oil and a 1:1 syn:anti mixture of diastereomers. Subsequent purification 
using 10% à 20% à 25% à 30% EtOAc/hexanes allowed for separation of diastereomers. A 








anti diastereomer was isolated with 10% of the syn. 
Run 1: (101 mg, 0.260 mmol, 65%), 0% rsm. Run 2: (104 mg, 0.268 mmol, 67%), 0% rsm. Run 
3: (106 mg, 0.272 mmol, 68%), 0% rsm.  Average: 67% yield ± 1.2, 0% rsm. 
Syn diastereomer (major): 1H-NMR (500 MHz, CDCl3) δ 7.45 (d, J = 8.5 Hz, 2H), 7.19 (d, J = 
8.5 Hz, 2H), 6.51 (d, J = 16.5 Hz, 1H), 6.07 (dd, J = 15.9, 7.8 Hz, 1H), 4.74-4.64 (m, 2H), 4.30-
4.21 (m, 2H), 4.16 (d, J = 4.7 Hz, 1H), 3.45 (ddt, J = 12.1, 8.2, 4.6 Hz, 1H), 2.75 (dtd, J = 14.6, 
11.8, 5.7 Hz, 1H), 1.82-1.73 (m, 1H), 1.25 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 
164.01, 134.92, 132.41, 131.96, 128.06, 126.68, 122.27, 72.84, 64.54, 62.66, 40.90, 25.39, 14.16. 
Anti diastereomer (minor): 1H-NMR (500 MHz, CDCl3) δ 7.44 (d, J = 8.5 Hz, 2H), 7.19 (d, J = 
8.4 Hz, 2H), 6.51 (d, J = 15.7 Hz, 1H), 5.93 (dd, J = 15.8, 8.6 Hz, 1H), 4.77-4.65 (m, 1H), 4.54 
(dt, J = 11.6, 3.4 Hz, 1H), 4.29-4.20 (m, 2H), 3.90 (d, J = 11.5 Hz, 1H), 3.54-3.42 (m, 1H), 2.06-
1.97 (m, 2H), 1.22 (t, J = 7.2 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ163.18, 134.86, 132.90, 
131.90, 128.04, 126.68, 122.21, 72.43, 67.69, 62.88, 42.02, 30.21, 14.15. 
HRMS (ESI) m/z calculated for C15H18O5SBr [M+H]+: 389.0058, found 389.0045. 
 
Ethyl (E)-4-(4-chlorostyryl)-1,2-oxathiane-3-carboxylate 2,2-dioxide [38]. 
Ethyl (E)-2-(((5-(4-chlorophenyl)pent-4-en-1-yl)oxy)sulfonyl)-2-
diazoacetate (149.1 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 0.040 
mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) 
were used. Product was purified via flash column chromatography on silica (75 mL SiO2) using 
20% EtOAc/hexanes. Pure product was isolated as a white solid and a 1.4:1 syn:anti mixture of 
diastereomers. Subsequent purification using 15% à 20% à 25% EtOAc/hexanes allowed for 








factored into yield calculations. The syn diastereomer was isolated with 6% of the anti, and the 
anti diastereomer was isolated with 10% of the syn. 
Run 1: (85.2 mg, 0.247 mmol, 62%), 0% rsm. Run 2: (78.5 mg, 0.228 mmol, 57%), 0% rsm. Run 
3: (82.6 mg, 0.240 mmol, 60%), 0% rsm.  Average: 60% yield ± 2.0, 0% rsm. 
Syn diastereomer (major): 1H-NMR (500 MHz, CDCl3) δ 7.33-7.23 (m, 4H), 6.53 (d, J = 15.9 
Hz, 1H), 6.05 (dd, J = 15.9, 7.8 Hz, 1H), 4.75-4.62 (m, 2H), 4.30-4.21 (m, 2H), 4.16 (d, J = 4.7 
Hz, 1H), 3.51-3.41 (m, 1H), 2.75 (dtd, J = 14.5, 11.6, 5.4 Hz, 1H), 1.82-1.72 (m, 1H), 1.25 (td, J 
= 7.1, 1.0 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ164.00, 134.49, 134.05, 132.31, 128.99, 
127.75, 126.56, 72.85, 64.58, 62.63, 40.87, 25.40, 14.14.   
Anti diastereomer (minor): 1H-NMR (500 MHz, CDCl3) δ 7.45-7.10 (m, 4H), 6.53 (d, J = 15.7 
Hz, 1H), 5.91 (dd, J = 15.8, 8.5 Hz, 1H), 4.76-4.67 (m, 1H), 4.54 (ddd, J = 11.6, 4.1, 2.6 Hz, 
1H), 4.31-4.18 (m, 2H), 3.90 (d, J = 11.6 Hz, 1H), 3.47 (ddd, J = 16.7, 11.4, 8.3 Hz, 1H), 2.07-
1.98 (m, 2H), 1.22 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 163.20, 134.43, 134.15, 
132.92, 129.02, 127.77, 126.57, 72.38, 67.83, 62.93, 42.04, 30.35, 14.19. 
HRMS (ESI) m/z calculated for C15H18O5SCl [M+H]+: 345.0563, found 345.0561. 
 
Ethyl (E)-4-(4-(trifluoromethyl)styryl)-1,2-oxathiane-3-carboxylate 2,2-dioxide [39]. 
Ethyl(E)-2-diazo-2-(((5-(4-(trifluoromethyl)phenyl)pent-4-en-1-yl)oxy)-
sulfonyl)acetate (163 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 
0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 equiv), 100 mg activated 
powdered 3Å mol sieves, and CH2Cl2 (8.0 mL, 0.05 M) were used. Product was purified via 
flash column chromatography on silica (75 mL SiO2) using 15% EtOAc/hexanes. Pure product 








purification using 15% EtOAc/hexanes allowed for separation of diastereomers. The syn 
diastereomer was isolated with 10% of the anti. 
Run 1: (65.1 mg, 0.172 mmol, 43%), 0% rsm. Run 2: (65.1 mg, 0.172 mmol, 43%), 0% rsm. Run 
3: (69.6 mg, 0.184 mmol, 46%), 0% rsm.  Average: 44% yield ± 1.7, 0% rsm. 
Syn diastereomer (major): 1H-NMR (500 MHz, CDCl3) δ 7.58 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 
8.1 Hz, 2H), 6.61 (d, J = 15.9 Hz, 1H), 6.18 (dd, J = 15.9, 7.7 Hz, 1H), 4.74-4.65 (m, 2H), 4.30-
4.21 (m, 2H), 4.18 (d, J = 4.7 Hz, 1H), 3.50 (ddt, J = 11.7, 7.7, 3.9 Hz, 1H), 2.78 (dtd, J = 14.5, 
11.7, 5.7 Hz, 1H), 1.83–1.76 (m, 1H), 1.26 (t, J = 7.1 Hz, 3H); 13C-NMR (126 MHz, CDCl3) 
δ164.09, 139.59, 132.38, 130.30 (q, J = 32.3 Hz), 128.79, 126.89, 125.93 (q, J = 3.8 Hz), 124.25 
(q, J = 273.42 Hz), 72.93, 64.63, 62.83, 41.00, 25.50, 14.26. 
Anti diastereomer (minor): 1H-NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.1 Hz, 2H), 7.42 (d, J = 
8.1 Hz, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.05 (dd, J = 15.8, 8.5 Hz, 1H), 4.73 (td, J = 11.6, 3.8 Hz, 
1H), 4.55 (ddd, J = 11.4, 4.3, 2.1 Hz, 1H), 4.29-4.20 (m, 2H), 3.94 (d, J = 11.5 Hz, 1H), 3.51 
(ddt, J = 15.9, 11.2, 5.2 Hz, 1H), 2.11 – 1.97 (m, 2H), 1.22 (t, J = 7.1 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 163.29, 139.54, 132.90, 130.31 (q, J = 32.3 Hz), 128.81, 126.88, 125.91 (q, J = 
3.8 Hz), 124.25 (q, J = 272.16 Hz), 72.50, 67.80, 63.08, 42.11, 30.33, 14.27.  
HRMS (ESI) m/z calculated for C16H18O5SF3 [M+H]+: 379.0827, found 379.0825. 
 
Ethyl (E)-4-styryl-1,2-oxathiolane-3-carboxylate 2,2-dioxide [40]. 
[FePc] Conditions: Ethyl (E)-2-diazo-2-(((4-phenylbut-3-en-1-
yl)oxy)sulfonyl)acetate (129.7 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 
0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 equiv), 100 








reaction was judged complete by TLC, the mixture was transferred to a 25 mL round-bottom 
flask, concentrated, and filtered through a celite plug with diethyl ether to remove the catalyst. 
This was then concentrated and analyzed by crude NMR which revealed that no cyclopropanated 
product was formed. The product was purified via flash column chromatography on silica (75 
mL SiO2) using 10% EtOAc/hexanes. Pure C—H insertion product was isolated as a colorless oil 
and an 11:1 inseparable mixture of diastereomers. Relative stereochemistry was not assigned. 
Only characterization of the major diastereomer is reported. 
Run 1: (72.4 mg, 0.244 mmol, 61%), 0% rsm. Run 2: (73.1 mg, 0.246 mmol, 62%), 0% rsm. Run 
3: (70.0 mg, 0.236 mmol, 59%), 0% rsm.  Average: 61% yield C—H ins. ± 1.1, 0% rsm. 
Rh2(OAc)4 Conditions: The general procedure for Rh2(OAc)4 catalyzed C—H alkylation was 
followed. Ethyl (E)-2-diazo-2-(((4-phenylbut-3-en-1-yl)oxy)sulfonyl)acetate (137.3 mg, 0.400 
mmol, 1.0 equiv), Rh2(OAc)4 (3.5 mg, 0.008 mmol, 0.02 equiv), and CH2Cl2 (8 mL, 0.05 M) 
were used. This was then concentrated and analyzed by crude NMR which revealed a 1:4 ratio of 
C—H insertion product to cyclopropanated product. The crude mixture was purified via flash 
column chromatography on silica (75 mL SiO2) using 10% à 15% à 20% EtOAc/hexanes. 
Pure C—H insertion product was isolated as a colorless oil and pure cyclopropanated product 
(more polar) was isolated as a white solid.  
Run 1: (16.5 mg, 0.056 mmol, 14% C—H ins.), (55.8 mg, 0.188 mmol, 47% cycloprop.), 0% 
rsm. Run 2: (14.2 mg, 0.048 mmol, 12% C—H ins.), (53.4 mg, 0.180 mmol, 45% cycloprop.), 
0% rsm. Run 3: (11.8 mg, 0.040 mmol, 10% C—H ins.), (54.6 mg, 0.184 mmol, 46% 
cycloprop.), 0% rsm.  Average: 12% yield C—H ins. ± 1.6, 46% yield cycloprop. ± 0.9, 0% 
rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.39-7.27 (m, 5H), 6.68 (d, J = 15.7 Hz, 1H), 6.04 (dd, J = 15.7, 
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8.5 Hz, 1H), 4.66 (dd, J = 9.2, 7.4 Hz, 1H), 4.39 (dq, J = 10.8, 7.2 Hz, 1H), 4.30 (dq, J = 10.8, 
7.1 Hz, 1H), 4.22 (br. t, J = 9.0 Hz, 1H), 4.12 (dt, J = 16.5, 8.2 Hz, 1H), 4.05 (d, J = 8.9 Hz, 1H), 
1.35 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 163.05, 135.97, 135.38, 128.81, 128.69, 
126.64, 122.34, 71.08, 64.69, 63.47, 44.12, 13.99.; HRMS (ESI) m/z calculated for C14H17O5S 
[M+H]+: 297.0797, found 297.0786. 
Ethyl 7-phenyl-3-oxa-2-thiabicyclo[4.1.0]heptane-1-carboxylate 2,2-dioxide. 
1H-NMR (500 MHz, CDCl3) δ 7.43-7.12 (m, 5H), 4.75 (td, J = 11.6, 4.7 Hz, 1H), 
4.45 (ddd, J = 11.9, 6.3, 2.5 Hz, 1H), 4.10-3.96 (m, 2H), 3.26 (d, J = 8.6 Hz, 1H), 
3.12 (td, J = 8.5, 2.2 Hz, 1H), 2.41 (dddd, J = 14.6, 8.5, 4.8, 2.5 Hz, 1H), 2.31 (dddd, J = 14.8, 
11.4, 6.3, 2.3 Hz, 1H), 0.98 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ162.89, 132.22, 
128.56, 128.52, 128.25, 71.15, 62.89, 49.86, 39.08, 27.96, 21.75, 13.80.; HRMS (ESI) m/z 
calculated for C14H17O5S [M+H]+: 297.0797, found 297.0788. 
 
Ethyl (E)-4-(prop-1-en-1-yl)-1,2-oxathiolane-3-carboxylate 2,2-dioxide [41]. 
[FePc] Conditions: Ethyl (E)-2-((pent-3-en-1-yloxy)sulfonyl)acetate (104.9 mg, 
0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 
(35.4 mg, 0.040 mmol, 0.10 equiv), 100 mg activated powdered 3Å mol sieves, and CH2Cl2 (8.0 
mL, 0.05 M) were used. After the reaction was judged complete by TLC, the mixture was 
transferred to a 25 mL round-bottom flask, concentrated, and filtered through a celite plug with 
diethyl ether to remove the catalyst. This was then concentrated and analyzed by crude NMR 
which revealed that no cyclopropanated product was formed. The product was purified via flash 
column chromatography on silica (75 mL SiO2) using 15% EtOAc/hexanes. Pure C—H insertion 










stereochemistry was not assigned. Only characterization of the major diastereomer is reported. 
Run 1: (40.0 mg, 0.171 mmol, 43%), 0% rsm. Run 2: (39.8 mg, 0.170 mmol, 43%), 0% rsm. Run 
3: (42.5 mg, 0.181 mmol, 45%), 0% rsm.  Average: 44% yield ± 1.3, 0% rsm. 
Rh2(OAc)4 Conditions: The general procedure for Rh2(OAc)4 catalyzed C—H alkylation was 
followed. Ethyl 2-diazo-2-((3-(4-methoxyphenyl)propoxy-3-d)sulfonyl)acetate (137.3 mg, 0.400 
mmol, 1.0 equiv), Rh2(OAc)4 (3.5 mg, 0.008 mmol, 0.02 equiv), and CH2Cl2 (8 mL, 0.05 M) 
were used. This was then concentrated and analyzed by crude NMR which revealed a 1:1 ratio of 
C—H insertion product to cyclopropanated product. Product was purified via flash column 
chromatography on silica (75 mL SiO2) using 15% à 25% EtOAc/hexanes. Pure C—H insertion 
product was isolated as a colorless oil and pure cyclopropanated product (more polar) was 
isolated as a white solid.  
Run 1: (17.6 mg, 0.075 mmol, 19% C—H ins.), (23.6 mg, 0.101 mmol, 25% cycloprop.), 0% 
rsm. Run 2: (17.4 mg, 0.074 mmol, 19% C—H ins.), (29.9 mg, 0.127 mmol, 32% cycloprop.), 
0% rsm. Run 3: (18.7 mg, 0.080 mmol, 20% C—H ins.), (29.2 mg, 0.124 mmol, 31% 
cycloprop.), 0% rsm.  Average: 19% yield C—H ins. ± 0.6, 29% yield cycloprop. ± 2.9, 0% 
rsm. 
1H-NMR (500 MHz, CDCl3) δ 5.80 (dqd, J = 15.3, 6.6, 0.8 Hz, 1H), 5.34 (ddq, J = 15.2, 7.9, 1.7 
Hz, 1H), 4.55 (dd, J = 9.1, 7.2 Hz, 1H), 4.37 (dq, J = 10.8, 7.1 Hz, 1H), 4.30 (dq, J = 10.6, 7.1 
Hz, 1H), 4.12-4.05 (m, 1H), 3.94- 3.85 (m, 2H), 1.72 (dd, J = 6.3, 1.8 Hz, 3H), 1.34 (t, J = 7.2 
Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ163.23, 132.79, 124.66, 71.35, 64.90, 63.45, 43.90, 
18.08, 14.09.; HRMS (ESI) m/z calculated for C9H14O5SNa [M+Na]+: 257.0460, found 
257.0452. 




 1H-NMR (500 MHz, CDCl3) δ4.64 (ddd, J = 11.9, 11.2, 5.0 Hz, 1H), 4.42- 4.29 (m, 3H), 2.35 
(td, J = 8.2, 2.3 Hz, 1H), 2.23 (dddd, J = 11.1, 10.3, 5.0, 2.7 Hz, 1H), 2.15 (dddd, J = 17.1, 11.2, 
6.2, 2.3 Hz, 1H), 1.99 (dq, J = 8.4, 6.3 Hz, 1H), 1.36 (t, J = 7.1 Hz, 3H), 1.19 (d, J = 6.2 Hz, 
3H).; 13C-NMR (126 MHz, CDCl3) δ164.33, 70.76, 63.04, 47.84, 31.03, 30.05, 21.53, 14.17, 
12.21.; HRMS (ESI) m/z calculated for C9H14O5SNa [M+Na]+: 257.0460, found 257.0457. 
 
Ethyl 4-((tert-butyldiphenylsilyl)oxy)-1,2-oxathiane-3-carboxylate 2,2-dioxide [42]. 
Ethyl 2-((3-((tert-butyldiphenylsilyl)oxy)propoxy)sulfonyl)-2-diazoacetate 
(98.1 mg, 0.200 mmol, 1.0 equiv), [FePc]Cl (12.1 mg, 0.020 mmol, 0.10 equiv), 
NaBArF4 (17.7 mg, 0.020 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.025 M) were used. Product 
was purified via flash column chromatography on silica (75 mL SiO2) using 5% à 10% à 15 
à 20% EtOAc/hexanes. Pure product was isolated as a white solid and a 1:1 syn:anti mixture of 
diastereomers. The diastereomers were inseparable by column chromatography and were 
characterized as a mixture. 
Run 1: (62.2 mg, 0.134 mmol, 67%), 0% rsm. Run 2: (64.3 mg, 0.139 mmol, 69%), 0% rsm. Run 
3: (61.9 mg, 0.134 mmol, 67%), 0% rsm.  Average: 68% yield ± 1.2, 0% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.71-7.60 (m, 4H Dmaj + 4H Dmin), 7.51-7.44 (m, 2H Dmaj + 2H 
Dmin), 7.44-7.33 (m, 4H Dmaj + 4H Dmin), 4.62-4.56 (m, 1H Dmaj), 4.48 (dt, J = 10.5, 5.0 Hz, 1H 
Dmin), 4.43 (ddd, J = 11.9, 5.2, 2.5 Hz, 1H Dmin), 4.38-4.30 (m, 1H Dmaj + 1H Dmin), 4.29-4.18 
(m, 2H Dmaj + 2H Dmin), 4.18-4.09 (m, 1H Dmaj + 1H Dmin), 4.01 (d, J = 9.1 Hz, 1H Dmaj), 2.75-
2.64 (m, 1H Dmin), 1.88 (h, J = 4.6, 4.1 Hz, 2H Dmaj), 1.64 (ddt, J = 14.2, 4.7, 2.5 Hz, 1H Dmin), 
1.31 (dt, J = 8.3, 7.1 Hz, 3H Dmaj + 3H Dmin), 1.05 (s, 9H Dmin), 1.01 (s, 9H Dmaj).; 13C-NMR 








132.14, 132.03, 130.64, 130.51, 130.46, 130.31, 129.83, 128.20, 128.11, 128.09, 127.99, 127.85, 
70.17, 69.90, 68.99, 68.74, 68.43, 66.37, 63.00, 62.65, 33.01, 28.94, 26.78, 26.76, 19.35, 19.23, 
14.07, 14.04.; HRMS (ESI) m/z calculated for C23H30O6SSiNa [M+Na]+: 485.1430, found 
485.1417. 
 
Ethyl 4-(4-methoxyphenyl)-1,2-oxathiane-3-carboxylate 2,2-dioxide [43]. 
Ethyl 2-diazo-2-((3-(4-methoxyphenyl)propoxy)sulfonyl)acetate [48] (137 mg, 
0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 
(35.4 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. 
Product was purified via flash column chromatography on silica using 10% → 25% 
EtOAc/hexanes. Pure product was isolated as a clear oil and a 1.1:1 syn:anti mixture of 
diastereomers. Subsequent purification using 10% → 25% EtOAc/hexanes allowed for 
separation of diastereomers. The anti diastereomer was isolated with 15% of the syn. 
Run 1: (84.1 mg, 0.268 mmol, 67%), 0% rsm. Run 2: (75.0 mg, 0.239 mmol, 60%), 0% rsm. Run 
3: (85.5 mg, 0.272 mmol, 68%), 0% rsm. Average: 65% yield ± 3.6%, 0% rsm. 
Syn diastereomer (major): 1H-NMR (400 MHz, CDCl3) δ 7.15 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 
8.8 Hz, 2H), 4.81 – 4.63 (m, 2H), 4.21 (d, J = 4.7 Hz, 1H), 4.18 – 3.93 (m, 2H), 3.87 - 3.80 (m, 
1H), 3.79 (s, 3H), 3.16 (tdd, J = 13.9, 11.7, 6.6 Hz, 1H), 1.80 (dd, J = 13.2, 1.8 Hz, 1H), 1.05 (t, J 
= 7.2, 3H).; 13C-NMR (126 MHz, CDCl3) δ 164.11, 159.43, 129.94, 128.42, 114.45, 73.20, 
66.51, 62.26, 55.41, 42.25, 24.34, 13.84. 
Anti diastereomer (minor): 1H-NMR (400 MHz, CDCl3) δ 7.14 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 
8.8 Hz, 2H), 4.74 (ddd, J = 13.4, 11.6, 2.2 Hz, 1H), 4.54 (ddd, J = 11.6, 4.9, 1.5 Hz, 1H), 4.17 (d, 





1.99 (d, J = 14.8, 1H), 1.05 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 162.95, 159.42, 
130.63, 128.60, 128.46, 114.52, 72.65, 69.01, 62.67, 55.43, 43.68, 32.53, 13.89. 
HRMS (ESI) m/z calculated for C14H18O6SNa [M+Na]+: 337.0721, found 337.0722. 
 
Ethyl 4-(1-(phenylsulfonyl)-1H-indol-3-yl)-1,2-oxathiane-3-carboxylate 2,2-dioxide [44]. 
 Ethyl 2-diazo-2-((3-(1-(phenylsulfonyl)-1H-indol-3-yl)propoxy)sulfonyl)acetate 
(196.6 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), 
NaBArF4 (35.4 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were 
used. Product was purified via flash column chromatography on silica using 5% → 25% 
EtOAc/hexanes. Pure product was isolated as a clear oil and a 1.1:1 syn:anti mixture of 
diastereomers. Diastereomers could not be separated. 
Run 1: (118 mg, 0.255 mmol, 64%), 0% rsm. Run 2: (119 mg, 0.256 mmol, 64%), 0% rsm. Run 
3: (116 mg, 0.250 mmol, 63%), 0% rsm. Average: 64% yield ± 0.5%, 0% rsm. 
Mixture of syn and anti diastereomers: 1H NMR (500 MHz, CDCl3) δ 8.01 (dd, J = 13.0, 8.3 Hz, 
1H Dmaj + 1H Dmin), 7.90 - 7.81 (m, 2H Dmaj + 2H Dmin), 7.61 - 7.52 (m, 2H Dmaj + 2H Dmin), 
7.50 - 7.42 (m, 3H Dmin + 3H Dmin), 7.41 - 7.23 (m, 2H Dmaj + 2H Dmin), 4.88 –4.66 (m, 2H Dmaj 
+ 1H Dmin), 4.57 (ddd, J = 11.8, 4.8, 1.6 Hz, 1H Dmin), 4.37 (d, J = 4.6 Hz, 1H Dmaj), 4.33 (d, J = 
12.0 Hz, 1H Dmin), 4.11 (ddd, J = 12.5, 8.2, 3.8 Hz, 1H Dmaj + 1H Dmin), 4.03 - 3.71 (m, 2H Dmaj 
+ 2H Dmin), 3.19 (qd, J = 13.3, 5.2 Hz, 1H Dmaj), 2.34 - 2.21 (m, 1H Dmin), 2.19 - 2.11 (m, 1H 
Dmin), 1.96 - 1.88 (m, 1H Dmaj), 0.88 (t, J = 7.1 Hz, 3H Dmaj), 0.80 (t, J = 7.1 Hz, 3H Dmin). 13C 
NMR (126 MHz, CDCl3) δ 163.84, 162.73, 141.47, 141.37, 137.64, 136.91, 136.41, 133.05, 
128.91, 128.02, 127.90, 127.86, 127.82, 127.77, 127.75, 127.07, 127.06, 73.11, 72.66, 68.47, 






C21H22NO7S2 [M+H]+: 464.0838, found 464.0829. 
 
Ethyl 4-(benzo[d][1,3]dioxol-5-yl)-1,2-oxathiane-3-carboxylate 2,2-dioxide [45]. 
 Ethyl 2-((3-(benzo[d][1,3]dioxol-5-yl)propoxy)sulfonyl)-2-diazoacetate (142.5 
mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), 
NaBArF4 (35.4 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8,0 mL, 0.05 M) 
were used. Product was purified via flash column chromatography on silica (75 mL SiO2) using 
15% EtOAc/hexanes. Pure product was isolated as a white solid and a 2:1 syn:anti mixture of 
diastereomers. Subsequent purification using 15% à 20% à 25% EtOAc/hexanes allowed for 
separation of diastereomers.  
Run 1: (71.1 mg, 0.217 mmol, 54%), 0% rsm. Run 2: (68.8 mg, 0.210 mmol, 52%), 0% rsm. Run 
3: (70.6 mg, 0.215 mmol, 54%), 0% rsm.  Average: 53% yield ± 0.8, 0% rsm. 
Syn diastereomer (major): 1H-NMR (500 MHz, CDCl3) δ 6.77 (d, J = 7.9 Hz, 1H), 6.74 – 6.68 
(m, 2H), 5.96 (s, 2H), 4.76 – 4.66 (m, 2H), 4.19 (d, J = 4.6 Hz, 1H), 4.16 – 4.03 (m, 2H), 3.77 
(dt, J = 13.3, 4.0 Hz, 1H), 3.13 (tdd, J = 13.8, 11.6, 6.4 Hz, 1H), 1.85 – 1.72 (m, 1H), 1.11 (t, J = 
7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ164.08, 148.26, 147.49, 131.73, 120.74, 108.76, 
107.72, 101.43, 73.09, 66.52, 62.39, 42.75, 24.50, 13.91.; HRMS (ESI) m/z calculated for 
C14H17O7S [M+H]+: 329.0695, found 329.0681. 
Anti diastereomer (minor): 1H-NMR (500 MHz, CDCl3) δ 6.76 (d, J = 8.0 Hz, 1H), 6.71-6.67 
(m, 2H), 5.96 (s, 2H), 4.73 (ddd, J = 12.9, 11.7, 2.2 Hz, 1H), 4.53 (ddd, J = 11.7, 4.9, 1.5 Hz, 
1H), 4.18-4.06 (m, 3H), 3.75 (td, J = 12.4, 3.7 Hz, 1H), 2.18 (dtd, J = 14.8, 12.9, 4.9 Hz, 1H), 
2.00 (ddt, J = 14.9, 3.6, 1.9 Hz, 1H), 1.11 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 






32.50, 13.91.; HRMS (ESI) m/z calculated for C14H17O7S [M+H]+: 329.0695, found 329.0688. 
 
	  
Free Carbene Generation Study: 
Procedure for UV-light mediated diazo decomposition: 
To a flame-dried quartz tube equipped with a rubber septum and stir bar was added 32 (55.3 mg, 
0.20 mmol, 1 equiv) in CH2Cl2 (4.0 mL, 0.05M) under an inert atmosphere. Argon was bubbled 
through the mixture for 10 minutes. The gas inlet was removed, the septum was wrapped in 
aluminum foil, and the reaction, while stirring, was irradiated with four 15W compact UV 
germicidal bulbs at room temperature. After 1 hour, the tube was removed and TLC analysis 
revealed complete consumption of starting material. The reaction mixture was then transferred to 
a 25 mL flask, concentrated and analyzed by crude NMR, which revealed the mixture was 
composed of predominantly one compound [47]. The product was purified via flash column 
chromatography on silica (40 mL SiO2) using 5% à 10% à 15% EtOAc/hexanes. Pure product 
was isolated as a colorless oil. No other products were isolated off the column. 
 
Ethyl (E)-3,3-dichloro-2-((hex-4-en-1-yloxy)sulfonyl)propanoate [47] 
Run 1: (24.8 mg, 0.074 mmol, 37%), 0% rsm. Run 2: (25.7 mg, 0.078 mmol, 
39%), 0% rsm. Run 3: (22.0 mg, 0.066 mmol, 33%), 0% rsm.  Average: 36% 
yield ± 2.5, 0% rsm. 
1H-NMR (500 MHz, CDCl3) δ 5.49 (dt, J = 15.1, 6.3 Hz, 1H), 5.37 (ddd, J = 15.0, 6.6, 1.3 Hz, 
1H), 4.59 (d, J = 11.9 Hz, 1H), 4.53 (td, J = 6.5, 1.2 Hz, 2H), 4.41 (m, 2H), 4.04 (d, J = 11.8 Hz, 
1H), 2.11 (tt, J = 6.9, 6.0 Hz, 2H), 1.84 (dt, J = 13.4, 6.9 Hz, 2H), 1.66 (dq, J = 6.3, 1.4 Hz, 3H), 







65.18, 47.05, 29.50, 28.29, 18.16, 14.07.; HRMS (ESI) m/z calculated for C11H18O5SCl2Na 
[M+Na]+: 355.0150, found 355.0146. 
Procedure for iron salt mediated diazo decomposition study: 
Into a 1 dram vial was added iron salt (0.040 mmol, 0.10 equiv) in a glovebox. The vial was 
sealed, taken out of the box, and the contents were added under a stream of nitrogen to a flame 
dried three neck 25 mL flask equipped with a stir bar, reflux condenser, glass stopper, and rubber 
septum. CH2Cl2 (5.0 mL, 0.08 M) was added and the flask was heated to reflux (~45˚C) for 10 
minutes. Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate 32 (110.5 mg, 0.400 mmol, 1.0 
equiv) was taken up with CH2Cl2 (3.0 mL, 0.13 M) in a glass syringe and added dropwise to the 
refluxing catalyst solution over the course of 2-3 minutes (final reaction concentration is 0.05 M). 
After complete addition of diazosulfonate, the reaction refluxed until judged complete by TLC 
(1-24 h).  The reaction mixture was cooled, adsorbed onto SiO2 or florisil, and applied directly to 
a silica column (75 mL SiO2) for purification to afford the desired sultone product. The 
recovered starting material (rsm) was eluted with 10% EtOAc/hexanes. No other compounds 
were isolated off the column. 
 
FeCl3 Conditions: Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 
mmol, 1.0 equiv), FeCl3 (6.5 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were 
used. 
Run 1: (99.5 mg rsm, 0.360 mmol, 90%). Run 2: (103.5 mg rsm, 0.375 mmol, 94%). Average: 
0% yield, 92% rsm. 
 
FeCl2 Conditions: Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 0.400 
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mmol, 1.0 equiv), FeCl2 (5.1 mg, 0.040 mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were 
used. 
Run 1: (109.3 mg rsm, 0.396 mmol, 99%). Run 2: (106.3 mg rsm, 0.385 mmol, 96%). Average: 
0% yield, 98% rsm. 
 
FeCl3/NaBArF4 Conditions: Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 
0.400 mmol, 1.0 equiv), FeCl3 (6.5 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 
mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. 
Run 1: (108.8 mg rsm, 0.394 mmol, 98%). Run 2: (108.2 mg rsm, 0.391 mmol, 98%). Average: 
0% yield, 98% rsm. 
 
FeCl2/NaBArF4 Conditions: Ethyl (E)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate (110.5 mg, 
0.400 mmol, 1.0 equiv), FeCl2 (5.1 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 
mmol, 0.10 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. 
Run 1: (108.9 mg rsm, 0.394 mmol, 98%). Run 2: (110.5 mg rsm, 0.400 mmol, 100%). Average: 
0% yield, 99% rsm. 
 
Intramolecular Kinetic Isotope Effect Study: 
	  
Method for KIE Determination: The column-purified product mixture (vide infra, ca. 20 mg in 
600 µL CDCl3) was analyzed by 13C-NMR (600 MHz instrument) 49,81. Cr(acac)3 (3.5-5.0 mg) 
was added directly to the solution in the NMR tube immediately prior to running the NMR study; 
this helps to significantly reduce delay times needed to obtain accurate integrations. The 
experiment was run under inverse-gated decoupling conditions without sample spinning. The 
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following parameters were used for the experiment, listed as Varian commands: 
temp=23 
dm=’nny’ (inverse-gated decoupling) 
d1=5 (initial delay) 
at=0.5 (acquisition time) 
setsw(180,0) (spectral width, in ppm) 
bs=64 (block size for FID) 
nt=2944 (number of scans) 
pw=7.0 (pulse width) 
pw90=7.0 (90° pulse width) 
The KIE was reported as the area of the deuterated peak over that of the non-deuterated peak for 
the benzylic carbon (~42 ppm). All diastereomeric peaks resolve in the 13C NMR and the sample 
can be analyzed accurately as a mixture. However, the KIE was calculated off of the major (syn) 
diastereomer of the product due to better signal to noise ratios. Three NMR experiments were 
run for each catalyst and an average value was calculated with error reported as a standard 
deviation. 
 
[FePc]Cl: C—H/C—D = 5.0 ± 0.1  
[FeCl8Pc]Cl: C—H/C—D = 4.8 ± 0.1 
[FeCl16Pc]Cl: C—H/C—D = 4.5 ± 0.1 




1.30 g (7.6 mmol) of 3-(4-methoxyphenyl)propan-3-d-1-ol82 were used, 
along with imidazole (620 mg, 9.1 mmol, 1.2 equiv), ClSO2CH2CO2Et 
(2.10 g, 11.3 mmol, 1.5 equiv), and THF (38 mL, 0.2 M). Flash column 
chromatography on silica using 20% EtOAc/hexanes as eluent gave 1.95 g (6.10 mmol) of pure 
product as a pale yellow oil (80% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.11 (d, J = 8.5 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 4.33 (t, J = 6.3 
Hz, 2H), 4.28 (q, J = 7.1 Hz, 2H), 4.08 (s, 2H), 3.79 (s, 3H), 2.68 (t, J = 7.7 Hz, 1H), 2.05 (q, J = 
6.7 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 161.96, 157.95, 132.17, 
129.28, 113.85, 71.40, 62.56, 55.10, 54.54, 30.77, 30.03 (t, J = 19.8 Hz), 13.85.; HRMS (ESI) 
m/z calculated for C14H19D1O6SNa [M+Na]+: 340.0941, found 340.0933. 
 
Ethyl 2-diazo-2-((3-(4-methoxyphenyl)propoxy-3-d)sulfonyl)acetate [47]. 
1.95 g (6.10 mmol) of ethyl 2-((3-(4-methoxyphenyl)propoxy-3-
d)sulfonyl)acetate were used, along with MeSO2N3 (1.63 g, 13.5 mmol, 2.2 
equiv), DBU (1.4  mL, 9.20 mmol, 1.5 equiv), and THF (15 mL, 0.4 M). Flash column 
chromatography on silica using 10% EtOAc/hexanes as eluent gave 1.74 g (5.07 mmol) of pure 
product as a yellow oil (83% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.10 (d, J = 8.5 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 4.34 (t, J = 6.4 
Hz, 2H), 4.33 (q, J = 7.1 Hz, 2H), 3.79 (s, 3H), 2.67 (t, J = 7.6 Hz, 1H), 2.04 (q, J = 6.5 Hz, 2H), 
1.33 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 159.53, 158.17, 132.20, 129.45, 114.05, 
72.60, 62.80, 55.34, 30.70, 30.24 (t, J = 19.7 Hz), 14.37.; HRMS (ESI) m/z calculated for 
C14H18DO6N2S [M+H]+: 344.1027, found 344.1020; IR (ATR, cm-1) 2970, 2918, 2130, 1722, 

















Ethyl 4-(4-methoxyphenyl)-1,2-oxathiane-3-carboxylate-4-d 2,2-dioxide: 
Product was isolated and characterized as a mixture of the two isomers as well as a minor 
amount of the non-deuterated product (formed from H-exchange at the acidified C3 site).  
Syn diastereomer (major): 1H-NMR (500 MHz, CDCl3) δ 
7.16 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 4.78-4.67 
(m, 2H), 4.21 (s, 1H), 4.13-3.98 (m, 2H), 3.80 (s, 3H), 3.18 
(ddd, J = 18.5, 13.9, 7.4 Hz, 1H), 1.79 (dt, J = 14.4, 1.9 Hz, 1H), 1.07 (t, J = 7.1 Hz, 3H).; 13C-
NMR (126 MHz, CDCl3) 164.27, 159.57, 130.06, 130.04, 128.56, 114.59, 73.35, 73.33, 66.65 
(non-deut), 66.58, 66.30 (t, J = 22.0 Hz), 62.44, 62.42, 55.56, 42.41 (non-deut), 42.31, 42.02 (t, J 
= 20.2 Hz), 24.47, 24.41, 14.00.; HRMS (ESI) m/z calculated for C14H18DO6S [M+H]+: 
316.0965, found 316.0968. 
 
[FePc] Conditions: The general procedure for [FePc]-catalyzed C—H alkylation was followed. 
Ethyl 2-diazo-2-((3-(4-methoxyphenyl)propoxy-3-d)sulfonyl)acetate (137.3 mg, 0.400 mmol, 1.0 
equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 
equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. Flash column chromatography on silica (75 
mL) using 10% à 15% à 20% à 25% EtOAc/hexanes gave the syn and anti diastereomers 
mostly separated. All of the fractions containing the syn product were collected, concentrated, 
and analyzed by 13C NMR. This procedure was repeated three times. 
Run 1: 4.94. Run 2: 5.05. Run 3: 5.06. Average: 5.0 ± 0.1  
 











major isomer minor isomer
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followed. Ethyl 2-diazo-2-((3-(4-methoxyphenyl)propoxy-3-d)sulfonyl)acetate (206.0 mg, 0.600 
mmol, 1.0 equiv), [FeCl8Pc]Cl (52.8 mg, 0.060 mmol, 0.10 equiv), NaBArF4 (53.2 mg, 0.060 
mmol, 0.10 equiv), and CH2Cl2 (12.0 mL, 0.05 M) were used. The reaction was allowed to stir 
for 16 hours. Flash column chromatography on silica (75 mL) using 10% à 15% à 20% à 
25% EtOAc/hexanes gave the syn and anti diastereomers mostly separated. All of the fractions 
containing the syn product were collected, concentrated, and analyzed by 13C NMR. This 
procedure was repeated three times. 
Run 1: 4.94. Run 2: 4.79. Run 3: 4.70. Average: 4.8 ± 0.1 
 
[FeCl16Pc] Conditions: The general procedure for [FePc]-catalyzed C—H alkylation was 
followed. Ethyl 2-diazo-2-((3-(4-methoxyphenyl)propoxy-3-d)sulfonyl)acetate [S42] (206.0 mg, 
0.600 mmol, 1.0 equiv), [FeCl16Pc]Cl (69.3 mg, 0.060 mmol, 0.10 equiv), NaBArF4 (53.2 mg, 
0.060 mmol, 0.10 equiv), and CH2Cl2 (12.0 mL, 0.05 M) were used. The reaction was allowed to 
stir for 16 hours. Flash column chromatography on silica (75 mL) using 10% à 15% à 20% à 
25% EtOAc/hexanes gave the syn and anti diastereomers mostly separated. All of the fractions 
containing the syn product were collected, concentrated, and analyzed by 13C NMR. 
Run 1: 4.55. Run 2: 4.57. Run 3: 4.45. Average: 4.5 ± 0.1 
 
Rh2(OAc)4 Conditions:  
The general procedure for Rh2(OAc)4 catalyzed C—H alkylation was followed. Ethyl 2-diazo-2-
((3-(4-methoxyphenyl)propoxy-3-d)sulfonyl)acetate [S42] (137.3 mg, 0.400 mmol, 1.0 equiv), 
Rh2(OAc)4 (3.5 mg, 0.008 mmol, 0.02 equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. Flash 
column chromatography on silica (75 mL) using 10% à 15% à 20% à 25% EtOAc/hexanes 
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gave the syn and anti diastereomers mostly separated. All of fractions containing the syn product 
were collected, concentrated, and analyzed by 13C NMR. This procedure was repeated three 
times. 
Run 1: 1.78. Run 2: 1.84. Run 3: 1.91. Average: 1.8 ± 0.1 
 
Determination of Kinetic Isotope Effect via Initial Rates: 
	  
 
General Procedure for Initial Rate Analysis: To a 1 dram flame-dried borosilicate vial 
containing a Teflon stir bar was added catalyst (0.010 mmol, 0.10 equiv) and NaBArF4 (8.9 mg, 
0.010 mmol, 0.10 equiv) in the glove box. The vial was removed and the contents were diluted 
with 1 mL of CH2Cl2, sealed with a Teflon septum cap, and heated to 40˚C for 10 minutes. 30 or 
30-d2 (34.2 mg, 0.2 mmol, 1.0 equiv) and internal standard nitrobenzene (0.04 mmol, 40 mol%), 
were dissolved in 1 mL of CH2Cl2 (400 µL, 0.5M) and added to the 1 dram vial in one portion. 
The septum cap was wrapped with Teflon tape. Aliquots (25 µL) were taken at the corresponding 
times from the reaction flask, and filtered through a silica pad with 500 µL of 1:1 
isopropanol/hexanes for normal phase HPLC (Zorbax CN, 4.6 x 250 nm) analysis. The yield was 
determined by integration of the product peaks relative to the nitrobenzene internal standard and 


































yield versus time. Rates are reported as the average of three runs, with the error denoted by 
standard deviation. Error for kinetic isotopes was calculated via propagation of the standard error 
of the mean for each set of rates. 
 
Ethyl 2-((3-(4-methoxyphenyl)propoxy-3,3-d2)sulfonyl)acetate [S43]. 
1.71 g (10.2 mmol) of 3-(4-methoxyphenyl)propan-3,3-d2-1-ol were used, 
along with imidazole (837.3 mg, 12.3 mmol, 1.2 equiv), ClSO2CH2CO2Et 
(2.90 g, 15.3 mmol, 1.5 equiv), and THF (51 mL, 0.2 M). Flash column 
chromatography on silica using 10% → 20% EtOAc/hexanes as eluent gave 2.75 g (8.64 mmol) 
of pure product as a clear oil (85% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.11 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 4.33 (t, J = 6.3 
Hz, 2H), 4.28 (q, J = 7.1 Hz, 2H), 4.07 (s, 2H), 3.79 (s, 3H), 2.04 (t, J = 6.3 Hz, 2H), 1.32 (t, J = 
7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 162.13, 158.24, 132.31, 129.51, 114.13, 71.58, 
62.89, 55.42, 55.00, 30.97, 14.12.; HRMS (ESI) m/z calculated for C14H19D2O6S [M+H]+: 
319.1184, found 319.1188. 
 
Ethyl 2-diazo-2-((3-(4-methoxyphenyl)propoxy-3,3-d2)sulfonyl)acetate [30-d2]. 
 1.30 g (4.0 mmol) of ethyl 2-((3-(4-methoxyphenyl)propoxy-3,3-
d2)sulfonyl)acetate [S43] were used, along with MeSO2N3 (1.06 mg, 8.80 
mmol, 2.2 equiv), DBU (895 µL, 6.0 mmol, 1.5 equiv), and THF (10 mL, 
0.4 M). Flash column chromatography on silica using 10% → 20% EtOAc/hexanes as eluent 
gave 1.21 g (3.51 mmol) of pure product as a yellow oil (88% yield). 














4H), 3.79 (s, 3H), 2.03 (t, J = 6.5 Hz, 2H), 1.33 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, 
CDCl3) δ 159.61, 158.26, 132.23, 129.50, 114.13, 72.65, 62.86, 55.42, 30.70, 14.43.; IR (ATR, 
cm-1) 3424.56, 2984.44, 2959.73, 2937.88, 2837.83, 2543.3, 2132.08, 1887.91, 1717.93, 1611.77, 
1581.55, 1513.07, 1465.1, 1444.66, 1372.35, 1286.84, 1244.11, 1224.78, 1176.61, 1089.82, 
1032.45, 1008.39, 993.33, 960.88, 919.92, 826.41, 807.79, 786.49, 738.48, 699.17, 684.54, 
612.94, 564.24, 552.45, 509.78, 468.23.; HRMS (ESI) m/z calculated for C14H17D2O6N2S 
[M+H]+: 345.1089, found 345.1084. 
[FePc]Cl: kH = 0.86 % yield/min;  kD = 0.29 % yield/min; kH/kD = 3.0 ± 0.2  
[FeCl16Pc]Cl: kH = 0.036 % yield/min;  kD = 0.025 % yield/min; kH/kD = 1.4 ± 0.1 
 Supplementary Figure 10:    Supplementary Figure 11: 
 
Supplementary Figure 12:    Supplementary Figure 13:
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[FePc] Run 2 
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[FePc]-D Run 1 
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Supplementary Figure 14:    Supplementary Figure 15: 
 
Supplementary Figure 16:    Supplementary Figure 17: 
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[FePc]-D Run 2 
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[FePc]-D Run 3 
y = 0.041x - 0.75 















[FeCl16Pc] Run 1 
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[FeCl16Pc] Run 2 
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[FeCl16Pc]-D Run 1 
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Supplementary Figure 20:    Supplementary Figure 21: 
 
 
Olefin Isomerization Study: 
 
Ethyl (Z)-2-((hex-4-en-1-yloxy)sulfonyl)acetate [S44]. 
0.50 g (5.0 mmol) of (Z)-hex-4-en-1-ol were used, along with imidazole (409 mg, 
6.0 mmol, 1.2 equiv), ClSO2CH2CO2Et (1.40 g, 7.5 mmol, 1.5 equiv), and THF 
(25 mL, 0.2 M). Flash column chromatography on silica using 10% 
EtOAc/hexanes as eluent gave 1.04 g (4.20 mmol) of pure product as a pale yellow oil (84% 
yield). 
1H-NMR (500 MHz, CDCl3) δ 5.57-5.49 (m, 1H), 5.35 (dtq, J = 11.0, 7.4, 1.8 Hz, 1H), 4.34 (t, J 
= 6.5 Hz, 2H), 4.28 (q, J = 7.1 Hz, 2H), 4.08 (s, 2H), 2.18 (q, J = 7.3 Hz, 2H), 1.89-1.79 (p, J = 
7.4 Hz, 2H), 1.62 (d, J = 6.9 Hz, 3H), 1.33 (t, J = 7.2 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 
162.03, 128.17, 125.67, 71.80, 62.64, 54.75, 28.94, 22.56, 13.93, 12.74.; HRMS (ESI) m/z 
calculated for C10H18O5SNa [M+Na]+: 273.0773, found 273.0771. 
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[FeCl16Pc]-D Run 2 
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Ethyl (Z)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate [S45]. 
1.04 g (4.20 mmol) of ethyl (Z)-2-((hex-4-en-1-yloxy)sulfonyl)acetate [S44] were 
used, along with MeSO2N3 (1.12 g, 9.20 mmol, 2.2 equiv), DBU (942  µL, 6.30 
mmol, 1.5 equiv), and THF (11 mL, 0.4 M). Flash column chromatography on 
silica using 5% EtOAc/hexanes as eluent gave 957 mg (3.46 mmol) of pure product as a yellow 
oil (83% yield). 
1H-NMR (500 MHz, CDCl3) δ 5.58-5.49 (m, 1H), 5.34 (dtq, J = 9.0, 7.3, 3.6, Hz, 1H), 4.36 (t, J 
= 6.6 Hz, 2H), 4.34 (q, J = 7.1 Hz, 2H), 2.17 (q, J = 7.4 Hz, 2H), 1.82 (p, J = 6.6 Hz, 2H), 1.61 
(dd, J = 6.9, 0.9 Hz, 3H), 1.33 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 159.57, 
128.16, 125.88, 73.05, 62.78, 28.82, 22.70, 14.37, 12.86.; HRMS (ESI) m/z calculated for 
C10H16O5N2SNa [M+Na]+: 299.0678, found 299.0675; IR (ATR, cm-1) 2970, 2941, 2130, 1721, 
1465, 1446, 1372, 1285, 1224, 1177, 1083, 1006, 991, 928, 836, 740, 704, 614. 
 
Ethyl (Z)-4-(prop-1-en-1-yl)-1,2-oxathiane-3-carboxylate 2,2-dioxide [(Z)-7]. 
Syn diastereomer (major): 1H-NMR (500 MHz, CDCl3) δ 5.69-5.63 (m, 1H), 5.25 
(t, J = 9.9 Hz, 1H), 4.71-4.64 (m, 1H), 4.63-4.57 (m, 1H), 4.34-4.20 (m, 2H), 4.00 
(d, J = 4.8 Hz, 1H), 3.57 (ddt, J = 13.4, 9.2, 4.5 Hz, 1H), 2.66-2.53 (m, 1H), 1.71 
(d, J = 7.1 Hz, 3H), 1.63-1.54 (m, 1H), 1.31 (t, J = 7.2 Hz, 3H).; 13C-NMR (126 MHz, CDCl3) δ 
164.16, 128.94, 126.84, 73.15, 64.11, 62.50, 35.43, 25.87, 14.09, 13.32.; HRMS (ESI) m/z 
calculated for C10H17O5S [M+H]+: 249.0797, found 249.0797. 
Anti diastereomer (minor): 1H-NMR (500 MHz, CDCl3) δ 5.64 (dq, J = 10.7, 6.9 
Hz, 1H), 5.14-5.06 (m, 1H), 4.70 (td, J = 11.7, 3.5 Hz, 1H), 4.49 (ddd, J = 11.6, 4.3, 

















1H), 1.91-1.77 (m, 2H), 1.71 (dd, J = 6.9, 1.8 Hz, 3H), 1.29 (t, J = 7.1 Hz, 3H).; 13C-NMR (126 
MHz, CDCl3) δ 163.42, 129.18, 127.25, 72.59, 68.00, 62.76, 36.74, 30.30, 14.10, 13.42.; HRMS 
(ESI) m/z calculated for C10H17O5S [M+H]+: 249.0797, found 249.0797. 
 
[FePc] Conditions: The general procedure for [FePc]-catalyzed C—H alkylation was followed. 
Ethyl (Z)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate [S45] (110.5 mg, 0.400 mmol, 1.0 
equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 0.10 
equiv), and CH2Cl2 (8.0 mL, 0.05 M) were used. The reaction went to complete conversion. By 
GC analysis of the crude product, Z/E was 3.5:1 (this ratio was confirmed by subjecting column-
purified Z/E mixtures of products to GC analysis). Product was purified via flash column 
chromatography on silica (75 mL SiO2) using 15% EtOAc/hexanes. Pure product was isolated as 
a white solid and as a mixture of diastereomers. By GC analysis of column-purified product 
mixtures, Z/E was 3:1. 
 
[FeCl8Pc] Conditions: The general procedure for [FePc]-catalyzed C—H alkylation was 
followed. Ethyl (Z)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate [S45] (110.5 mg, 0.400 mmol, 
1.0 equiv), [FeCl8Pc]Cl (35.2 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 
0.10 equiv), and CH2Cl2 (8 mL, 0.05 M) were used. After 16 h, the reaction did not go to 
complete conversion; crude reaction samples containing unreacted diazosulfonate ester 
decomposed by GC analysis, producing unreliable data. Thus, the reaction was purified via flash 
column chromatography on silica (75 mL SiO2) using 10à15% EtOAc/hexanes to remove 
unreacted starting material. Pure product was isolated as a white solid and as a mixture of 
diastereomers. By GC analysis of column-purified product mixtures, Z/E was 7:1. 
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[FeCl16Pc] Conditions: The general procedure for [FePc]-catalyzed C—H alkylation was 
followed. Ethyl (Z)-2-diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate [S45] (110.5 mg, 0.400 mmol, 
1.0 equiv), [FeCl16Pc]Cl (46.8 mg, 0.040 mmol, 0.10 equiv), NaBArF4 (35.4 mg, 0.040 mmol, 
0.10 equiv), and CH2Cl2 (8 mL, 0.05 M) were used. After 16 h, the reaction did not go to 
complete conversion; crude reaction samples containing unreacted diazosulfonate ester 
decomposed by GC analysis, producing unreliable data. Thus, the reaction was purified via flash 
column chromatography on silica (75 mL SiO2) using 10à15% EtOAc/hexanes to remove 
unreacted starting material. Pure product was isolated as a white solid and as a mixture of 
diastereomers. By GC analysis of column-purified product mixtures, Z/E was 10:1. 
 
Rh2(OAc)4 Conditions:  
The general procedure for Rh2(OAc)4 catalyzed C—H alkylation was followed. Ethyl (Z)-2-
diazo-2-((hex-4-en-1-yloxy)sulfonyl)acetate [S45] (110.5 mg, 0.400 mmol, 1.0 equiv), 
Rh2(OAc)4 (3.54 mg, 0.008 mmol, 0.02 equiv), and CH2Cl2 (8 mL, 0.05 M) were used. By GC 
analysis of the crude product, Z/E was >20:1 (this ratio was confirmed by subjecting column-
purified Z/E mixtures of products to GC analysis). Product was purified via flash column 
chromatography on silica (75 mL SiO2) using 15% EtOAc/hexanes. Pure product was isolated as 






Thermal Decomposition of Diazo Esters: 
 
The following procedure was adapted from a literature report67 of an iron catalyzed C—H 
insertion reaction, wherein a 66% yield of C—H alkylation of cyclohexane was reported with the 
use of 2 mol% Fe(TPP)Cl at 80˚C. We conducted the reaction in the same fashion, but without 
the addition of catalyst.  
Procedure for metal-free C—H functionalization of cyclohexane: 
Methyl 2-phenyldiazoacetate83 (70.5 mg, 0.40 mmol) was added into a new, flame-dried flask 
equipped with a reflux condenser. Distilled and thoroughly degassed cyclohexane (11.7 mL) was 
then added and N2 was bubbled through the solution for 10 minutes. The mixture stirred at 80˚C 
for 24 hours. The mixture was then cooled, concentrated, and purified via flash chromatography 
on silica using 10% EtOAc/hexanes. Due to co-elution with the diazoester starting material, the 
yield was determined via NMR with mesitylene as an internal standard. 1H NMR spectrum 
matched literature values84. We also repeated this experiment with glassware that had been 
washed with EDTA (to remove trace metals) and observed the same results.  
Run 1: (43.7 mg, 0.188 mmol, 47% yield). Run 2: (29.7 mg, 0.128 mmol, 32% yield). Run 3: 
(40.9 mg, 0.176 mmol, 44% yield). Average: 41% yield [S46] ± 6.5. 
These results are consistent with other reports in the literature where a nearly identical 
yield was achieved without catalyst (Supplementary Figure 22). According to Woo, the 
following transformation occurred in 78% yield under iron catalysis67. According to Davies, the 
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